KR20160117492A - Triazine compound and method for producing same - Google Patents

Triazine compound and method for producing same Download PDF

Info

Publication number
KR20160117492A
KR20160117492A KR1020167022802A KR20167022802A KR20160117492A KR 20160117492 A KR20160117492 A KR 20160117492A KR 1020167022802 A KR1020167022802 A KR 1020167022802A KR 20167022802 A KR20167022802 A KR 20167022802A KR 20160117492 A KR20160117492 A KR 20160117492A
Authority
KR
South Korea
Prior art keywords
group
carbon atoms
atom
compound
triazine
Prior art date
Application number
KR1020167022802A
Other languages
Korean (ko)
Other versions
KR102365498B1 (en
Inventor
노부미치 아라이
유지 오카
케이스케 노무라
츠요시 타나카
료헤이 타카하시
Original Assignee
토소가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 토소가부시키가이샤 filed Critical 토소가부시키가이샤
Publication of KR20160117492A publication Critical patent/KR20160117492A/en
Application granted granted Critical
Publication of KR102365498B1 publication Critical patent/KR102365498B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • H01L51/0052
    • H01L51/0067
    • H01L51/5072
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/16Electron transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom

Abstract

내열성이 우수하고, 유기 전계발광소자의 장수명화 또는 발광 효율이 우수한 전자수송 재료를 제공하는 것. 하기 일반식 (1)로 표시되는 트라이아진 화합물, 및 이것을 구성 성분으로 하는 유기 전계발광소자를 제공한다.

Figure pct00094

(일반식 (1) 중, 2개의 Ar4는 동일하고, 수소 원자 등을 나타낸다. Ar1 및 Ar2는, 각각 독립적으로, 탄소수 6 내지 18의 단환, 연결 또는 축환 방향족 탄화수소기 등을 나타낸다. Ar3은, 탄소수 6 내지 18의 단환, 연결 또는 축환 방향족 탄화수소기 등을 나타낸다. Z1 및 Z2 중 어느 한쪽이 질소 원자를 나타내고, 또 한쪽은 C-H를 나타낸다.)An object of the present invention is to provide an electron transporting material which is excellent in heat resistance and has a long life or an excellent luminous efficiency of an organic electroluminescent device. A triazine compound represented by the following general formula (1), and an organic electroluminescent device comprising the same.
Figure pct00094

(In the general formula (1), two Ar 4 s are the same and represent a hydrogen atom, etc. Ar 1 and Ar 2 each independently represent a monocyclic, a linking or a cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms. Ar 3 represents a monocyclic, a linking or a cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms, either of Z 1 and Z 2 represents a nitrogen atom, and the other represents CH.

Description

트라이아진 화합물 및 그의 제조 방법{TRIAZINE COMPOUND AND METHOD FOR PRODUCING SAME}[0001] TRIAZINE COMPOUND AND METHOD FOR PRODUCING SAME [0002]

본 발명은, 트라이아진 화합물과 그의 제조 방법, 및 그것을 함유하는 유기 전계발광소자에 관한 것이다. 더욱 상세하게는, 트라이아진 골격에 다이아릴피리딜기를 조합시킨 구조를 특징으로 하는, 유기 전계발광소자용 재료로서 유용한 트라이아진 화합물과 그의 제조 방법에 관한 것으로, 해당 트라이아진 화합물을 유기 화합물층의 적어도 1층에 이용하는 것을 특징으로 하는 고효율, 저전압 및 고내구성의 유기 전계발광소자에 관한 것이다.TECHNICAL FIELD The present invention relates to a triazine compound, a production method thereof, and an organic electroluminescent device containing the same. More particularly, the present invention relates to a triazine compound useful as a material for an organic electroluminescence device, which is characterized by a structure in which a triaryl skeleton is combined with a diarylpyridyl group, and a process for producing the triazine compound. And an organic electroluminescent device having a high efficiency, a low voltage and a high durability.

유기 전계발광소자는, 발광 재료를 함유하는 발광층을, 정공수송층과 전자수송층 사이에 두고, 또한 그 외측에 양극과 음극을 설치한 것을 기본 구성으로 하고, 발광층에 주입된 정공 및 전자의 재결합에 의해 생기는 여기자가 실활할 때의 광의 방출(형광 또는 인광)을 이용하는 발광 소자이며, 이미 소형의 디스플레이뿐만 아니라 대형 텔레비전이나 조명 등의 용도에 이용되고 있다. 또, 상기 정공수송층은 정공수송층과 정공주입층에, 상기 발광층은, 전자 블록층과 발광층과 정공 블록층에, 상기 전자수송층은 전자수송층과 전자주입층으로 분할되어 구성될 경우도 있다. 또한, 유기 전계발광소자의 캐리어 수송층(전자수송층 또는 정공수송층)으로서, 금속, 유기금속화합물 또는 기타 유기 화합물을 도핑시킨 공증착막을 이용할 경우도 있다.The organic electroluminescent device has a basic constitution in which a light emitting layer containing a light emitting material is disposed between a hole transporting layer and an electron transporting layer and an anode and a cathode are provided on the outer side thereof. By the recombination of holes and electrons injected into the light emitting layer (Fluorescence or phosphorescence) when excitons generated by excitons are inactivated, and they are used in applications such as large-sized televisions and lighting as well as small-sized displays. The hole transporting layer may be divided into a hole transporting layer and a hole injecting layer, the light emitting layer may be divided into an electron blocking layer, a light emitting layer and a hole blocking layer, and the electron transporting layer may be divided into an electron transporting layer and an electron injecting layer. As the carrier transporting layer (electron transporting layer or hole transporting layer) of the organic electroluminescent device, a co-evaporated film doped with a metal, an organic metal compound or other organic compound may be used.

종래의 유기 전계발광소자는, 무기 발광 다이오드에 비해서 구동 전압이 높고, 발광 휘도나 발광 효율도 낮으며, 소자 수명도 현저하게 낮아, 실용화에는 이르지 않고 있었다. 최근의 유기 전계발광소자는 서서히 개량되고 있지만, 발광 효율 특성, 구동 전압 특성, 장수명 특성에 있어서, 더욱 우수한 재료가 요구되고 있다. 또, 차재용도 등, 용도에 따라서는 높은 내열성을 필요로 할 경우도 있어, 재료는 높은 유리 전위 온도(Tg)가 요구되고 있다.The conventional organic electroluminescent device has a driving voltage higher than that of the inorganic light emitting diode, low emission luminance and low luminous efficiency, and remarkably low device lifetime. Although recent organic electroluminescent devices have been gradually improved, a more excellent material is demanded in terms of light emitting efficiency, driving voltage characteristics, and longevity. In addition, high heat resistance may be required depending on the application, such as in-vehicle use, and a high glass transition temperature (Tg) of the material is required.

유기 전계발광소자용의 장수명성이 우수한 전자수송 재료로서, 특허문헌 1 또는 2에 개시된 트라이아진 화합물을 들 수 있다. 그러나, 재료의 Tg, 및 해당 재료를 이용한 유기 전계발광소자의 전압, 수명 및 발광 효율의 점에서 더 한층의 개량이 요구되고 있었다.As the electron transporting material excellent in long life reputation for the organic electroluminescent device, the triazine compound disclosed in Patent Document 1 or 2 can be exemplified. However, further improvement has been required in view of the Tg of the material and the voltage, lifetime, and luminous efficiency of the organic electroluminescent device using the material.

JPJP 2011-0635842011-063584 AA JPJP 2008-2803302008-280330 AA

본 발명의 목적은, 내열성이 우수하고, 유기 전계발광소자의 장수명성, 저전압구동성 또는 발광 효율이 우수한 전자수송 재료를 제공하는 것이다.An object of the present invention is to provide an electron transporting material excellent in heat resistance and excellent in longevity, low voltage driving property, or light emitting efficiency of an organic electroluminescent device.

본 발명자들은, 앞서의 과제를 해결하기 위하여 예의 검토를 거듭한 결과, 다이아릴피리딜기가 결합한 트라이아진 화합물(이하, 「트라이아진 화합물(1)」이라고도 칭함)의 내열성이 높고, 해당 화합물을 전자수송 재료로서 이용한 유기 전계발광소자가, 종래 공지의 재료를 이용한 경우에 비해서 저전압화, 장수명화 또는 고발광 효율화하는 것을 찾아내고, 본원 발명을 완성시키기에 이르렀다.DISCLOSURE OF THE INVENTION The present inventors have intensively studied to solve the above problems, and as a result, they have found that a triazine compound having a diarylpyridyl group bonded thereto (hereinafter, also referred to as "triazine compound (1) The present inventors have found that the organic electroluminescent device used as a transport material has a lower voltage, a longer life, or a higher luminous efficiency compared to the case of using a conventionally known material, thereby completing the present invention.

즉, 본 발명은, 이하의 [1] 내지 [21]에 존재한다.That is, the present invention exists in the following [1] to [21].

[1] 후술하는 일반식 (1)로 표시되는 트라이아진 화합물.[1] A triazine compound represented by the following general formula (1).

[2] 후술하는 일반식 (1)' 또는 (1)"로 표시되는, [1]에 기재된 트라이아진 화합물.[2] The triazine compound according to [1], which is represented by the following general formula (1) 'or (1)'.

[3] Ar4가 페닐기, 메틸기 또는 수소 원자인 [1] 또는 [2]에 기재된 트라이아진 화합물.[3] The triazine compound according to [1] or [2], wherein Ar 4 is a phenyl group, a methyl group or a hydrogen atom.

[4] Ar4가 수소 원자인 [1] 내지 [3] 중 어느 하나에 기재된 트라이아진 화합물.[4] The triazine compound according to any one of [1] to [3], wherein Ar 4 is a hydrogen atom.

[5] Ar1 및 Ar2가, 각각 독립적으로, 탄소수 6 내지 18의 단환, 연결 또는 축환방향족 탄화수소기(해당 기는, 불소 원자, 탄소수 1 내지 4의 알킬기, 탄소수 1 내지 4의 알콕시기, 페닐기 또는 피리딜기로 치환되어 있어도 됨)인 [1] 내지 [4] 중 어느 하나에 기재된 트라이아진 화합물.[5] The compound according to [1], wherein each of Ar 1 and Ar 2 is independently a monocyclic, a linking or a cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms (the group is selected from the group consisting of a fluorine atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, Or a pyridyl group.) The triazine compound according to any one of [1] to [4].

[6] Ar1 및 Ar2가, 각각 독립적으로, 페닐기, 나프틸기 또는 페난트릴기(이들 기는, 불소 원자, 메틸기, 페닐기 또는 피리딜기로 치환되어 있어도 됨)인 [1] 내지 [5] 중 어느 하나에 기재된 트라이아진 화합물.[6] The compound according to any one of [1] to [5], wherein Ar 1 and Ar 2 are each independently a phenyl group, a naphthyl group or a phenanthryl group (these groups may be substituted with a fluorine atom, a methyl group, a phenyl group or a pyridyl group) A triazine compound according to any one of claims 1 to 3.

[7] Ar1 및 Ar2가, 각각 독립적으로, 페닐기, 바이페닐기, 나프틸기 또는 페난트릴기인 [1] 내지 [6] 중 어느 하나에 기재된 트라이아진 화합물.[7] The triazine compound according to any one of [1] to [6], wherein Ar 1 and Ar 2 are each independently a phenyl group, a biphenyl group, a naphthyl group or a phenanthryl group.

[8] Ar1 및 Ar2가 페닐기인 [1] 내지 [7] 중 어느 하나에 기재된 트라이아진 화합물.[8] The triazine compound according to any one of [1] to [7], wherein Ar 1 and Ar 2 are phenyl groups.

[9] Ar3이, 탄소수 6 내지 18의 단환, 연결 혹은 축환방향족 탄화수소기(해당 기는, 페닐기 또는 피리딜기로 치환되어 있어도 됨) 또는 6원환만으로 구성되는 탄소수 3 내지 13의 단환 혹은 축환 질소 함유 방향족 탄화수소기(해당 기는, 페닐기, 바이페닐기 또는 나프틸기로 치환되어 있어도 됨)인 [1] 내지 [8] 중 어느 하나에 기재된 트라이아진 화합물.[9] A compound according to any one of [1] to [7], wherein Ar 3 is a monocyclic or a condensed nitrogen-containing compound having 3 to 13 carbon atoms consisting of a monocyclic, a linking or a cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms (the group may be substituted with a phenyl group or a pyridyl group) The triazine compound according to any one of [1] to [8], which is an aromatic hydrocarbon group (the group may be substituted with a phenyl group, a biphenyl group or a naphthyl group).

[10] Ar3이, 페닐기, 나프틸기 또는 바이페닐기(이들 기는, 페닐기 또는 피리딜기로 치환되어 있어도 됨) 또는 탄소수 3 내지 9의 단환 또는 축환 질소 함유 방향족 탄화수소기(해당 기는, 페닐기, 바이페닐기 또는 나프틸기로 치환되어 있어도 됨)인 [1] 내지 [9] 중 어느 하나에 기재된 트라이아진 화합물.[10] A compound according to any one of [1] to [10], wherein Ar 3 is a phenyl group, a naphthyl group or a biphenyl group (these groups may be substituted with a phenyl group or a pyridyl group) or a monocyclic or a cyclic nitrogen- Or a naphthyl group), which is a triazine compound according to any one of [1] to [9].

[11] Ar3이, 페닐기, 바이페닐기, 터페닐기, 나프틸기, 피리딜페닐기, 피리딜기, 피라질기, 피리미딜기, 퀴놀릴기, 아이소퀴놀릴기, 페닐피리딜기, 바이페닐피리딜기, 페닐피라질기, 바이페닐피라질기, 페닐피리미딜기, 바이페닐피리미딜기, 페닐퀴놀릴기, 바이페닐퀴놀릴기 또는 페닐이소퀴놀릴기인 [1] 내지 [10] 중 어느 하나에 기재된 트라이아진 화합물.[11] A compound according to any one of [1] to [11], wherein Ar 3 is a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a pyridylphenyl group, a pyridyl group, a pyrazyl group, a pyrimidyl group, a quinolyl group, an isoquinolyl group, The triazine compound according to any one of [1] to [10], which is a compound represented by any one of [1] to [10], which is a phenylpyridyl group, a phenylpyridyl group, a biphenylpyrazyl group, a phenylpyrimidyl group, a biphenylpyrimidyl group, a phenylquinolyl group, a biphenylquinolyl group or a phenylisoquinolyl group compound.

[12] Ar3이, 페닐기, 바이페닐기, 나프틸기, 피리딜기, 페닐피리딜기, 피라질기, 피리미딜기, 퀴놀릴기 또는 아이소퀴놀릴기인 [1] 내지 [11] 중 어느 하나에 기재된 트라이아진 화합물.[12] The compound according to any one of [1] to [11], wherein Ar 3 is a phenyl group, a biphenyl group, a naphthyl group, a pyridyl group, a phenylpyridyl group, a pyrazyl group, a pyrimidyl group, a quinolyl group or an isoquinolyl group Azine compound.

[13] 후술하는 일반식 (2)로 표시되는 화합물과, 후술하는 일반식 (3) 및 후술하는 일반식 (4)로 표시되는 화합물을, 염기의 존재 하 또는 염기의 비존재 하에, 팔라듐 촉매의 존재 하에서, 순차 또는 동시에 커플링 반응시키는 것을 특징으로 하는, [1] 내지 [12] 중 어느 하나에 기재된 트라이아진 화합물의 제조 방법.[13] A process for producing a compound represented by the general formula (2) described below, a compound represented by the general formula (3) and a compound represented by the general formula (4) described below in the presence of a base or in the absence of a base, The method for producing a triazine compound according to any one of [1] to [12], wherein the triazine compound is subjected to a coupling reaction either sequentially or simultaneously in the presence of a base.

[14] 후술하는 일반식 (5)로 표시되는 화합물과, 후술하는 일반식 (6)로 표시되는 화합물을, 염기의 존재 하 또는 염기의 비존재 하에, 팔라듐 촉매의 존재 하에서, 커플링 반응시키는 것을 특징으로 하는, [1] 내지 [12] 중 어느 하나에 기재된 트라이아진 화합물의 제조 방법.[14] The compound represented by the general formula (5) described later and the compound represented by the general formula (6) described below are subjected to a coupling reaction in the presence of a base or in the absence of a base in the presence of a palladium catalyst A method for producing a triazine compound according to any one of [1] to [12], which comprises the steps of:

[15] 후술하는 일반식 (7)로 표시되는 화합물과, 후술하는 일반식 (8)로 표시되는 화합물을, 염기의 존재 하 또는 염기의 비존재 하에, 팔라듐 촉매의 존재 하에서, 커플링 반응시키는 것을 특징으로 하는, [1] 내지 [12] 중 어느 하나에 기재된 트라이아진 화합물의 제조 방법.[15] The compound represented by the general formula (7) described below and the compound represented by the general formula (8) described below are subjected to a coupling reaction in the presence of a base or in the absence of a base in the presence of a palladium catalyst A method for producing a triazine compound according to any one of [1] to [12], which comprises the steps of:

[16] 팔라듐 촉매가, 제3급 포스핀을 배위자로서 지니는 팔라듐 촉매인 [13], [14] 또는 [15]에 기재된 제조 방법.[16] The production method described in [13], [14] or [15], wherein the palladium catalyst is a palladium catalyst having a tertiary phosphine as a ligand.

[17] 팔라듐 촉매가, 트라이페닐포스핀 또는 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐을 배위자로서 지니는 팔라듐 촉매인 것을 특징으로 하는 [13], [14], [15] 또는 [16]에 기재된 제조 방법.[17] The process according to [13], wherein the palladium catalyst is palladium catalyst having triphenylphosphine or 2-dicyclohexylphosphino-2 ', 4', 6'-triisopropylbiphenyl as a ligand. 14], [15] or [16].

[18] 후술하는 일반식 (9)로 표시되는 화합물.[18] A compound represented by the following general formula (9).

[19] 후술하는 일반식 (5)로 표시되는, [14]에 기재된 화합물.[19] The compound according to [14], which is represented by the following general formula (5).

[20] [1] 내지 [12] 중 어느 하나에 기재된 트라이아진 화합물을 함유하는 것을 특징으로 하는, 유기 전계발광소자.[20] An organic electroluminescent device characterized by containing a triazine compound according to any one of [1] to [12].

[21] 트라이아진 화합물을 전자수송층에 함유하는 것을 특징으로 하는, [20]에 기재된 유기 전계발광소자.[21] The organic electroluminescent device according to [20], wherein the electron transport layer contains a triazine compound.

본 발명에 따르면, 내열성이 우수한 트라이아진 화합물을 제공할 수 있고, 저전압, 장수명 또는 발광 효율이 우수한 유기 전계발광소자를 제공할 수 있다.According to the present invention, it is possible to provide an organic electroluminescent device which can provide a triazine compound having excellent heat resistance and is excellent in low voltage, long life or luminous efficiency.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명의 트라이아진 화합물은, 하기 일반식 (1)로 표시된다(이하, 트라이아진 화합물(1)이라고도 칭한다):The triazine compound of the present invention is represented by the following general formula (1) (hereinafter also referred to as triazine compound (1)):

Figure pct00001
Figure pct00001

(일반식 (1) 중,(In the general formula (1)

2개의 Ar4는, 동일하고, 수소 원자, 불소 원자, 메틸기, 메톡시기 또는 페닐기를 나타낸다.The two Ar 4 are the same and represent a hydrogen atom, a fluorine atom, a methyl group, a methoxy group or a phenyl group.

Ar1 및 Ar2는, 각각 독립적으로, 탄소수 6 내지 18의 단환, 연결 혹은 축환방향족 탄화수소기 또는 6원환만으로 구성되는 탄소수 3 내지 13의 단환 혹은 축환 질소 함유 방향족 탄화수소기(이들 기는, 각각 독립적으로, 불소 원자, 탄소수 1 내지 4의 알킬기, 탄소수 1 내지 4의 알콕시기, 페닐기 또는 피리딜기로 치환되어 있어도 됨)를 나타낸다.Ar 1 and Ar 2 each independently represent a monocyclic or a cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms which is composed of a monocyclic, a linking or a cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms or a 6-membered ring, , A fluorine atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a phenyl group, or a pyridyl group).

Ar3은, 탄소수 6 내지 18의 단환, 연결 혹은 축환방향족 탄화수소기(해당 기는, 불소 원자, 탄소수 1 내지 4의 알킬기, 탄소수 1 내지 4의 알콕시기, 페닐기 또는 피리딜기로 치환되어 있어도 됨) 또는 6원환만으로 구성되는 탄소수 3 내지 13의 단환 혹은 축환 질소 함유 방향족 탄화수소기(해당 기는, 불소 원자, 탄소수 1 내지 4의 알킬기, 탄소수 1 내지 4의 알콕시기, 피리딜기, 페닐기, 나프틸기 또는 바이페닐기로 치환되어 있어도 됨)를 나타낸다.Ar 3 represents a monocyclic, fused or cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms (the group may be substituted by a fluorine atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a phenyl group, or a pyridyl group) A monocyclic or a cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms (the group is selected from the group consisting of a fluorine atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a pyridyl group, a phenyl group, a naphthyl group, Or may be substituted with a halogen atom).

Z1 및 Z2 중 어느 한쪽이 질소 원자를 나타내고, 또 한쪽은 C-H를 나타낸다.)Provided that one of Z 1 and Z 2 represents a nitrogen atom and the other represents CH.

또한, 본 발명은, 상기 트라이아진 화합물(1), 그의 제조 방법, 그것을 함유하는 유기 전계발광소자 및 일반식 (1)로 표시되는 트라이아진 화합물을 제조하기 위해서 유용한 제조 중간체(후술하는 일반식 (5) 또는 (9)로 표시되는 화합물)에 관한 것이다.The present invention also relates to a triazine compound (1), a production method thereof, an organic electroluminescent device containing it, and a production intermediate useful for producing a triazine compound represented by the general formula (1) 5) or (9)).

본 발명의 트라이아진 화합물(1)에 있어서의 치환기는 각각 이하와 같이 정의된다.The substituents in the triazine compound (1) of the present invention are each defined as follows.

일반식 (1) 중, 2개의 Ar4는 동일한 치환기를 나타낸다.In the general formula (1), two Ar 4 represent the same substituent.

Ar4는, 수소 원자, 불소 원자, 메틸기, 메톡시기 또는 페닐기를 나타낸다. 이 중, 전자수송성 재료 특성이 우수한 점에서, 수소 원자, 메틸기 또는 페닐기가 바람직하고, 합성이 용이한 점에서 수소 원자가 더욱 바람직하다.Ar 4 represents a hydrogen atom, a fluorine atom, a methyl group, a methoxy group or a phenyl group. Of these, a hydrogen atom, a methyl group or a phenyl group is preferable from the viewpoint of excellent electron transporting material characteristics, and a hydrogen atom is more preferable because of easy synthesis.

Ar1 및 Ar2는, 각각 독립적으로, 탄소수 6 내지 18의 단환, 연결 혹은 축환방향족 탄화수소기 또는 6원환만으로 구성되는 탄소수 3 내지 13의 단환 혹은 축환 질소 함유 방향족 탄화수소기(이들 기는, 불소 원자, 탄소수 1 내지 4의 알킬기, 탄소수 1 내지 4의 알콕시기, 페닐기 또는 피리딜기로 치환되어 있어도 됨)를 나타낸다.Ar 1 and Ar 2 each independently represent a monocyclic or a cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms which is composed of a monocyclic, a linking or a cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms or a 6-membered ring (these groups are fluorine, An alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a phenyl group, or a pyridyl group).

Ar1 및 Ar2는 동일해도 상이해도 된다.Ar 1 and Ar 2 may be the same or different.

Ar1 및 Ar2에 있어서의, 탄소수 6 내지 18의 단환, 연결 또는 축환방향족 탄화수소기로서는, 특별히 한정하는 것이 아니지만, 페닐기, 바이페닐기, 나프틸기, 페난트릴기, 안트릴기, 피레닐기, 트라이페닐레닐기, 크리세닐기, 플루오란테닐기, 아세나프틸레닐기, 플루오레닐기 또는 벤조플루오레닐기 등을 바람직한 예로서 들 수 있다.The monocyclic, bicyclic or tricyclic aromatic hydrocarbon group having 6 to 18 carbon atoms in Ar 1 and Ar 2 is not particularly limited and examples thereof include a phenyl group, a biphenyl group, a naphthyl group, a phenanthryl group, an anthryl group, a pyrenyl group, A phenanthrenyl group, a phenrenyl group, a chrysenyl group, a fluoranthenyl group, an acenaphthylenyl group, a fluorenyl group or a benzofluorenyl group.

Ar1 및 Ar2에 있어서의, 6원환만으로 구성되는 탄소수 3 내지 13의 단환 또는 축환 질소 함유 방향족 탄화수소기로서는, 특별히 한정하는 것이 아니지만, 피리딜기, 피라질기, 피리미딜기, 피리다질기, 트라이아질기, 퀴놀릴기, 아이소퀴놀릴기, 페난트리딜기, 벤조퀴놀릴기 또는 아크리딜기 등을 바람직한 예로서 들 수 있다.The monocyclic or cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms and composed of only a 6-membered ring in Ar 1 and Ar 2 is not particularly limited, but may be a pyridyl group, a pyrazyl group, a pyrimidyl group, a pyridazyl group, a tri Preferred examples thereof include an alkoxy group, an alkoxy group, an alkoxy group, an alkoxy group, an alkoxy group, an alkoxy group, an alkoxy group, an alkoxy group,

Ar1 및 Ar2에 있어서의, 탄소수 1 내지 4의 알킬기로서는, 특별히 한정하는 것이 아니지만, 메틸기, 에틸기, 프로필기, 아이소프로필기, n-뷰틸기 또는 t-뷰틸기 등을 바람직한 예로서 들 수 있다.The alkyl group having 1 to 4 carbon atoms in Ar 1 and Ar 2 is not particularly limited and preferable examples thereof include methyl group, ethyl group, propyl group, isopropyl group, n-butyl group and t-butyl group have.

Ar1 및 Ar2에 있어서의, 탄소수 1 내지 4의 알콕시기로서는, 특별히 한정하는 것이 아니지만, 메톡시기, 에톡시기, n-프로폭시기, 아이소프로폭시기, n-뷰톡시기 또는 t-뷰톡시기 등을 바람직한 예로서 들 수 있다.The alkoxy group having 1 to 4 carbon atoms in Ar 1 and Ar 2 is not particularly limited, but methoxy group, ethoxy group, n-propoxy group, isopropoxy group, n-butoxy group or t- And the like can be mentioned as preferable examples.

Ar1 및 Ar2에 있어서의, 불소 원자로 치환된 탄소수 6 내지 18의 단환, 연결 또는 축환방향족 탄화수소기로서는, 특별히 한정하는 것이 아니지만, 플루오로페닐기, 펜타플루오로페닐기, 다이플루오로바이페닐기, 플루오로나프틸기, 다이플루오로나프틸기, 플루오로페난트릴기, 다이플루오로페난트릴기, 플루오로안트릴기, 다이플루오로안트릴기, 플루오로피레닐기, 다이플루오로피레닐기, 플루오로트라이페닐레닐기, 다이플루오로트라이페닐레닐기, 플루오로크리세닐기, 다이플루오로크리세닐기, 플루오로플루오란테닐기, 다이플루오로플루오란테닐기, 플루오로아세나프틸레닐기 또는 다이플루오로아세나프틸기 등을 바람직한 예로서 들 수 있다.The monocyclic, bicyclic or cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms and substituted with a fluorine atom in Ar 1 and Ar 2 is not particularly limited, and examples thereof include a fluorophenyl group, a pentafluorophenyl group, a difluorobiphenyl group, A fluorophenanthryl group, a difluorophenanthryl group, a fluoroanthryl group, a difluoroanthryl group, a fluoropyranyl group, a difluoropyranyl group, a fluorotrienyl group, a fluoropyranyl group, A trifluoromethanesulfonyl group, a fluorenylsulfonyl group, a fluorenylsulfonyl group, a fluorenyl group, a fluorenyl group, a fluorenyl group, a fluorenyl group, a fluorenyl group, a trifluoromethanesulfonyl group, a phenylenelyl group, a difluorotriphenylenyl group, a fluorochrysinyl group, a difluorochrysenyl group, An acenaphthyl group and the like can be mentioned as preferable examples.

Ar1 및 Ar2에 있어서의, 탄소수 1 내지 4의 알킬기로 치환된 탄소수 6 내지 18의 단환, 연결 또는 축환방향족 탄화수소기로서는, 특별히 한정하는 것이 아니지만, 메틸페닐기, 메틸바이페닐기, 메틸나프틸기, 메틸페난트릴기, 메틸안트릴기, 메틸피레닐기, 메틸트라이페닐레닐기, 메틸크리세닐기, 메틸플루오란테닐기, 메틸아세나프틸레닐기, 다이메틸페닐기, 다이메틸바이페닐기, 다이메틸나프틸기, 다이메틸페난트릴기, 다이메틸안트릴기, 다이메틸피레닐기, 다이메틸트라이페닐레닐기, 다이메틸크리세닐기, 다이메틸플루오란테닐기, 다이메틸아세나프틸레닐기, 다이메틸플루오레닐기 또는 다이메틸벤조플루오레닐기 등을 바람직한 예로서 들 수 있다.The monocyclic, linking or cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms and substituted with an alkyl group having 1 to 4 carbon atoms in Ar 1 and Ar 2 is not particularly limited and examples thereof include a methylphenyl group, a methylbiphenyl group, a methylnaphthyl group, A methylpentanyl group, a methylphenanthryl group, a methyl anthryl group, a methylpyranyl group, a methyltriphenylenyl group, a methylcyclenyl group, a methylfluorenenyl group, a methylenacenaphthylenyl group, a dimethylphenyl group, a dimethylbiphenyl group, a dimethylnaphthyl group , A dimethylphenanthryl group, a dimethyl anthryl group, a dimethylpyranyl group, a dimethyltriphenylenyl group, a dimethylcyclenyl group, a dimethylfluorenanthienyl group, a dimethylacenaphthylenyl group, a dimethylfluorenyl group Or a dimethylbenzofluorenyl group and the like can be mentioned as preferable examples.

Ar1 및 Ar2에 있어서의, 탄소수 1 내지 4의 알콕시기로 치환된 탄소수 6 내지 18의 단환, 연결 또는 축환방향족 탄화수소기로서는, 특별히 한정하는 것이 아니지만, 메톡시페닐기, 메톡시바이페닐기, 메톡시나프틸기, 메톡시페난트릴기, 메톡시안트릴기, 메톡시피레닐기, 메톡시트라이페닐레닐기, 메톡시크리세닐기, 메톡시플루오란테닐기, 메톡시아세나프틸레닐기, 다이메톡시페닐기, 다이메톡시바이페닐기, 다이메톡시나프틸기, 다이메톡시페난트릴기, 다이메톡시안트릴기, 다이메톡시피레닐기, 다이메톡시트라이페닐레닐기, 다이메톡시크리세닐기, 다이메톡시플루오란테닐기, 다이메톡시아세나프틸레닐기, 다이메톡시플루오레닐기 또는 다이메톡시벤조플루오레닐기 등을 바람직한 예로서 들 수 있다.The monocyclic, bicyclic or tricyclic aromatic hydrocarbon group having 6 to 18 carbon atoms substituted with an alkoxy group having 1 to 4 carbon atoms in Ar 1 and Ar 2 is not particularly limited, but methoxyphenyl group, methoxybiphenyl group, methoxy A naphthyl group, a methoxyphenanthryl group, a methoxyanthryl group, a methoxypyrenyl group, a methoxy triphenylenyl group, a methoxycyclenyl group, a methoxyfluoranthienyl group, a methoxyacenaphthylenyl group, a dimethoxyphenyl group , A dimethoxybiphenyl group, a dimethoxynaphthyl group, a dimethoxyphenanthryl group, a dimethoxyanthryl group, a dimethoxypyranyl group, a dimethoxy triphenylrenyl group, a dimethoxycychenecyl group, a dimethoxy A dimethoxyacenaphthylenyl group, a dimethoxyfluorenyl group or a dimethoxybenzofluorenyl group, and the like can be mentioned as preferable examples.

Ar1 및 Ar2에 있어서의, 페닐기로 치환된 탄소수 6 내지 18의 단환, 연결 또는 축환방향족 탄화수소기로서는, 특별히 한정하는 것이 아니지만, 페닐나프틸기, 페닐페난트릴기, 안트릴기, 페닐피레닐기, 페닐트라이페닐레닐기, 페닐크리세닐기, 페닐플루오란테닐기, 페닐아세나프틸레닐기, 다이페닐페닐기, 다이페닐바이페닐기, 다이페닐나프틸기, 다이페닐페난트릴기, 안트릴기, 다이페닐피레닐기, 다이페닐트라이페닐레닐기, 다이페닐크리세닐기, 다이페닐플루오란테닐기, 다이페닐아세나프틸레닐기, 다이페닐플루오레닐기 또는 다이페닐벤조플루오레닐기 등을 바람직한 예로서 들 수 있다.The monocyclic, bicyclic or cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms substituted with a phenyl group in Ar 1 and Ar 2 is not particularly limited, but a phenylnaphthyl group, a phenylphenanthryl group, an anthryl group, a phenylpyranyl group , Phenyltriphenylenyl group, phenylcyclenyl group, phenylfluorenanthienyl group, phenylacenaphthylenyl group, diphenylphenyl group, diphenylbiphenyl group, diphenylnaphthyl group, diphenylphenanthryl group, anthryl group, diphenyl Preferred examples thereof include a pyrenyl group, a diphenyltriphenylenyl group, a diphenylcyclenyl group, a diphenylfluoranthanyl group, a diphenylacenaphthylenyl group, a diphenylfluorenyl group or a diphenylbenzofluorenyl group and the like .

Ar1 및 Ar2에 있어서의, 피리딜기로 치환된 탄소수 6 내지 18의 단환, 연결 또는 축환방향족 탄화수소기로서는, 특별히 한정하는 것이 아니지만, 피리딜페닐기, 피리딜바이페닐기, 피리딜나프틸기, 피리딜페난트릴기, 안트릴기, 피리딜피레닐기, 피리딜트라이페닐레닐기, 피리딜크리세닐기, 피리딜플루오란테닐기, 피리딜아세나프틸레닐기, 다이피리딜피리딜기, 다이피리딜비피리딜기, 다이피리딜나프틸기, 다이피리딜페난트릴기, 안트릴기, 다이피리딜피레닐기, 다이피리딜트라이페닐레닐기, 다이피리딜크리세닐기, 다이피리딜플루오란테닐기, 다이피리딜아세나프틸레닐기, 다이피리딜플루오레닐기 또는 다이피리딜벤조플루오레닐기 등을 바람직한 예로서 들 수 있다.The monocyclic, bicyclic or tricyclic aromatic hydrocarbon group having 6 to 18 carbon atoms substituted with a pyridyl group in Ar 1 and Ar 2 is not particularly limited, and examples thereof include a pyridylphenyl group, a pyridylbiphenyl group, a pyridylnaphthyl group, A pyridylphenyl group, a pyridylphenanthryl group, an anthryl group, an pyridylpyranyl group, a pyridyl triphenylenyl group, a pyridylcyclenyl group, a pyridyl fluoranthienyl group, a pyridylacenaphthylenyl group, A thiadiazolyl group, a thiadiazolyl group, a pyridyl group, a pyridyl group, a pyridyl group, a pyridyl group, a pyridyl group, a pyridyl group, a pyrimidyl group, A pyridyl acenaphthyl group, a dipyridyl fluorenyl group or a dipyridyl benzofluorenyl group, and the like.

Ar1 및 Ar2에 있어서의, 불소 원자로 치환된 탄소수 3 내지 13의 단환 또는 축환 질소 함유 방향족 탄화수소기로서는, 특별히 한정하는 것이 아니지만, 플루오로피리딜기, 플루오로피라질기, 플루오로피리미딜기, 플루오로피리다질기, 플루오로트라이아질기, 플루오로퀴놀릴기, 플루오로아이소퀴놀릴기, 플루오로페난트리딜기, 플루오로벤조퀴놀릴기 또는 플루오로아크리딜기 등을 바람직한 예로서 들 수 있다.The monocyclic or cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms and substituted with a fluorine atom in Ar 1 and Ar 2 is not particularly limited, and examples thereof include a fluoropyridyl group, a fluoropyridyl group, a fluoropyrimidyl group, Preferable examples include fluoropyridyl group, fluorotriacyl group, fluoroquinolyl group, fluoro isoquinolyl group, fluorophenanthridyl group, fluorobenzoquinolyl group and fluoroacridyl group .

Ar1 및 Ar2에 있어서의, 탄소수 1 내지 4의 알킬기로 치환된 탄소수 3 내지 13의 단환 또는 축환 질소 함유 방향족 탄화수소기로서는, 특별히 한정하는 것이 아니지만, 메틸피리딜기, 메틸피라질기, 메틸피리미딜기, 메틸피리다질기, 메틸트라이아질기, 메틸퀴놀릴기, 메틸이소퀴놀릴기, 메틸페난트리딜기, 메틸벤조퀴놀릴기 또는 메틸아크리딜기 등을 바람직한 예로서 들 수 있다.The monocyclic or cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms and substituted with an alkyl group having 1 to 4 carbon atoms in Ar 1 and Ar 2 is not particularly limited and examples thereof include a methylpyridyl group, Methylpyrrolidyl group, methylpyridazyl group, methyltriazyl group, methylquinolyl group, methylisoquinolyl group, methylphenanthryl group, methylbenzoquinolyl group or methylacryidyl group.

Ar1 및 Ar22에 있어서의, 탄소수 1 내지 4의 알콕시기로 치환된 탄소수 3 내지 13의 단환 또는 축환 질소 함유 방향족 탄화수소기로서는, 특별히 한정하는 것이 아니지만, 메톡시피리딜기, 메톡시피라질기, 메톡시피리미딜기, 메톡시피리다질기, 메톡시트라이아질기, 메톡시퀴놀릴기, 메톡시아이소퀴놀릴기, 메톡시페난트리딜기, 메톡시벤조퀴놀릴기 또는 메톡시아크리딜기 등을 바람직한 예로서 들 수 있다.The monocyclic or cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms which is substituted with an alkoxy group having 1 to 4 carbon atoms in Ar 1 and Ar 2 2 is not particularly limited and examples thereof include a methoxypyridyl group, A methoxypyridazinyl group, a methoxypyridazyl group, a methoxy triacyl group, a methoxyquinolyl group, a methoxy isoquinolyl group, a methoxyphenanthryl group, a methoxybenzoquinolyl group or a methoxyacridyl group are preferably used For example.

Ar1 및 Ar22에 있어서의, 페닐기로 치환된 탄소수 3 내지 13의 단환 또는 축환 질소 함유 방향족 탄화수소기로서는, 특별히 한정하는 것이 아니지만, 페닐피리딜기, 페닐피라질기, 페닐피리미딜기, 페닐피리다질기, 페닐트라이아질기, 페닐퀴놀릴기, 페닐이소퀴놀릴기, 페닐페난트리딜기, 페닐벤조퀴놀릴기 또는 페닐아크리딜기 등을 바람직한 예로서 들 수 있다.The monocyclic or cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms substituted with a phenyl group in Ar 1 and Ar 2 2 is not particularly limited, but a phenylpyridyl group, a phenylpyrazyl group, a phenylpyrimidyl group, Preferable examples include a polyvalent group, a phenyltriazyl group, a phenylquinolyl group, a phenylisoquinolyl group, a phenylphenanthryl group, a phenylbenzoquinolyl group or a phenylacryl group.

Ar1 및 Ar2에 있어서의, 피리딜기로 치환된 탄소수 3 내지 13의 단환 또는 축환 질소 함유 방향족 탄화수소기로서는, 특별히 한정하는 것이 아니지만, 바이피리딜기, 피리딜피라질기, 피리딜피리미딜기, 피리딜피리다질기, 피리딜트라이아질기, 피리딜퀴놀릴기, 피리딜이소퀴놀릴기, 피리딜페난트리딜기, 피리딜벤조퀴놀릴기 또는 피리딜아크리딜기 등을 바람직한 예로서 들 수 있다.The monocyclic or cyclic nitrogen-containing aromatic hydrocarbon group of 3 to 13 carbon atoms substituted with a pyridyl group in Ar 1 and Ar 2 is not particularly limited, but a bipyridyl group, a pyridylpyrazyl group, a pyridylpyrimidyl group, Preferable examples thereof include pyridylpyridazyl, pyridyltriazyl, pyridylquinolyl, pyridyl isoquinolyl, pyridylphenanthryl, pyridylbenzoquinolyl and pyridylcaridyl groups.

Ar1 및 Ar2는, 전자수송성 재료 특성이 우수한 점에서, 각각 독립적으로, 탄소수 6 내지 18의 단환, 연결 또는 축환방향족 탄화수소기(해당 기는, 불소 원자, 탄소수 1 내지 4의 알킬기, 탄소수 1 내지 4의 알콕시기, 페닐기 또는 피리딜기로 치환되어 있어도 됨)인 것이 바람직하고, 각각 독립적으로, 페닐기, 나프틸기 또는 페난트릴기(이들 기는, 불소 원자, 메틸기, 페닐기 또는 피리딜기로 치환되어 있어도 됨)인 것이 보다 바람직하며, 각각 독립적으로, 페닐기, 바이페닐기, 나프틸기 또는 페난트릴기인 것이 더욱 바람직하다.Each of Ar 1 and Ar 2 is independently a monocyclic, a linking or a cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms (this group is a fluorine atom, an alkyl group having 1 to 4 carbon atoms, A phenyl group or a pyridyl group), and each independently represents a phenyl group, a naphthyl group or a phenanthryl group (these groups may be substituted with a fluorine atom, a methyl group, a phenyl group or a pyridyl group) ), More preferably independently of each other, a phenyl group, a biphenyl group, a naphthyl group or a phenanthryl group.

Ar1 및 Ar2의 구체예로서는, 특별히 한정하는 것은 아니지만, 페닐기, p-톨릴기, m-톨릴기, o-톨릴기, 2,4-다이메틸페닐기, 3,5-다이메틸페닐기, 메시틸기, 2-에틸페닐기, 3-에틸페닐기, 4-에틸페닐기, 2,4-다이에틸페닐기, 3,5-다이에틸페닐기, 2-프로필페닐기, 3-프로필페닐기, 4-프로필페닐기, 2,4-다이프로필페닐기, 3,5-다이프로필페닐기, 2-아이소프로필페닐기, 3-아이소프로필페닐기, 4-아이소프로필페닐기, 2,4-다이아이소프로필페닐기, 3,5-다이아이소프로필페닐기, 2-뷰틸페닐기, 3-뷰틸페닐기, 4-뷰틸페닐기, 2,4-다이뷰틸페닐기, 3,5-다이뷰틸페닐기, 2-tert-뷰틸페닐기, 3-tert-뷰틸페닐기, 4-tert-뷰틸페닐기, 2,4-다이-tert-뷰틸페닐기, 3,5-다이-tert-뷰틸페닐기, 바이페닐-2-일기, 바이페닐-3-일기, 바이페닐-4-일기, 3-메틸바이페닐-4-일기, 2'-메틸바이페닐-4-일기, 4'-메틸바이페닐-4-일기, 2,2'-다이메틸바이페닐-4-일기, 2',4',6'-트라이메틸바이페닐-4-일기, 6-메틸바이페닐-3-일기, 5-메틸바이페닐-3-일기, 2'-메틸바이페닐-3-일기, 4'-메틸바이페닐-3-일기, 6,2'-다이메틸바이페닐-3-일기, 2',4',6'-트라이메틸바이페닐-3-일기, 5-메틸바이페닐-2-일기, 6-메틸바이페닐-2-일기, 2'-메틸바이페닐-2-일기, 4'-메틸바이페닐-2-일기, 6,2'-다이메틸바이페닐-2-일기, 2',4',6'-트라이메틸바이페닐-2-일기, 3-에틸바이페닐-4-일기, 4'-에틸바이페닐-4-일기, 2',4',6'-트라이에틸바이페닐-4-일기, 6-에틸바이페닐-3-일기, 4'-에틸바이페닐-3-일기, 5-에틸바이페닐-2-일기, 4'-에틸바이페닐-2-일기, 2',4',6'-트라이에틸바이페닐-2-일기, 3-프로필바이페닐-4-일기, 4'-프로필바이페닐-4-일기, 2',4',6'-트라이프로필바이페닐-4-일기, 6-프로필바이페닐-3-일기, 4'-프로필바이페닐-3-일기, 5-프로필바이페닐-2-일기, 4'-프로필바이페닐-2-일기, 2',4',6'-트라이프로필바이페닐-2-일기, 3-아이소프로필바이페닐-4-일기, 4'-아이소프로필바이페닐-4-일기, 2',4',6'-트라이아이소프로필바이페닐-4-일기, 6-아이소프로필바이페닐-3-일기, 4'-아이소프로필바이페닐-3-일기, 5-아이소프로필바이페닐-2-일기, 4'-아이소프로필바이페닐-2-일기, 2',4',6'-트라이아이소프로필바이페닐-2-일기, 3-뷰틸바이페닐-4-일기, 4'-뷰틸바이페닐-4-일기, 2',4',6'-트라이뷰틸바이페닐-4-일기, 6-뷰틸바이페닐-3-일기, 4'-뷰틸바이페닐-3-일기, 5-뷰틸바이페닐-2-일기, 4'-뷰틸바이페닐-2-일기, 2',4',6'-트라이뷰틸바이페닐-2-일기, 3-tert-뷰틸바이페닐-4-일기, 4'-tert-뷰틸바이페닐-4-일기, 2',4',6'-트라이-tert-뷰틸바이페닐-4-일기, 6-tert-뷰틸바이페닐-3-일기, 4'-tert-뷰틸바이페닐-3-일기, 5-tert-뷰틸바이페닐-2-일기, 4'-tert-뷰틸바이페닐-2-일기, 2',4',6'-트라이-tert-뷰틸바이페닐-2-일기, 2-피리딜기, 3-피리딜기, 4-피리딜기, 2-메틸피리딘-3-일기, 2-메틸피리딘-4-일기, 2-메틸피리딘-5-일기, 2-메틸피리딘-6-일기, 3-메틸피리딘-2-일기, 3-메틸피리딘-4-일기, 3-메틸피리딘-5-일기, 3-메틸피리딘-6-일기, 4-메틸피리딘-2-일기, 4-메틸피리딘-3-일기, 2,6-다이메틸피리딘-3-일기, 2,6-다이메틸피리딘-4-일기, 3,6-다이메틸피리딘-2-일기, 3,6-다이메틸피리딘-4-일기, 3,6-다이메틸피리딘-5-일기, 2-페닐피리딘-6-일기, 3-페닐피리딘-6-일기, 4-페닐피리딘-6-일기, 5-페닐피리딘-6-일기, 2-페닐피리딘-3-일기, 2-페닐피리딘-5-일기, 3-페닐피리딘-5-일기, 4-페닐피리딘-3-일기, 3-페닐피리딘-4-일기, 2-페닐피리딘-4-일기, 2-(2-피리딜)페닐기, 3-(2-피리딜)페닐기, 4-(2-피리딜)페닐기, 2-(3-피리딜)페닐기, 3-(3-피리딜)페닐기, 4-(3-피리딜)페닐기, 2-(4-피리딜)페닐기, 3-(4-피리딜)페닐기, 4-(4-피리딜)페닐기, 1-나프틸기, 2-나프틸기, 1-페닐나프탈렌-2-일기, 1-페닐나프탈렌-3-일기, 1-페닐나프탈렌-4-일기, 1-페닐나프탈렌-5-일기, 1-페닐나프탈렌-6-일기, 1-페닐나프탈렌-7-일기, 1-페닐나프탈렌-8-일기, 2-페닐나프탈렌-1-일기, 2-페닐나프탈렌-3-일기, 2-페닐나프탈렌-4-일기, 2-페닐나프탈렌-5-일기, 2-페닐나프탈렌-6-일기, 2-페닐나프탈렌-7-일기, 2-페닐나프탈렌-8-일기, 1-메틸나프탈렌-4-일기, 1-메틸나프탈렌-5-일기, 1-메틸나프탈렌-6-일기, 1-메틸나프탈렌-7-일기, 1-메틸나프탈렌-8-일기, 2-메틸나프탈렌-1-일기, 2-메틸나프탈렌-3-일기, 2-메틸나프탈렌-4-일기, 2-메틸나프탈렌-5-일기, 2-메틸나프탈렌-6-일기, 2-메틸나프탈렌-7-일기, 2-메틸나프탈렌-8-일기, 1-페난톨릴기, 2-페난톨릴기, 3-페난톨릴기, 4-페난톨릴기, 9-페난톨릴기, 1-페닐페난트렌-2-일기, 1-페닐페난트렌-3-일기, 1-페닐페난트렌-4-일기, 1-페닐페난트렌-5-일기, 1-페닐페난트렌-6-일기, 1-페닐페난트렌-7-일기, 1-페닐페난트렌-8-일기, 1-페닐페난트렌-9-일기, 1-페닐페난트렌-10-일기, 2-페닐페난트렌-1-일기, 2-페닐페난트렌-3-일기, 2-페닐페난트렌-4-일기, 2-페닐페난트렌-5-일기, 2-페닐페난트렌-6-일기, 2-페닐페난트렌-7-일기, 2-페닐페난트렌-8-일기, 2-페닐페난트렌-9-일기, 2-페닐페난트렌-10-일기, 3-페닐페난트렌-1-일기, 3-페닐페난트렌-2-일기, 3-페닐페난트렌-4-일기, 3-페닐페난트렌-5-일기, 3-페닐페난트렌-6-일기, 3-페닐페난트렌-7-일기, 3-페닐페난트렌-8-일기, 3-페닐페난트렌-9-일기, 3-페닐페난트렌-10-일기, 4-페닐페난트렌-1-일기, 4-페닐페난트렌-2-일기, 4-페닐페난트렌-3-일기, 4-페닐페난트렌-5-일기, 4-페닐페난트렌-6-일기, 4-페닐페난트렌-7-일기, 4-페닐페난트렌-8-일기, 4-페닐페난트렌-9-일기, 4-페닐페난트렌-10-일기, 1-메틸페난트렌-2-일기, 1-메틸페난트렌-3-일기, 1-메틸페난트렌-4-일기, 1-메틸페난트렌-5-일기, 1-메틸페난트렌-6-일기, 1-메틸페난트렌-7-일기, 1-메틸페난트렌-8-일기, 1-메틸페난트렌-9-일기, 1-메틸페난트렌-10-일기, 2-메틸페난트렌-1-일기, 2-메틸페난트렌-3-일기, 2-메틸페난트렌-4-일기, 2-메틸페난트렌-5-일기, 2-메틸페난트렌-6-일기, 2-메틸페난트렌-7-일기, 2-메틸페난트렌-8-일기, 2-메틸페난트렌-9-일기, 2-메틸페난트렌-10-일기, 3-메틸페난트렌-1-일기, 3-메틸페난트렌-2-일기, 3-메틸페난트렌-4-일기, 3-메틸페난트렌-5-일기, 3-메틸페난트렌-6-일기, 3-메틸페난트렌-7-일기, 3-메틸페난트렌-8-일기, 3-메틸페난트렌-9-일기, 3-메틸페난트렌-10-일기, 4-메틸페난트렌-1-일기, 4-메틸페난트렌-2-일기, 4-메틸페난트렌-3-일기, 4-메틸페난트렌-5-일기, 4-메틸페난트렌-6-일기, 4-메틸페난트렌-7-일기, 4-메틸페난트렌-8-일기, 4-메틸페난트렌-9-일기, 4-메틸페난트렌-10-일기, 1-안톨릴기, 2-안톨릴기, 9-안톨릴기, 1-페닐안트라센-2-일기, 1-페닐안트라센-3-일기, 1-페닐안트라센-4-일기, 1-페닐안트라센-5-일기, 1-페닐안트라센-6-일기, 1-페닐안트라센-7-일기, 1-페닐안트라센-8-일기, 1-페닐안트라센-9-일기, 1-페닐안트라센-10-일기, 2-페닐안트라센-1-일기, 2-페닐안트라센-3-일기, 2-페닐안트라센-4-일기, 2-페닐안트라센-5-일기, 2-페닐안트라센-6-일기, 2-페닐안트라센-7-일기, 2-페닐안트라센-8-일기, 2-페닐안트라센-9-일기, 2-페닐안트라센-10-일기, 9-페닐안트라센-1-일기, 9-페닐안트라센-2-일기, 9-페닐안트라센-3-일기, 9-페닐안트라센-4-일기, 9-페닐안트라센-5-일기, 1-피레닐기, 2-피레닐기, 4-피레닐기, 1-페닐피렌-2-일기, 1-페닐피렌-3-일기, 1-페닐피렌-4-일기, 1-페닐피렌-5-일기, 1-페닐피렌-6-일기, 1-페닐피렌-7-일기, 1-페닐피렌-8-일기, 1-페닐피렌-9-일기, 1-페닐피렌-10-일기, 2-페닐피렌-1-일기, 2-페닐피렌-3-일기, 2-페닐피렌-4-일기, 2-페닐피렌-5-일기, 2-페닐피렌-6-일기, 2-페닐피렌-7-일기, 2-페닐피렌-8-일기, 2-페닐피렌-9-일기, 2-페닐피렌-10-일기, 9-페닐피렌-1-일기, 9-페닐피렌-2-일기, 9-페닐피렌-3-일기, 9-페닐피렌-4-일기, 9-페닐피렌-5-일기, 9-페닐피렌-6-일기, 9-페닐피렌-7-일기, 9-페닐피렌-8-일기, 9-페닐피렌-10-일기, 1-메틸피렌-2-일기, 1-메틸피렌-3-일기, 1-메틸피렌-4-일기, 1-메틸피렌-5-일기, 1-메틸피렌-6-일기, 1-메틸피렌-7-일기, 1-메틸피렌-8-일기, 1-메틸피렌-9-일기, 1-메틸피렌-10-일기, 2-메틸피렌-1-일기, 2-메틸피렌-3-일기, 2-메틸피렌-4-일기, 2-메틸피렌-5-일기, 2-메틸피렌-6-일기, 2-메틸피렌-7-일기, 2-메틸피렌-8-일기, 2-메틸피렌-9-일기, 2-메틸피렌-10-일기, 9-메틸피렌-1-일기, 9-메틸피렌-2-일기, 9-메틸피렌-3-일기, 9-메틸피렌-4-일기, 9-메틸피렌-5-일기, 9-메틸피렌-6-일기, 9-메틸피렌-7-일기, 9-메틸피렌-8-일기, 9-메틸피렌-10-일기, 플루오란텐-1-일기, 플루오란텐-1-일기, 플루오란텐-2-일기, 플루오란텐-3-일기, 플루오란텐-4-일기, 플루오란텐-5-일기, 플루오란텐-6-일기, 플루오란텐-7-일기, 플루오란텐-8-일기, 플루오란텐-9-일기, 플루오란텐-10-일기, 트라이페닐렌-1-일기, 트라이페닐렌-2-일기, 아세나프틸렌-1-일기, 아세나프틸렌-3-일기, 아세나프틸렌-4-일기, 아세나프틸렌-5-일기, 크리센-1-일기, 크리센-2-일기, 크리센-5-일기, 크리센-6-일기, 2-퀴놀릴기, 3-퀴놀릴기, 4-퀴놀릴기, 5-퀴놀릴기, 6-퀴놀릴기, 7-퀴놀릴기, 8-퀴놀릴기, 1-아이소퀴놀릴기, 3-아이소퀴놀릴기, 4-아이소퀴놀릴기, 5-아이소퀴놀릴기, 6-아이소퀴놀릴기, 7-아이소퀴놀릴기, 8-아이소퀴놀릴기, 퀴녹살린-2-일기, 퀴녹살린-5-일기, 퀴녹살린-6-일기, 퀴나졸린-2-일기, 퀴나졸린-4-일기, 퀴나졸린-5-일기, 퀴나졸린-6-일기, 퀴나졸린-7-일기, 퀴나졸린-8-일기, 피라진-2-일기, 피리미딘-2-일기, 피리미딘-4-일기, 피리미딘-5-일기, 아크리딘-1-일기, 아크리딘-1-일기, 아크리딘-2-일기, 아크리딘-3-일기, 아크리딘-4-일기, 아크리딘-9-일기, 페난트리딘-1-일기, 페난트리딘-1-일기, 페난트리딘-2-일기, 페난트리딘-3-일기, 페난트리딘-4-일기, 페난트리딘-6-일기, 페난트리딘-7-일기, 페난트리딘-8-일기, 페난트리딘-9-일기, 페난트리딘-10-일기, 페나딘-1-일기, 페나딘-2-일기, 벤조[h]퀴놀린-2-일기, 벤조[h]퀴놀린-3-일기, 벤조[h]퀴놀린-4-일기, 벤조[h]퀴놀린-5-일기, 벤조[h]퀴놀린-6-일기, 벤조[h]퀴놀린-7-일기, 벤조[h]퀴놀린-8-일기, 벤조[h]퀴놀린-9-일기, 벤조[h]퀴놀린-10-일기 등을 바람직한 예로서 들 수 있다. 이들 치환기 중, 전자수송성 재료 특성이 우수한 점에서, 페닐기, p-톨릴기, 바이페닐-3-일기, 바이페닐-4-일기, 3-(2-피리딜)페닐기, 4-(2-피리딜)페닐기, 3-(3-피리딜)페닐기, 4-(3-피리딜)페닐기, 2-피리딜기, 3-피리딜기, 2-페닐피리딘-6-일기, 2-페닐피리딘-5-일기, 2-페닐피리딘-4-일기, 3-페닐피리딘-5-일기, 3-페닐피리딘-6-일기, 1-나프틸기, 2-나프틸기, 1-페난트릴기, 2-페난트릴기, 3-페난트릴기 또는 9-페난트릴기가 바람직하고, 페닐기, p-톨릴기, 바이페닐-3-일기, 바이페닐-4-일기, 1-나프틸기 또는 9-페난트릴기가 보다 바람직하다.Specific examples of Ar 1 and Ar 2 include, but are not limited to, phenyl, p-tolyl, m-tolyl, o-tolyl, 2,4- Ethylphenyl, 4-ethylphenyl, 2,4-diethylphenyl, 3,5-diethylphenyl, 2-propylphenyl, 3-propylphenyl, 4-propylphenyl, 2,4 Isopropylphenyl group, 2,4-diisopropylphenyl group, 3,5-diisopropylphenyl group, 2-isopropylphenyl group, 2-isopropylphenyl group, Butylphenyl group, 3-tert-butylphenyl group, 4-tert-butylphenyl group, 2-tert-butylphenyl group, 3- Butylphenyl group, a biphenyl-2-yl group, a biphenyl-3-yl group, a biphenyl-4-yl group, a 3-methylbiphenyl- 4-yl group, 2'-methylbiphenyl-4-yl group, 4'- Yl group, 5-methylbiphenyl-4-yl group, 2, 4'- Methyl biphenyl-3-yl group, 6'-dimethylbiphenyl-3-yl group, 2 ', 4' , A 6'-trimethylbiphenyl-3-yl group, a 5-methylbiphenyl-2-yl group, a 6-methylbiphenyl- Methylbiphenyl-4-yl group, 4'-methylbiphenyl-4-yl group, Ethyl biphenyl-4-yl group, 2 ', 4', 6'-triethylbiphenyl-4-yl group, Yl group, 4'-ethylbiphenyl-2-yl group, 2 ', 4', 6'-triethylbiphenyl- Biphenyl-4-yl group, 2 ', 4', 6'-tripropylbiphenyl-4-yl group, 6-propylbiphenyl- -Yl group, a 5-propylbiphenyl-2-yl group, a 4'-propylbiphenyl-2-yl group, a 2 ' Isopropyl biphenyl-4-yl group, 4'-isopropyl biphenyl-4-yl group, 2'- Isopropylbiphenyl-2-yl group, 2 ', 4', 6'-triisopropylbiphenyl-2-yl group, 3'- Butylbiphenyl-4-yl group, 4'-butylbiphenyl-4-yl group, 2 ', 4', 6'- Butylbiphenyl-2-yl group, 2 ', 4', 6'-tributylbiphenyl-2-yl group, 3- tert-butylbiphenyl-4-yl group, 4'-tert-butylbiphenyl-4-yl group, 2 ', 4', 6'- 3-yl group, 4'-tert-butylbiphenyl-3-yl group, 5-tert- A biphenyl-2-yl group, a 4'-tert-butylbiphenyl-2-yl group, a 2'or 4'6'- Yl group, a 2-methylpyridin-6-yl group, a 3-methylpyridin-2-yl group, a 2-methylpyridin- , A 3-methylpyridin-4-yl group, a 3-methylpyridin-5-yl group, Dimethylpyridin-4-yl group, 3,6-dimethylpyridin-3-yl group, 2,6-dimethylpyridin- Yl group, a 2-phenylpyridin-6-yl group, a 3-phenylpyridin-6-yl group, , 2-phenylpyridin-4-yl group, 2-phenylpyridin-4-yl group, 2-phenylpyridin-5-yl group, (2-pyridyl) phenyl group, 3- (2-pyridyl) phenyl group, 4- (4-pyridyl) phenyl group, 4- (3-pyridyl) phenyl group, 2- Phenyl naphthalene-4-yl group, a 1-phenylnaphthalen-5-yl group, a 1-phenylnaphthalen-5-yl group, Phenyl naphthalene-1-yl group, a 2-phenylnaphthalene-3-yl group, a 2-phenylnaphthalene-4-yl group, 2-phenylnaphthalen-4-yl group, 1-methylnaphthalen-4-yl group, 1-methylnaphthalen-4-yl group, Methylnaphthalen-1-yl group, 2-methylnaphthalen-3-yl group, 2-methylnaphthalen-1-yl group, Methylnaphthalen-4-yl group, 2-methylnaphthalen-5-yl group, 2-methylnaphthalen-6-yl group, 2- Reel, two-ply Phenanthren-3-yl group, a 1-phenylphenanthrene-4-yl group, a 1-phenylphenanthrene-2-yl group, , A 1-phenylphenanthrene-5-yl group, a 1-phenylphenanthrene-6-yl group, a 1-phenylphenanthrene-7-yl group, a 1-phenylphenanthrene- , 2-phenylphenanthrene-1-yl group, 2-phenylphenanthrene-3-yl group, 2-phenylphenanthrene-4-yl group, 2-phenylphenanthrene- , A 2-phenylphenanthrene-6-yl group, a 2-phenylphenanthrene-7-yl group, a 2-phenylphenanthrene-8-yl group, a 2-phenylphenanthrene- , 3-phenylphenanthrene-1-yl group, 3-phenylphenanthrene-2-yl group, 3-phenylphenanthrene- Yl group, 3-phenylphenanthrene-10-yl group, 4-phenylphenanthrene-1-yl group, , 4-phenylphenanthrene-2-yl group, 4-phenylphenanthrene-3-yl , A 4-phenylphenanthrene-5-yl group, a 4-phenylphenanthrene-6-yl group, a 4-phenylphenanthrene- Methylphenanthrene-3-yl group, 1-methylphenanthrene-4-yl group, 1-methylphenanthrene-5-yl group , 1-methylphenanthren-6-yl group, 1-methylphenanthren-7-yl group, 1-methylphenanthrene-8-yl group, , 2-methylphenanthrene-1-yl group, 2-methylphenanthrene-3-yl group, 2-methylphenanthrene- , 2-methylphenanthrene-10-yl group, 3-methylphenanthrene-1-yl group, 2-methylphenanthrene- , 3-methylphenanthrene-2-yl group, 3-methylphenanthrene-4-yl group, 3-methylphenanthrene- , 3-methylphenanthrene-8-yl group, 3-methylphenanthrene-9-yl group, 3- Methylphenanthrene-2-yl group, 4-methylphenanthrene-3-yl group, 4-methylphenanthrene-5-yl group, 4- Methylphenanthrene-9-yl group, 4-methylphenanthrene-10-yl group, 1- (4-methylphenanthren- 1-phenylanthracene-4-yl group, 1-phenylanthracene-5-yl group, 1-phenylanthracene-5-yl group, 1-phenylanthracene-9-yl group, 1-phenylanthracene-10-yl group, 2-phenylanthracene-1-yl group, A 2-phenylanthracene-6-yl group, a 2-phenylanthracene-7-yl group, a 2- A phenanthracene-1-yl group, a 9-phenylanthracene-2-yl group, a 9-phenylanthracene-9-yl group, A phenyl group, a 2-pyridyl group, a 1-phenylpyran-2-yl group, a 1-phenylpyranyl group, Yl group, a 1-phenylpyran-7-yl group, a 1-phenylpyran-8-yl group, 1-yl group, 2-phenylpyran-3-yl group, 2-phenylpyran-4-yl group, 2-phenylpyran-10-yl group, Yl group, a 2-phenylpyran-9-yl group, a 2-phenylpyran-10-yl group, A 9-phenylpyran-5-yl group, a 9-phenylpyran-2-yl group, Yl group, a 1-methylpyran-2-yl group, a 1-methylpyran-3-yl group, a 1-methylpyran- Methylpyran-7-yl group, 1-methylpyran-8-yl group, 1-methylpyran-9-yl group, - diary, 1 Methylpyran-1-yl group, 2-methylpyran-5-yl group, 2-methylpyran-1-yl group, Yl group, a 2-methylpyran-10-yl group, a 9-methylpyran-1-yl group, a 9- Methylpyran-4-yl group, 9-methylpyran-5-yl group, 9-methylpyran-6-yl group, Yl group, a fluoranthene-1-yl group, a fluoranthene-2-yl group, a fluoranthene-1-yl group, A fluoranthene-6-yl group, a fluoranthene-7-yl group, a fluoranthene-8-yl group, a fluoranthene-9-yl group, An acenaphthylene-1-yl group, an acenaphthylene-3-yl group, an acenaphthylene-4-yl group, an acenaphthylene-1-yl group, Yl group, a chrysene-1-yl group, a chrysene-2-yl group, a chrysene- 6-quinolyl group, 7-quinolyl group, 8-quinolyl group, l-quinolyl group, 1- Isoquinolyl group, 8-isoquinolyl group, quinoxaline group, 5-isoquinolyl group, 6-isoquinolyl group, A quinazolin-4-yl group, a quinazolin-5-yl group, a quinazolin-6-yl group, a quinazolin-7-yl group, A pyrimidin-2-yl group, a pyrimidin-4-yl group, a pyrimidin-5-yl group, an acridine-1-yl group, an acridine- An acridine-4-yl group, an acridine-9-yl group, a phenanthridin-1-yl group, a phenanthridin-1-yl group , A phenanthridin-6-yl group, a phenanthridin-7-yl group, a phenanthridin-8-yl group, a phenanthridin-4-yl group, 9-yl group, phenanthridin-10-yl group, Benzo [h] quinolin-4-yl group, benzo [h] quinolin-2-yl group, benzo [h] quinolin- Yl group, benzo [h] quinolin-6-yl group, benzo [h] quinolin-7-yl group, benzo [h] 10-diol, and the like can be mentioned as preferable examples. Among these substituents, a phenyl group, a p-tolyl group, a biphenyl-3-yl group, a biphenyl-4-yl group, a 3- (2-pyridyl) (3-pyridyl) phenyl group, a 2-pyridyl group, a 3-pyridyl group, a 2-phenylpyridin-6-yl group, 2-naphthyl group, a 1-phenanthryl group, a 2-phenanthryl group, a 2-phenanthryl group, a 3-phenylpyridin- Phenanthryl group or 9-phenanthryl group is preferable, and a phenyl group, p-tolyl group, biphenyl-3-yl group, biphenyl-4-yl group, 1-naphthyl group or 9-phenanthryl group is more preferable.

Ar3은, 탄소수 6 내지 18의 단환, 연결 혹은 축환방향족 탄화수소기(해당 기는, 불소 원자, 탄소수 1 내지 4의 알킬기, 탄소수 1 내지 4의 알콕시기, 페닐기 또는 피리딜기로 치환되어 있어도 됨) 또는 6원환만으로 구성되는 탄소수 3 내지 13의 단환 혹은 축환 질소 함유 방향족 탄화수소기(해당 기는, 불소 원자, 탄소수 1 내지 4의 알킬기, 탄소수 1 내지 4의 알콕시기, 피리딜기, 페닐기, 나프틸기 또는 바이페닐기로 치환되어 있어도 됨)를 나타낸다.Ar 3 represents a monocyclic, fused or cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms (the group may be substituted by a fluorine atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a phenyl group, or a pyridyl group) A monocyclic or a cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms (the group is selected from the group consisting of a fluorine atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a pyridyl group, a phenyl group, a naphthyl group, Or may be substituted with a halogen atom).

Ar3에 있어서 표시되는 「탄소수 6 내지 18의 단환, 연결 또는 축환 방향족 탄화수소기」, 「탄소수 1 내지 4의 알킬기」, 「탄소수 1 내지 4의 알콕시기」, 「6원환만으로 구성되는 탄소수 3 내지 13의 단환, 또는 축환 질소 함유 방향족 탄화수소기」, 「불소 원자로 치환된 탄소수 6 내지 18의 단환, 연결 또는 축환 방향족 탄화수소기」, 「탄소수 1 내지 4의 알킬기로 치환된 탄소수 6 내지 18의 단환, 연결 또는 축환 방향족 탄화수소기」, 「탄소수 1 내지 4의 알콕시기로 치환된 탄소수 6 내지 18의 단환, 연결 또는 축환 방향족 탄화수소기」, 「페닐기로 치환된 탄소수 6 내지 18의 단환, 연결 또는 축환 방향족 탄화수소기」, 「피리딜기로 치환된 탄소수 6 내지 18의 단환, 연결 또는 축환 방향족 탄화수소기」, 「불소 원자로 치환된 탄소수 3 내지 13의 단환, 또는 축환 질소 함유 방향족 탄화수소기」, 「탄소수 1 내지 4의 알킬기로 치환된 탄소수 3 내지 13의 단환, 또는 축환 질소 함유 방향족 탄화수소기」, 「탄소수 1 내지 4의 알콕시기로 치환된 탄소수 3 내지 13의 단환, 또는 축환 질소 함유 방향족 탄화수소기」, 「페닐기로 치환된 탄소수 3 내지 13의 단환, 또는 축환 질소 함유 방향족 탄화수소기」,및 「피리딜기로 치환된 탄소수 3 내지 13의 단환, 또는 축환 질소 함유 방향족 탄화수소기」에 대해서는, Ar1 또는 Ar2에서 예시한 것과 같은 치환기를 예시할 수 있다."Monocyclic ring having 6 to 18, connection or chukhwan aromatic hydrocarbon group" represented in Ar 3, "C 1 -C 4 alkyl group", the number of carbon atoms that is composed only of "alkoxy group having 1 to 4 carbon atoms", "6-membered ring from 3 to Quot; monocyclic, fused or cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms substituted with a fluorine atom ", monocyclic ring having 6 to 18 carbon atoms substituted with an alkyl group having 1 to 4 carbon atoms, Linking or condensed aromatic hydrocarbon group having 6 to 18 carbon atoms substituted with a phenyl group "," monocyclic, linking or condensed aromatic hydrocarbon group having 6 to 18 carbon atoms substituted with an alkoxy group having 1 to 4 carbon atoms "," monocyclic, Quot ;, " monocyclic, fused or condensed aromatic hydrocarbon group having 6 to 18 carbon atoms substituted with pyridyl group "," monocyclic ring having 3 to 13 carbon atoms substituted with fluorine atom, Quot; is a monocyclic or a cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms substituted with an alkyl group having 1 to 4 carbon atoms "," a cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms substituted with an alkoxy group having 1 to 4 carbon atoms A monocyclic or a cyclic nitrogen-containing aromatic hydrocarbon group substituted with a phenyl group, "and a" monocyclic ring having 3 to 13 carbon atoms substituted with a pyridyl group, or a cyclic nitrogen-containing aromatic hydrocarbon group substituted with a pyridyl group " As the aromatic hydrocarbon group ", substituents such as those exemplified for Ar 1 or Ar 2 can be exemplified.

Ar3에 있어서의, 바이페닐기로 치환된 6원환만으로 구성되는 탄소수 3 내지 13의 단환 또는 축환 질소 함유 방향족 탄화수소기로서는, 바이페닐피리딜기, 바이페닐피라질기, 바이페닐피리미딜기, 바이페닐피리다질기, 바이페닐트라이아질기, 바이페닐퀴놀릴기, 바이페닐이소퀴놀릴기, 바이페닐페난트리딜기, 바이페닐벤조퀴놀릴기, 바이페닐아크리딜기 등을 바람직한 예로서 들 수 있다.Examples of the monocyclic or cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms composed of only 6-membered rings substituted with a biphenyl group in Ar 3 include biphenylpyridyl group, biphenylpyrazyl group, biphenylpyrimidyl group, Preferable examples include a polysulfide, a biphenyltriazole, a biphenylquinolyl group, a biphenylisoquinolyl group, a biphenylphenanthryl group, a biphenylbenzoquinolyl group, and a biphenylacridyl group.

Ar3에 있어서의, 나프틸기로 치환된 6원환만으로 구성되는 탄소수 3 내지 13의 단환 또는 축환 질소 함유 방향족 탄화수소기로서는, 특별히 한정하는 것이 아니지만, 나프틸피리딜기, 나프틸피라질기, 나프틸피리미딜기, 나프틸트라이아질기 또는 나프틸퀴놀릴기 등을 바람직한 예로서 들 수 있다.The monocyclic or cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms and composed of only 6-membered rings substituted with a naphthyl group in Ar 3 is not particularly limited, but a naphthylpyridyl group, a naphthylpyridyl group, Naphthyltriazinyl group or naphthylquinolyl group may be mentioned as preferred examples.

Ar3은, 전자수송성 재료 특성이 우수한 점에서, 탄소수 6 내지 18의 단환, 연결 혹은 축환방향족 탄화수소기(해당 기는, 페닐기 또는 피리딜기로 치환되어 있어도 됨) 또는 6원환만으로 구성되는 탄소수 3 내지 13의 단환 혹은 축환 질소 함유 방향족 탄화수소기(해당 기는, 페닐기, 바이페닐기 또는 나프틸기로 치환되어 있어도 됨)인 것이 바람직하고, 페닐기, 나프틸기, 혹은 바이페닐기(이들 기는, 페닐기 또는 피리딜기로 치환되어 있어도 됨) 또는 탄소수 3 내지 9의 단환 또는 축환 질소 함유 방향족 탄화수소기(해당 기는, 페닐기, 바이페닐기 또는 나프틸기로 치환되어 있어도 됨)인 것이 보다 바람직하고, 페닐기, 바이페닐기, 터페닐기, 나프틸기, 피리딜페닐기, 피리딜기, 피라질기, 피리미딜기, 퀴놀릴기, 아이소퀴놀릴기, 페닐피리딜기, 바이페닐피리딜기, 페닐피라질기, 바이페닐피라질기, 페닐피리미딜기, 바이페닐피리미딜기, 페닐퀴놀릴기, 바이페닐퀴놀릴기 또는 페닐이소퀴놀릴기인 것이 더욱 바람직하고, 페닐기, 바이페닐기, 나프틸기, 피리딜기, 페닐피리딜기, 피라질기, 피리미딜기, 퀴놀릴기 또는 아이소퀴놀릴기인 것이 더욱 바람직하다.Ar 3 has 3 to 13 carbon atoms which is composed of a monocyclic, a linking or a cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms (the group may be substituted with a phenyl group or a pyridyl group) or a 6-membered ring only in view of excellent electron- (The group may be substituted with a phenyl group, a biphenyl group, or a naphthyl group), and a phenyl group, a naphthyl group, or a biphenyl group (these groups are substituted with a phenyl group or a pyridyl group) Or a monocyclic or a cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 9 carbon atoms (the group may be substituted with a phenyl group, a biphenyl group or a naphthyl group), more preferably a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group , A pyridylphenyl group, a pyridyl group, a pyrazyl group, a pyrimidyl group, a quinolyl group, an isoquinolyl group, a phenylpyridyl group, More preferably a phenyl group, a biphenyl group, a naphthyl group, a phenyl group, a biphenyl group, a biphenyl group, a biphenyl group, a thienyl group, , A pyridyl group, a phenylpyridyl group, a pyrazyl group, a pyrimidyl group, a quinolyl group or an isoquinolyl group.

Ar3의 구체예로서는, 특별히 한정하는 것은 아니지만, 페닐기, p-톨릴기, m-톨릴기, o-톨릴기, 2,4-다이메틸페닐기, 3,5-다이메틸페닐기, 메시틸기, 2-에틸페닐기, 3-에틸페닐기, 4-에틸페닐기, 2,4-다이에틸페닐기, 3,5-다이에틸페닐기, 2-프로필페닐기, 3-프로필페닐기, 4-프로필페닐기, 2,4-다이프로필페닐기, 3,5-다이프로필페닐기, 2-아이소프로필페닐기, 3-아이소프로필페닐기, 4-아이소프로필페닐기, 2,4-다이아이소프로필페닐기, 3,5-다이아이소프로필페닐기, 2-뷰틸페닐기, 3-뷰틸페닐기, 4-뷰틸페닐기, 2,4-다이뷰틸페닐기, 3,5-다이뷰틸페닐기, 2-tert-뷰틸페닐기, 3-tert-뷰틸페닐기, 4-tert-뷰틸페닐기, 2,4-다이-tert-뷰틸페닐기, 3,5-다이-tert-뷰틸페닐기, 바이페닐-2-일기, 바이페닐-3-일기, 바이페닐-4-일기, 3-메틸바이페닐-4-일기, 2'-메틸바이페닐-4-일기, 4'-메틸바이페닐-4-일기, 2,2'-다이메틸바이페닐-4-일기, 2',4',6'-트라이메틸바이페닐-4-일기, 6-메틸바이페닐-3-일기, 5-메틸바이페닐-3-일기, 2'-메틸바이페닐-3-일기, 4'-메틸바이페닐-3-일기, 6,2'-다이메틸바이페닐-3-일기, 2',4',6'-트라이메틸바이페닐-3-일기, 5-메틸바이페닐-2-일기, 6-메틸바이페닐-2-일기, 2'-메틸바이페닐-2-일기, 4'-메틸바이페닐-2-일기, 6,2'-다이메틸바이페닐-2-일기, 2',4',6'-트라이메틸바이페닐-2-일기, 3-에틸바이페닐-4-일기, 4'-에틸바이페닐-4-일기, 2',4',6'-트라이에틸바이페닐-4-일기, 6-에틸바이페닐-3-일기, 4'-에틸바이페닐-3-일기, 5-에틸바이페닐-2-일기, 4'-에틸바이페닐-2-일기, 2',4',6'-트라이에틸바이페닐-2-일기, 3-프로필바이페닐-4-일기, 4'-프로필바이페닐-4-일기, 2',4',6'-트라이프로필바이페닐-4-일기, 6-프로필바이페닐-3-일기, 4'-프로필바이페닐-3-일기, 5-프로필바이페닐-2-일기, 4'-프로필바이페닐-2-일기, 2',4',6'-트라이프로필바이페닐-2-일기, 3-아이소프로필바이페닐-4-일기, 4'-아이소프로필바이페닐-4-일기, 2',4',6'-트라이아이소프로필바이페닐-4-일기, 6-아이소프로필바이페닐-3-일기, 4'-아이소프로필바이페닐-3-일기, 5-아이소프로필바이페닐-2-일기, 4'-아이소프로필바이페닐-2-일기, 2',4',6'-트라이아이소프로필바이페닐-2-일기, 3-뷰틸바이페닐-4-일기, 4'-뷰틸바이페닐-4-일기, 2',4',6'-트라이뷰틸바이페닐-4-일기, 6-뷰틸바이페닐-3-일기, 4'-뷰틸바이페닐-3-일기, 5-뷰틸바이페닐-2-일기, 4'-뷰틸바이페닐-2-일기, 2',4',6'-트라이뷰틸바이페닐-2-일기, 3-tert-뷰틸바이페닐-4-일기, 4'-tert-뷰틸바이페닐-4-일기, 2',4',6'-트라이-tert-뷰틸바이페닐-4-일기, 6-tert-뷰틸바이페닐-3-일기, 4'-tert-뷰틸바이페닐-3-일기, 5-tert-뷰틸바이페닐-2-일기, 4'-tert-뷰틸바이페닐-2-일기, 2',4',6'-트라이-tert-뷰틸바이페닐-2-일기, 2-피리딜기, 3-피리딜기, 4-피리딜기, 2-메틸피리딘-3-일기, 2-메틸피리딘-4-일기, 2-메틸피리딘-5-일기, 2-메틸피리딘-6-일기, 3-메틸피리딘-2-일기, 3-메틸피리딘-4-일기, 3-메틸피리딘-5-일기, 3-메틸피리딘-6-일기, 4-메틸피리딘-2-일기, 4-메틸피리딘-3-일기, 2,6-다이메틸피리딘-3-일기, 2,6-다이메틸피리딘-4-일기, 3,6-다이메틸피리딘-2-일기, 3,6-다이메틸피리딘-4-일기, 3,6-다이메틸피리딘-5-일기, 2-페닐피리딘-6-일기, 3-페닐피리딘-6-일기, 4-페닐피리딘-6-일기, 5-페닐피리딘-6-일기, 2-페닐피리딘-3-일기, 2-페닐피리딘-5-일기, 3-페닐피리딘-5-일기, 4-페닐피리딘-3-일기, 3-페닐피리딘-4-일기, 2-페닐피리딘-4-일기, 2-(2-피리딜)페닐기, 3-(2-피리딜)페닐기, 4-(2-피리딜)페닐기, 2-(3-피리딜)페닐기, 3-(3-피리딜)페닐기, 4-(3-피리딜)페닐기, 2-(4-피리딜)페닐기, 3-(4-피리딜)페닐기, 4-(4-피리딜)페닐기, 1-나프틸기, 2-나프틸기, 1-페닐나프탈렌-2-일기, 1-페닐나프탈렌-3-일기, 1-페닐나프탈렌-4-일기, 1-페닐나프탈렌-5-일기, 1-페닐나프탈렌-6-일기, 1-페닐나프탈렌-7-일기, 1-페닐나프탈렌-8-일기, 2-페닐나프탈렌-1-일기, 2-페닐나프탈렌-3-일기, 2-페닐나프탈렌-4-일기, 2-페닐나프탈렌-5-일기, 2-페닐나프탈렌-6-일기, 2-페닐나프탈렌-7-일기, 2-페닐나프탈렌-8-일기, 1-메틸나프탈렌-4-일기, 1-메틸나프탈렌-5-일기, 1-메틸나프탈렌-6-일기, 1-메틸나프탈렌-7-일기, 1-메틸나프탈렌-8-일기, 2-메틸나프탈렌-1-일기, 2-메틸나프탈렌-3-일기, 2-메틸나프탈렌-4-일기, 2-메틸나프탈렌-5-일기, 2-메틸나프탈렌-6-일기, 2-메틸나프탈렌-7-일기, 2-메틸나프탈렌-8-일기, 1-페난톨릴기, 2-페난톨릴기, 3-페난톨릴기, 4-페난톨릴기, 9-페난톨릴기, 1-페닐페난트렌-2-일기, 1-페닐페난트렌-3-일기, 1-페닐페난트렌-4-일기, 1-페닐페난트렌-5-일기, 1-페닐페난트렌-6-일기, 1-페닐페난트렌-7-일기, 1-페닐페난트렌-8-일기, 1-페닐페난트렌-9-일기, 1-페닐페난트렌-10-일기, 2-페닐페난트렌-1-일기, 2-페닐페난트렌-3-일기, 2-페닐페난트렌-4-일기, 2-페닐페난트렌-5-일기, 2-페닐페난트렌-6-일기, 2-페닐페난트렌-7-일기, 2-페닐페난트렌-8-일기, 2-페닐페난트렌-9-일기, 2-페닐페난트렌-10-일기, 3-페닐페난트렌-1-일기, 3-페닐페난트렌-2-일기, 3-페닐페난트렌-4-일기, 3-페닐페난트렌-5-일기, 3-페닐페난트렌-6-일기, 3-페닐페난트렌-7-일기, 3-페닐페난트렌-8-일기, 3-페닐페난트렌-9-일기, 3-페닐페난트렌-10-일기, 4-페닐페난트렌-1-일기, 4-페닐페난트렌-2-일기, 4-페닐페난트렌-3-일기, 4-페닐페난트렌-5-일기, 4-페닐페난트렌-6-일기, 4-페닐페난트렌-7-일기, 4-페닐페난트렌-8-일기, 4-페닐페난트렌-9-일기, 4-페닐페난트렌-10-일기, 1-메틸페난트렌-2-일기, 1-메틸페난트렌-3-일기, 1-메틸페난트렌-4-일기, 1-메틸페난트렌-5-일기, 1-메틸페난트렌-6-일기, 1-메틸페난트렌-7-일기, 1-메틸페난트렌-8-일기, 1-메틸페난트렌-9-일기, 1-메틸페난트렌-10-일기, 2-메틸페난트렌-1-일기, 2-메틸페난트렌-3-일기, 2-메틸페난트렌-4-일기, 2-메틸페난트렌-5-일기, 2-메틸페난트렌-6-일기, 2-메틸페난트렌-7-일기, 2-메틸페난트렌-8-일기, 2-메틸페난트렌-9-일기, 2-메틸페난트렌-10-일기, 3-메틸페난트렌-1-일기, 3-메틸페난트렌-2-일기, 3-메틸페난트렌-4-일기, 3-메틸페난트렌-5-일기, 3-메틸페난트렌-6-일기, 3-메틸페난트렌-7-일기, 3-메틸페난트렌-8-일기, 3-메틸페난트렌-9-일기, 3-메틸페난트렌-10-일기, 4-메틸페난트렌-1-일기, 4-메틸페난트렌-2-일기, 4-메틸페난트렌-3-일기, 4-메틸페난트렌-5-일기, 4-메틸페난트렌-6-일기, 4-메틸페난트렌-7-일기, 4-메틸페난트렌-8-일기, 4-메틸페난트렌-9-일기, 4-메틸페난트렌-10-일기, 1-안톨릴기, 2-안톨릴기, 9-안톨릴기, 1-페닐안트라센-2-일기, 1-페닐안트라센-3-일기, 1-페닐안트라센-4-일기, 1-페닐안트라센-5-일기, 1-페닐안트라센-6-일기, 1-페닐안트라센-7-일기, 1-페닐안트라센-8-일기, 1-페닐안트라센-9-일기, 1-페닐안트라센-10-일기, 2-페닐안트라센-1-일기, 2-페닐안트라센-3-일기, 2-페닐안트라센-4-일기, 2-페닐안트라센-5-일기, 2-페닐안트라센-6-일기, 2-페닐안트라센-7-일기, 2-페닐안트라센-8-일기, 2-페닐안트라센-9-일기, 2-페닐안트라센-10-일기, 9-페닐안트라센-1-일기, 9-페닐안트라센-2-일기, 9-페닐안트라센-3-일기, 9-페닐안트라센-4-일기, 9-페닐안트라센-5-일기, 1-피레닐기, 2-피레닐기, 4-피레닐기, 1-페닐피렌-2-일기, 1-페닐피렌-3-일기, 1-페닐피렌-4-일기, 1-페닐피렌-5-일기, 1-페닐피렌-6-일기, 1-페닐피렌-7-일기, 1-페닐피렌-8-일기, 1-페닐피렌-9-일기, 1-페닐피렌-10-일기, 2-페닐피렌-1-일기, 2-페닐피렌-3-일기, 2-페닐피렌-4-일기, 2-페닐피렌-5-일기, 2-페닐피렌-6-일기, 2-페닐피렌-7-일기, 2-페닐피렌-8-일기, 2-페닐피렌-9-일기, 2-페닐피렌-10-일기, 9-페닐피렌-1-일기, 9-페닐피렌-2-일기, 9-페닐피렌-3-일기, 9-페닐피렌-4-일기, 9-페닐피렌-5-일기, 9-페닐피렌-6-일기, 9-페닐피렌-7-일기, 9-페닐피렌-8-일기, 9-페닐피렌-10-일기, 1-메틸피렌-2-일기, 1-메틸피렌-3-일기, 1-메틸피렌-4-일기, 1-메틸피렌-5-일기, 1-메틸피렌-6-일기, 1-메틸피렌-7-일기, 1-메틸피렌-8-일기, 1-메틸피렌-9-일기, 1-메틸피렌-10-일기, 2-메틸피렌-1-일기, 2-메틸피렌-3-일기, 2-메틸피렌-4-일기, 2-메틸피렌-5-일기, 2-메틸피렌-6-일기, 2-메틸피렌-7-일기, 2-메틸피렌-8-일기, 2-메틸피렌-9-일기, 2-메틸피렌-10-일기, 9-메틸피렌-1-일기, 9-메틸피렌-2-일기, 9-메틸피렌-3-일기, 9-메틸피렌-4-일기, 9-메틸피렌-5-일기, 9-메틸피렌-6-일기, 9-메틸피렌-7-일기, 9-메틸피렌-8-일기, 9-메틸피렌-10-일기, 플루오란텐-1-일기, 플루오란텐-1-일기, 플루오란텐-2-일기, 플루오란텐-3-일기, 플루오란텐-4-일기, 플루오란텐-5-일기, 플루오란텐-6-일기, 플루오란텐-7-일기, 플루오란텐-8-일기, 플루오란텐-9-일기, 플루오란텐-10-일기, 트라이페닐렌-1-일기, 트라이페닐렌-2-일기, 아세나프틸렌-1-일기, 아세나프틸렌-3-일기, 아세나프틸렌-4-일기, 아세나프틸렌-5-일기, 크리센-1-일기, 크리센-2-일기, 크리센-5-일기, 크리센-6-일기, 2-퀴놀릴기, 3-퀴놀릴기, 4-퀴놀릴기, 5-퀴놀릴기, 6-퀴놀릴기, 7-퀴놀릴기, 8-퀴놀릴기, 1-아이소퀴놀릴기, 3-아이소퀴놀릴기, 4-아이소퀴놀릴기, 5-아이소퀴놀릴기, 6-아이소퀴놀릴기, 7-아이소퀴놀릴기, 8-아이소퀴놀릴기, 퀴녹살린-2-일기, 퀴녹살린-5-일기, 퀴녹살린-6-일기, 퀴나졸린-2-일기, 퀴나졸린-4-일기, 퀴나졸린-5-일기, 퀴나졸린-6-일기, 퀴나졸린-7-일기, 퀴나졸린-8-일기, 피라진-2-일기, 피리미딘-2-일기, 피리미딘-4-일기, 피리미딘-5-일기, 아크리딘-1-일기, 아크리딘-1-일기, 아크리딘-2-일기, 아크리딘-3-일기, 아크리딘-4-일기, 아크리딘-9-일기, 페난트리딘-1-일기, 페난트리딘-1-일기, 페난트리딘-2-일기, 페난트리딘-3-일기, 페난트리딘-4-일기, 페난트리딘-6-일기, 페난트리딘-7-일기, 페난트리딘-8-일기, 페난트리딘-9-일기, 페난트리딘-10-일기, 페나딘-1-일기, 페나딘-2-일기, 벤조[h]퀴놀린-2-일기, 벤조[h]퀴놀린-3-일기, 벤조[h]퀴놀린-4-일기, 벤조[h]퀴놀린-5-일기, 벤조[h]퀴놀린-6-일기, 벤조[h]퀴놀린-7-일기, 벤조[h]퀴놀린-8-일기, 벤조[h]퀴놀린-9-일기, 벤조[h]퀴놀린-10-일기, 2-(바이페닐-4-일)피리딘-4-일기, 2-(바이페닐-4-일)피리딘-4-일기, 2-(바이페닐-4-일)피리딘-5-일기, 2-(바이페닐-4-일)피리딘-5-일기, 2-(바이페닐-3-일)피리딘-4-일기, 2-(바이페닐-3-일)피리딘-5-일기, 2-(바이페닐-3-일)피리딘-5-일기, 3-(바이페닐-4-일)피리딘-5-일기, 3-(바이페닐-4-일)피리딘-6-일기, 3-(바이페닐-3-일)피리딘-5-일기, 3-(바이페닐-3-일)피리딘-6-일기, 4-(바이페닐-4-일)피리딘-2-일기, 4-(바이페닐-3-일)피리딘-2-일기, 2-(바이페닐-4-일)피리미딘-4-일기, 2-(바이페닐-4-일)피리미딘-5-일기, 4-(바이페닐-4-일)피리미딘-2-일기, 4-(바이페닐-4-일)피리미딘-6-일기, 5-(바이페닐-4-일)피리미딘-2-일기, 2-(바이페닐-3-일)피리미딘-4-일기, 2-(바이페닐-3-일)피리미딘-5-일기, 4-(바이페닐-3-일)피리미딘-2-일기, 4-(바이페닐-3-일)피리미딘-6-일기, 5-(바이페닐-3-일)피리미딘-2-일기, 2-(바이페닐-4-일)피라진-5-일기 또는 2-(바이페닐-3-일)피라진-5-일기, 6-(1-나프틸)피리딘-2-일기, 6-(1-나프틸)피리딘-3-일기, 6-(1-나프틸)피리딘-4-일기, 5-(1-나프틸)피리딘-2-일기, 5-(1-나프틸)피리딘-3-일기, 6-(2-나프틸)피리딘-2-일기, 6-(2-나프틸)피리딘-3-일기, 6-(2-나프틸)피리딘-4-일기, 5-(2-나프틸)피리딘-2-일기, 5-(2-나프틸)피리딘-3-일기, 5-(1-나프틸)피라진-1-일기, 또는 5-(2-나프틸)피라진-1-일기 등을 바람직한 예로서 들 수 있다. 이들 치환기 중, 전자수송성 재료 특성이 우수한 점에서, 페닐기, 바이페닐-3-일기, 바이페닐-4-일기, 2-피리딜기, 3-피리딜기, 4-피리딜기, 3-(2-피리딜)페닐기, 4-(2-피리딜)페닐기, 3-(3-피리딜)페닐기, 4-(3-피리딜)페닐기, 2-피리딜기, 3-피리딜기, 2-페닐피리딘-6-일기, 2-페닐피리딘-5-일기, 2-페닐피리딘-4-일기, 3-페닐피리딘-5-일기, 3-페닐피리딘-6-일기, 1-나프틸기, 2-나프틸기, 2-퀴놀릴기, 3-퀴놀릴기, 4-퀴놀릴기, 5-퀴놀릴기, 6-퀴놀릴기, 7-퀴놀릴기, 8-퀴놀릴기, 1-아이소퀴놀릴기, 3-아이소퀴놀릴기, 4-아이소퀴놀릴기, 5-아이소퀴놀릴기, 6-아이소퀴놀릴기, 7-아이소퀴놀릴기, 8-아이소퀴놀릴기, 2-페난트리딜기, 또는 6-(2-나프틸)피리딘-3-일기가 보다 바람직하고, 페닐기, 바이페닐-3-일기, 바이페닐-4-일기, 2-피리딜기, 3-피리딜기, 2-퀴놀릴기, 3-퀴놀릴기, 1-아이소퀴놀릴기, 3-아이소퀴놀릴기 또는 4-아이소퀴놀릴기가 더욱 바람직하다.Specific examples of Ar 3 include, but are not limited to, a phenyl group, a p-tolyl group, an m-tolyl group, an o-tolyl group, a 2,4-dimethylphenyl group, Ethylphenyl group, 4-ethylphenyl group, 2,4-diethylphenyl group, 3,5-diethylphenyl group, 2-propylphenyl group, 3-propylphenyl group, Isopropylphenyl group, a 2,4-diisopropylphenyl group, a 3,5-diisopropylphenyl group, a 2-butylphenyl group, a 2-methylphenyl group, Butylphenyl group, 2-tert-butylphenyl group, 3-tert-butylphenyl group, 4-tert-butylphenyl group, Di-tert-butylphenyl group, 3,5-di-tert-butylphenyl group, biphenyl-2-yl group, biphenyl- , 2'-methylbiphenyl-4-yl group, 4'-methylbai Methylbiphenyl-3-yl group, a 5'-methylbiphenyl-4-yl group, a 2'- Methyl biphenyl-3-yl group, 2'-methylbiphenyl-3-yl group, 4'- Methylbiphenyl-2-yl group, 2'-methylbiphenyl-2-yl group, 4'-methylbiphenyl-2-yl group, 2-yl group, 6,2'-dimethylbiphenyl-2-yl group, 2 ', 4', 6'-trimethylbiphenyl- Ethyl biphenyl-3-yl group, 4'-ethylbiphenyl-3-yl group, 5-ethylbiphenyl-4-yl group, Yl group, 4'-ethylbiphenyl-2-yl group, 2 ', 4', 6'-triethylbiphenyl- Propylbiphenyl-3-yl group, a 4'-propylbiphenyl-3-yl group, a 4'- Isopropylbiphenyl-4-yl group, 3-isopropylbiphenyl-4-yl group, Isopropylbiphenyl-3-yl group, 4'-isopropylbiphenyl-4-yl group, 2'4 ', 6'-triisopropylbiphenyl- Isopropylbiphenyl-2-yl group, 3'-yl group, 5'-isopropylbiphenyl-2-yl group, 4'- 4-yl group, 4'-butylbiphenyl-4-yl group, 2 ', 4', 6'-tributylbiphenyl- 2-yl group, 3-tert-butyl-2-yl group, 4'-yl group, 4'-tert-butylbiphenyl-4-yl group, 2'4'6'-tri-tert- -Yl group, 4'-tert-butylbiphenyl-3-yl group, 5-tert- 2-yl group, 2'-tri-butylbiphenyl-2-yl group, 2-pyridyl group, 3-pyridyl group, Yl group, a 2-methylpyridin-6-yl group, a 3-methylpyridin-2-yl group, a 2-methylpyridin- Methylpyridin-2-yl group, a 4-methylpyridin-3-yl group, a 2,6-di 3-yl group, 3,6-dimethylpyridin-4-yl group, 3,6-dimethylpyridin-4-yl group, Yl group, a 2-phenylpyridin-6-yl group, a 3-phenylpyridin-6-yl group, 2-phenylpyridin-4-yl group, 2-phenylpyridin-5-yl group, (2-pyridyl) phenyl group, 3- (2-pyridyl) phenyl group, 4- (4-pyridyl) phenyl group, 4- (3-pyridyl) phenyl group, 2- A naphthyl group, a 2-naphthyl group, a 1-phenylnaphthalen-2-yl group, a 1-phenylnaphthalen-3-yl group, a 1-phenylnaphthalen- 1-yl group, 2-phenylnaphthalen-3-yl group, 2-phenylnaphthalen-4-yl group, 2-phenylnaphthalen- Phenylnaphthalen-4-yl group, 1-methylnaphthalene-5-yl group, 2-phenylnaphthalen-6-yl group, 2- Methyl naphthalene-1-yl group, 2-methylnaphthalen-3-yl group, 2-methyl naphthalene-2-yl group, A naphthalene-4-yl group, a 2-methylnaphthalen-5-yl group, a 2-methylnaphthalen-6-yl group, Phenantholyl , 1-phenylphenanthrene-3-yl group, 1-phenylphenanthrene-4-yl group, 1-phenylphenanthrene-2-yl group, A 1-phenylphenanthrene-9-yl group, a 1-phenylphenanthrene-9-yl group, a 1-phenylphenanthrene-6-yl group, A 2-phenylphenanthrene-4-yl group, a 2-phenylphenanthrene-5-yl group, a 2-phenylphenanthrene- 2-phenylphenanthren-9-yl group, 2-phenylphenanthrene-10-yl group, 3-phenylphenanthrene-6-yl group, 3-phenylphenanthrene-5-yl group, 3-phenylphenanthrene-6-yl group, 3-phenylphenanthrene-2-yl group, Yl group, 3-phenylphenanthrene-10-yl group, 4-phenylphenanthrene-1-yl group, 4-phenylphenanthrene- Phenylphenanthrene-2-yl group, 4-phenylphenanthrene-3-yl group, 4- Phenanthren-9-yl group, 4-phenylphenanthrene-9-yl group, 4-phenylphenanthrene-6-yl group, Methylphenanthrene-3-yl group, 1-methylphenanthrene-4-yl group, 1-methylphenanthrene-5-yl group, 1-methyl Yl group, 1-methylphenanthrene-10-yl group, 1-methylphenanthrene-10-yl group, 2-methyl Methylphenanthrene-4-yl group, 2-methylphenanthrene-5-yl group, 2-methylphenanthrene-6-yl group, 2-methyl Methylphenanthrene-10-yl group, a 3-methylphenanthrene-1-yl group, a 3-methylphenanthrene-9-yl group, Methylphenanthren-5-yl group, 3-methylphenanthren-6-yl group, 3-methylphenanthren-7-yl group, 3-methyl A phenanthren-8-yl group, a 3-methylphenanthrene-9-yl group, And n is an integer of 1 to 4, and n is an integer of 0 to 3. The term " naphthylthien-2-yl group " Yl group, 4-methylphenanthrene-10-yl group, 4-methylphenanthrene-8-yl group, 4-methylphenanthrene- 1-phenylanthracene-4-yl group, 1-phenylanthracene-5-yl group, 1- 1-phenylanthracene-10-yl group, 2-phenylanthracene-10-yl group, 2-phenylanthracene- A phenanthracene-6-yl group, a 2-phenylanthracene-7-yl group, a 2-phenylthiophenanthracene-5-yl group, Anthracene-8-yl group, 2-phenylanthracene-9-yl group, 2-phenylanthracene-10-yl group, , A 9-phenylanthracene-4-yl group, a 9-phenylanthracene-5-yl group, a 1-pyrenyl group, Yl group, a 1-phenylpyran-8-yl group, a 1-phenylpyran-4-yl group, Yl group, a 2-phenylpyran-4-yl group, a 2-phenylpyran-5-yl group, Yl group, 2-phenylpyrylene-10-yl group, 9-phenylpyrene-9-yl group, Yl group, a 9-phenylpyran-5-yl group, a 9-phenylpyran-6-yl group, Methylpyran-2-yl group, a 1-methylpyran-3-yl group, a 1-methylpyran-8-yl group, Methylpyran-8-yl group, 1-methylpyran-9-yl group, 1-methylpyran-6-yl group, -methyl Yl group, 2-methylpyrylene-5-yl group, 2-methylpyrylene-6-yl group, Methylpyran-9-yl group, a 9-methylpyran-1-yl group, a 9-methylpyran-8-yl group, Yl group, a 9-methylpyrylene-6-yl group, a 9-methylpyrrene-7-yl group, Yl group, a fluoranthene-1-yl group, a fluoranthene-2-yl group, a fluoranthene-3-yl group, Yl group, fluoranthen-5-yl group, fluoranthene-6-yl group, fluoranthen-7-yl group, fluoranthene-8-yl group, fluoranthene- An acenaphthylene-1-yl group, an acenaphthylene-4-yl group, an acenaphthylene-1-yl group, Yl group, a chrysene-1-yl group, a chrysene-2-yl group, a chrysene-5-yl group, A 2-quinolyl group, a 3-quinolyl group, a 4-quinolyl group, a 5-quinolyl group, a 6-quinolyl group, a 7-quinolyl group, Isoquinolyl group, 8-isoquinolyl group, quinoxalin-2-yl group, 4-isoquinolyl group, 4-isoquinolyl group, 5-isoquinolyl group, 6-isoquinolyl group, A quinazolin-5-yl group, a quinazolin-6-yl group, a quinazolin-6-yl group, a quinazolin- A pyrimidin-2-yl group, a pyrimidin-4-yl group, a pyrimidin-5-yl group, an acridine-1-yl group, an acridine- An acridine-2-yl group, an acridine-3-yl group, an acridine-4-yl group, an acridine-9-yl group, a phenanthridin- A phenanthridin-6-yl group, a phenanthridin-7-yl group, a phenanthridin-8-yl group, a phenanthridin-4-yl group, A 9-yl group, a phenanthridine-10-yl group, Yl group, benzo [h] quinolin-2-yl group, benzo [h] quinolin-3-yl group, benzo [h] Yl group, benzo [h] quinolin-6-yl group, benzo [h] quinolin-7-yl group, benzo [h] quinolin- (Biphenyl-4-yl) pyridin-4-yl group, 2- (biphenyl-4-yl) pyridin- Yl group, 2- (biphenyl-3-yl) pyridin-5-yl group, 2- (Biphenyl-4-yl) pyridin-5-yl group, 3- (biphenyl- Yl) pyridin-2-yl group, 4- (biphenyl-3-yl) pyridin- (Biphenyl-4-yl) pyrimidin-2-yl group, 2- (biphenyl- Yl) pyrimidin-2-yl group, 4- (biphenyl-4-yl) (Biphenyl-3-yl) pyrimidin-2-yl group, 2- (biphenyl- (Biphenyl-3-yl) pyrimidin-5-yl group, 4- Yl group or a 2- (biphenyl-3-yl) pyrazin-5-yl group, 6- (1-naphthyl) pyridine- (1-naphthyl) pyridin-2-yl group, 5- (1-naphthyl) pyridin- (2-naphthyl) pyridin-3-yl group, 6- (2-naphthyl) pyridin- A 5- (2-naphthyl) pyridin-1-yl group, or a 5- (2-naphthyl) Naphthyl) pyrazin-1-yl group, and the like. Among these substituents, preferred are a phenyl group, a biphenyl-3-yl group, a biphenyl-4-yl group, a 2-pyridyl group, a 3-pyridyl group, (3-pyridyl) phenyl group, a 2-pyridyl group, a 3-pyridyl group, a 2-phenylpyridine-6 3-phenylpyridin-6-yl group, 1-naphthyl group, 2-naphthyl group, 2-naphthyl group, 2-phenylpyridin-4-yl group, Quinolyl group, 8-quinolyl group, 1-isoquinolyl group, 3-quinolyl group, 3-quinolyl group, 4-quinolyl group, Isoquinolyl group, 8-isoquinolyl group, 2-phenanthrityl group, or 6- (4-isoquinolyl group, 2-naphthyl) pyridin-3-yl group is more preferable and a phenyl group, a biphenyl-3-yl group, a biphenyl-4-yl group, a 2-pyridyl group, a 3-pyridyl group, 1-iso Quinolyl group, more preferably a 3-isoquinolyl group, or 4-isoquinolyl.

Z1 및 Z2 중 어느 한쪽이 질소 원자를 나타내고, 또 한쪽은 C-H를 나타낸다.Provided that either one of Z 1 and Z 2 represents a nitrogen atom and the other represents CH.

본 화합물은 유기 전계발광소자의 구성 성분의 일부로서 이용하면, 고발광 효율화, 장수명화, 저전압화 등의 효과가 얻어진다. 특히, 전자수송층으로서 이용한 경우에 이 효과가 현저하게 나타난다.When this compound is used as a part of the constituent components of the organic electroluminescent device, effects such as high luminous efficiency, long life, and low voltage can be obtained. Particularly, this effect is remarkable when used as an electron transporting layer.

일반식 (1)로 표시되는 화합물은, 전자수송 재료로서의 특성이 우수한 점에서 하기 일반식 (1)' 또는 (1)"로 표시되는 것이 보다 바람직하다.The compound represented by the general formula (1) is more preferably represented by the following general formula (1) 'or (1)' in view of excellent properties as an electron transporting material.

Figure pct00002
Figure pct00002

(일반식 (1)' 및 (1)" 중, Ar1, Ar2, Ar3, 2개의 Ar4, Z1 및 Z2는, 상기 일반식 (1)과 같은 의미이다.)(In the general formulas (1) 'and (1)', Ar 1 , Ar 2 , Ar 3 and two Ar 4 , Z 1 and Z 2 have the same meanings as in the general formula (1).)

일반식 (1)로 표시되는 화합물의 특히 바람직한 화합물의 구체예로서는, 다음 (A-1)로부터 (A-288)을 예시할 수 있지만, 본 발명은 이들로 한정되는 것은 아니다.Specific examples of the particularly preferable compound of the compound represented by the general formula (1) include the following (A-1) to (A-288), but the present invention is not limited thereto.

Figure pct00003
Figure pct00003

Figure pct00004
Figure pct00004

Figure pct00005
Figure pct00005

Figure pct00006
Figure pct00006

Figure pct00007
Figure pct00007

Figure pct00008
Figure pct00008

Figure pct00009
Figure pct00009

Figure pct00010
Figure pct00010

Figure pct00011
Figure pct00011

Figure pct00012
Figure pct00012

Figure pct00013
Figure pct00013

Figure pct00014
Figure pct00014

Figure pct00015
Figure pct00015

Figure pct00016
Figure pct00016

Figure pct00017
Figure pct00017

Figure pct00018
Figure pct00018

Figure pct00019
Figure pct00019

Figure pct00020
Figure pct00020

Figure pct00021
Figure pct00021

Figure pct00022
Figure pct00022

Figure pct00023
Figure pct00023

Figure pct00024
Figure pct00024

Figure pct00025
Figure pct00025

Figure pct00026
Figure pct00026

Figure pct00027
Figure pct00027

Figure pct00028
Figure pct00028

Figure pct00029
Figure pct00029

Figure pct00030
Figure pct00030

Figure pct00031
Figure pct00031

Figure pct00032
Figure pct00032

Figure pct00033
Figure pct00033

Figure pct00034
Figure pct00034

다음에, 본 발명의 제조 방법에 대해서 설명한다.Next, the production method of the present invention will be described.

본 발명의 트라이아진 화합물(1)은, 염기의 존재 하 또는 비존재 하에, 팔라듐 촉매의 존재 하에서, 다음 반응식 (1)The triazine compound (1) of the present invention can be prepared by reacting the triazine compound (1) in the presence of a base or in the absence of a base in the presence of a palladium catalyst,

Figure pct00035
Figure pct00035

(반응식 (1) 중, Ar1, Ar2, Ar3, Ar4, Z1 및 Z2는, 상기와 같은 치환기를 나타낸다. Y1 및 Y2는, 각각 독립적으로, 후술하는 이탈기를 나타낸다. M1 및 M2는, 각각 독립적으로, 후술하는 치환기를 나타낸다.)(In the reaction formula (1), Ar 1 , Ar 2 , Ar 3 , Ar 4 , Z 1 and Z 2 each represent the same substituent as described above, and Y 1 and Y 2 each independently represent a leaving group described below. M 1 and M 2 each independently represent a substituent described later.)

반응식 (2)Reaction formula (2)

Figure pct00036
Figure pct00036

(반응식 (2) 중, Ar1, Ar2, Ar3, Ar4, Z1 및 Z2는, 상기와 같은 치환기를 나타낸다. Y1 및 Y2는, 각각 독립적으로, 후술하는 이탈기를 나타낸다. M1 및 M2는, 각각 독립적으로, 후술하는 치환기를 나타낸다.)(In the reaction formula (2), Ar 1 , Ar 2 , Ar 3 , Ar 4 , Z 1 and Z 2 each represent a substituent as defined above.) Y 1 and Y 2 each independently represent a leaving group described below. M 1 and M 2 each independently represent a substituent described later.)

반응식 (3)Reaction formula (3)

Figure pct00037
Figure pct00037

(반응식 (3) 중, Ar1, Ar2, Ar3, Ar4, Z1 및 Z2는, 상기와 같은 치환기를 나타낸다. Y3은 후술하는 이탈기를 나타낸다. M3은 후술하는 치환기를 나타낸다.),(In the formula (3), Ar 1 , Ar 2 , Ar 3 , Ar 4 , Z 1 and Z 2 each represent a substituent as described above, Y 3 represents a leaving group described later, and M 3 represents a substituent .),

또는 반응식 (4)Or (4)

Figure pct00038
Figure pct00038

(반응식 (4) 중, Ar1, Ar2, Ar3, Ar4, Z1 및 Z2는, 상기와 같은 치환기를 나타낸다. Y4는 후술하는 이탈기를 나타낸다. M4는 후술하는 치환기를 나타낸다.)(In the formula (4), Ar 1 , Ar 2 , Ar 3 , Ar 4 , Z 1 and Z 2 each represent a substituent as described above, Y 4 represents a leaving group to be described later, and M 4 represents a substituent .)

로 표시되는 방법에 의해 제조할 수 있다.As shown in FIG.

또, 이후, 일반식 (2)로 표시되는 화합물에 대해서는 화합물(2)라고 칭한다. 또한, 화합물(3) 내지 화합물(10)에 대해서도 마찬가지 의미로 한다.Hereinafter, the compound represented by the general formula (2) is referred to as the compound (2). The same applies to the compounds (3) to (10).

M1, M2, M3 및 M4는, 각각 독립적으로, ZnR1, MgR2, Sn(R3)3 또는 B(OR4)2를 나타낸다. 단, R1 및 R2는, 각각 독립적으로, 염소 원자, 브로민 원자 또는 요오드 원자를 나타내고, R3은 탄소수 1로부터 4의 알킬기 또는 페닐기를 나타내며, R4는 수소 원자, 탄소수 1로부터 4의 알킬기 또는 페닐기를 나타내고, B(OR4)2의 2개의 R4는, 동일 또는 상이해도 된다. 또한, 2개의 R4는 일체로 되어서 산소 원자 및 붕소 원자를 포함해서 환을 형성할 수도 있다.M 1 , M 2 , M 3 and M 4 each independently represent ZnR 1 , MgR 2 , Sn (R 3 ) 3 or B (OR 4 ) 2 . However, R 1 and R 2 are, each independently, a chlorine atom, a bromine atom or an iodine atom, R 3 represents an alkyl group or a phenyl group of 4 from having 1, R 4 is a 4-from a hydrogen atom, a C 1 An alkyl group or a phenyl group, and two R 4 groups of B (OR 4 ) 2 may be the same or different. The two R 4 may be monosubstituted to form a ring including an oxygen atom and a boron atom.

ZnR1, MgR2로서는, ZnCl, ZnBr, ZnI, MgCl, MgBr, MgI 등을 예시할 수 있다.Examples of ZnR 1 and MgR 2 include ZnCl 2 , ZnBr, ZnI, MgCl 2, MgBr, and MgI.

Sn(R3)3로서는 Sn(Me)3, Sn(Bu)3 등을 예시할 수 있다.Examples of Sn (R 3 ) 3 include Sn (Me) 3 and Sn (Bu) 3 .

B(OR4)2로서는, B(OH)2, B(OMe)2, B(OiPr)2, B(OBu)2 등을 예시할 수 있다. 또한, 2개의 R4가 일체로 되어서 산소 원자 및 붕소 원자를 포함해서 환을 형성했을 경우의 B(OR4)2의 예로서는, 다음 (C-1)로부터 (C-6)으로 표시되는 기를 예시할 수 있고, 수율이 양호한 점에서 (C-2)로 표시되는 기가 바람직하다.Examples of B (OR 4 ) 2 include B (OH) 2 , B (OMe) 2 , B (OiPr) 2 and B (OBu) 2 . Examples of B (OR 4 ) 2 in the case where two R 4 are combined to form a ring including an oxygen atom and a boron atom include the groups represented by the following (C-1) to (C-6) And the group represented by (C-2) is preferred in view of good yield.

Figure pct00039
Figure pct00039

반응식 (1) 또는 반응식 (2)에서 이용되는 화합물(3)은, 예를 들면, 일본국 공개 특허 제2005-268199호 공보의 [0105] 내지 [0121], 일본국 공개 특허 제2008-280330호 공보의 [0061] 내지 [0076] 또는 일본국 공개 특허 제2001-335516호 공보의 [0047] 내지 [0082]에 개시되어 있는 방법을 조합시켜서 제조할 수 있다. 화합물(3)로서는, 다음의 (B-1)로부터 (B-18)을 예시할 수 있지만, 본 발명은 이들로 한정되는 것은 아니다.The compound (3) used in the reaction formula (1) or the reaction formula (2) is, for example, a compound represented by the formulas [0105] to [0121] of JP 2005-268199, Can be produced by combining the methods disclosed in publications [0061] to [0076] of JP-A No. 2001-335516 or [0047] to [0082] of JP-A No. 2001-335516. As the compound (3), the following (B-1) to (B-18) can be exemplified, but the present invention is not limited thereto.

Figure pct00040
Figure pct00040

Figure pct00041
Figure pct00041

반응식 (1) 또는 반응식 (2)에서 이용되는 화합물(4)은, 예를 들면, 일본국 공개 특허 제2008-280330호 공보의 [0061] 내지 [0076]에 개시되어 있는 방법 또는 일본국 공개 특허 제2001-335516호 공보 [0047] 내지 [0082]에 개시되어 있는 방법을 이용해서 제조할 수 있다. 화합물(4) 중의 M2는 상기 M1과 마찬가지의 치환기를 예시할 수 있다. 화합물(4)로서는, 다음의 (D-1)로부터 (D-20)을 예시할 수 있지만, 본 발명은 이들로 한정되는 것은 아니다.The compound (4) used in Reaction Scheme (1) or Reaction Scheme (2) can be synthesized by a method disclosed in, for example, JP-A-2008-280330 [0061] to [0076] Can be produced by using the method disclosed in JP-A-2001-335516 and the method disclosed in JP-A-2001-335516. M 2 in the compound (4) may be the same as the substituent described above for M 1 . As the compound (4), the following (D-1) to (D-20) can be exemplified, but the present invention is not limited thereto.

Figure pct00042
Figure pct00042

Figure pct00043
Figure pct00043

반응식 (3)에서 이용되는 화합물(6)은, 상기 화합물(4)의 M2를 Y3으로 치환한 골격을 예시할 수 있다.The compound (6) used in the reaction formula (3) can be exemplified by a skeleton in which M 2 of the compound (4) is substituted with Y 3 .

반응식 (4)에서 이용되는 화합물(8)은, 상기 화합물(3)의 M1을 Y4로 치환한 골격을 예시할 수 있다.The compound (8) used in the reaction formula (4) can be exemplified by a skeleton wherein M 1 of the compound (3) is substituted with Y 4 .

화합물(6)의 Y3 및 화합물(8)의 Y4는 각각 독립적으로 이탈기를 나타내고, 특별히 한정하는 것이 아니지만, 예를 들면 염소 원자, 브로민 원자, 요오드 원자 또는 트라이플레이트(triflate) 등을 들 수 있다. 이 중, 반응 수율이 양호한 점에서 브로민 원자 또는 염소 원자가 바람직하다. 단, 원료의 입수성으로부터 트라이플레이트를 이용한 쪽이 바람직할 경우도 있다.The Y 3 of the compound (6) and the Y 4 of the compound (8) each independently represent a leaving group and are not particularly limited. Examples thereof include a chlorine atom, a bromine atom, an iodine atom or a triflate, . Of these, a bromine atom or a chlorine atom is preferable in that the reaction yield is good. However, it may be preferable to use a triplate from the availability of the raw material.

화합물(2)의 Y1 및 Y2는 각각 독립적으로 이탈기를 나타내고, 해당 이탈기로서는, 특별히 한정하는 것이 아니지만, 예를 들면 염소 원자, 브로민 원자, 요오드 원자 또는 트라이플레이트 등을 들 수 있다. 이 중, 반응 수율이 양호한 점에서 브로민 원자 또는 염소 원자가 바람직하다. 또한, 반응의 선택성을 향상시키기 위해서 Y1 및 Y2는 다른 이탈기를 가지고 있는 쪽이 더욱 바람직하다.Y 1 and Y 2 in the compound (2) each independently represent a leaving group, and the leaving group is not particularly limited, and examples thereof include a chlorine atom, a bromine atom, an iodine atom or a triflate. Of these, a bromine atom or a chlorine atom is preferable in that the reaction yield is good. Further, in order to improve the selectivity of the reaction, it is more preferable that Y 1 and Y 2 have other leaving groups.

계속해서, 반응식 (1)에 대해서 설명한다. 「공정 1」은 화합물(2)를, 염기의 존재 하 또는 비존재 하에, 팔라듐 촉매의 존재 하에, 화합물(3)과 반응시켜, 합성 중간체인 화합물(9)를 얻는 방법이며, 스즈키-미야우라 반응 반응(Suzuki-Miyaura reaction), 네기시 반응(Negishi reaction), 타마오-쿠마다 반응(Tamao-Kumada reaction) 및 스틸레 반응(Stille reaction) 등의, 일반적인 커플링 반응의 반응 조건을 적용함으로써, 수율 양호하게 목적물을 얻을 수 있다.Next, the reaction formula (1) will be described. "Process 1" is a process for obtaining a compound (9) as a synthetic intermediate by reacting a compound (2) with a compound (3) in the presence or absence of a base in the presence of a palladium catalyst, By applying the reaction conditions of a typical coupling reaction such as a Suzuki-Miyaura reaction, a Negishi reaction, a Tamao-Kumada reaction, and a Stille reaction, The desired product can be obtained in a satisfactory yield.

「공정 1」에서 이용하는 것이 가능한 팔라듐 촉매로서는, 염화 팔라듐, 아세트산 팔라듐, 트라이플루오로아세트산 팔라듐, 질산 팔라듐 등의 염을 예시할 수 있다. 또한, π-아릴팔라듐클로라이드 다이머, 팔라듐아세틸아세토네이트, 트리스(다이벤질리덴아세톤)다이팔라듐, 다이클로로비스(트라이페닐포스핀)팔라듐, 테트라키스(트라이페닐포스핀)팔라듐 및 다이클로로(1,1'-비스(다이페닐포스피노)페로센)팔라듐 등의 착화합물을 예시할 수 있다. 중에서도, 제3급 포스핀을 배위자로서 지니는 팔라듐 착체는 반응 수율이 양호한 점에서 더욱 바람직하고, 입수 용이하고, 반응 수율이 양호한 점에서, 트라이페닐포스핀을 배위자로서 지니는 팔라듐 착체가 특히 바람직하다.Examples of the palladium catalyst that can be used in "Step 1" include palladium chloride, palladium acetate, palladium trifluoroacetate, and palladium nitrate. (Triphenylphosphine) palladium, tetrakis (triphenylphosphine) palladium and dichloro (1, 2-diisopropylbenzene) palladium, , 1'-bis (diphenylphosphino) ferrocene) palladium, and the like. Among these, a palladium complex having a tertiary phosphine as a ligand is more preferable in view of a good reaction yield, and a palladium complex having triphenylphosphine as a ligand is particularly preferable because it is easy to obtain and the reaction yield is good.

제3급 포스핀을 배위자로서 지니는 팔라듐 착체는, 팔라듐염 또는 착화합물에 제3급 포스핀을 첨가하여, 반응계 중에서 조제할 수도 있다. 이때 이용 가능한 제3급 포스핀으로서는, 트라이페닐포스핀, 트라이메틸포스핀, 트라이뷰틸포스핀, 트라이(tert-뷰틸)포스핀, 트라이사이클로헥실포스핀, tert-뷰틸다이페닐포스핀, 9,9-다이메틸-4,5-비스(다이페닐포스피노)잔텐, 2-(다이페닐포스피노)-2'-(N,N-다이메틸아미노)바이페닐, 2-(다이-tert-뷰틸포스피노)바이페닐, 2-(다이사이클로헥실포스피노)바이페닐, 비스(다이페닐포스피노)메탄, 1,2-비스(다이페닐포스피노)에탄, 1,3-비스(다이페닐포스피노)프로판, 1,4-비스(다이페닐포스피노)부탄, 1,1'-비스(다이페닐포스피노)페로센, 트라이(2-퓨릴)포스핀, 트라이(o-톨릴)포스핀, 트리스(2,5-자일릴)포스핀、(±)-2,2'-비스(다이페닐포스피노)-1,1'-바이나프틸, 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐 등을 예시할 수 있다. 입수 용이하고, 반응 수율이 양호한 점에서, 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐 또는 트라이페닐포스핀이 바람직하다. 제3급 포스핀과 팔라듐염 또는 착화합물의 몰비는, 1:10 내지 10:1이 바람직하고, 반응 수율이 양호한 점에서 1:2 내지 5:1이 더욱 바람직하다.The palladium complex having a tertiary phosphine as a ligand can be prepared in a reaction system by adding a tertiary phosphine to a palladium salt or a complex compound. Examples of usable tertiary phosphines include triphenylphosphine, trimethylphosphine, tributylphosphine, tri (tert-butyl) phosphine, tricyclohexylphosphine, tert-butyldiphenylphosphine, (Diphenylphosphino) -2'- (N, N-dimethylamino) biphenyl, 2- (di-tert-butyl Bis (diphenylphosphino) ethane, 1,3-bis (diphenylphosphino) biphenyl, bis (diphenylphosphino) ) Propane, 1,4-bis (diphenylphosphino) butane, 1,1'-bis (diphenylphosphino) ferrocene, tri (2-furyl) phosphine, tri Bis (diphenylphosphino) -1,1'-binaphthyl, 2-dicyclohexylphosphino-2 ', 4' 6'-triisopropylbiphenyl, and the like. 2-dicyclohexylphosphino-2 ', 4', 6'-triisopropylbiphenyl or triphenylphosphine is preferred because it is readily available and has a good reaction yield. The molar ratio of the tertiary phosphine to the palladium salt or complex is preferably 1:10 to 10: 1, and more preferably 1: 2 to 5: 1 in terms of good reaction yield.

「공정 1」에서 이용하는 것이 가능한 염기로서는, 수산화나트륨, 수산화칼륨, 탄산 나트륨, 탄산 칼륨, 탄산 리튬, 탄산 세슘, 인산 칼륨, 인산 나트륨, 플루오르화나트륨, 플루오르화칼륨, 플루오르화세슘 등을 예시할 수 있고, 수율이 양호한 점에서 탄산 칼륨이 바람직하다. 염기와 화합물(3)의 몰비는, 1:2로부터 10:1이 바람직하고, 수율이 양호한 점에서 1:1로부터 3:1이 더욱 바람직하다.Examples of the base which can be used in "Process 1" include sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, lithium carbonate, cesium carbonate, potassium phosphate, sodium phosphate, sodium fluoride, potassium fluoride and cesium fluoride And potassium carbonate is preferable in that the yield is good. The molar ratio of the base to the compound (3) is preferably from 1: 2 to 10: 1, more preferably from 1: 1 to 3: 1 in terms of good yield.

「공정 1」에서 이용하는 화합물(2)과 화합물(3)의 몰비는, 1:2로부터 5:1이 바람직하고, 수율이 양호한 점에서 1:2로부터 2:1이 더욱 바람직하다.The molar ratio of the compound (2) to the compound (3) used in the " process 1 " is preferably 1: 2 to 5: 1, and more preferably 1: 2 to 2: 1.

「공정 1」에서 이용하는 것이 가능한 용매로서, 물, 다이메틸설폭사이드, 다이메틸폼아마이드, 테트라하이드로퓨란, 1,4-다이옥산, 다이메톡시에탄, 톨루엔, 벤젠, 다이에틸에터, 에탄올, 메탄올 또는 자일렌 등을 예시할 수 있고, 이것들을 적당히 조합시켜서 이용해도 된다. 수율이 양호한 점에서 다이옥산 또는 THF와 물의 혼합 용매를 이용하는 것이 바람직하다.As a solvent which can be used in the " Process 1 ", water, dimethylsulfoxide, dimethylformamide, tetrahydrofuran, 1,4-dioxane, dimethoxyethane, toluene, benzene, diethylether, Or xylene, and these may be used in appropriate combination. It is preferable to use dioxane or a mixed solvent of THF and water in view of good yield.

「공정 1」은, 0℃ 내지 150℃로부터 적당히 선택된 온도에서 실시할 수 있고, 수율이 양호한 점에서 50℃에서부터 100℃에서 행하는 것이 더욱 바람직하다.&Quot; Process 1 " can be carried out at a temperature appropriately selected from 0 ° C to 150 ° C, and more preferably at 50 ° C to 100 ° C from the viewpoint of good yield.

화합물(9)는, 「공정 1」의 종료 후에 통상의 처리를 함으로써 얻어진다. 필요에 따라서, 재결정, 칼럼 크로마토그래피 또는 승화 등으로 정제해도 된다. 「공정 2」는 화합물(9)를, 경우에 따라서는 염기의 존재 하에, 팔라듐 촉매의 존재 하에 화합물(4)와 반응시켜, 본 발명의 트라이아진 화합물(1)을 얻는 방법이며, 스즈키-미야우라 반응 반응, 네기시 반응, 타마오-쿠마다 반응, 스틸레 반응 등의, 일반적인 커플링 반응의 반응 조건을 적용함으로써, 수율 양호하게 목적물을 얻을 수 있다. 「공정 2」는 「공정 1」에서 제시한 조건과 마찬가지 반응 조건을 선택할 수 있다. 단, 「공정 1」과 같은 반응 조건일 필요는 없다. 또 합성 중간체인 화합물(9)를 단리시키지 않고 「공정 1」의 반응계 중에 화합물(4)을 추가하고, 트라이아진 화합물(1)을 합성할 수도 있다. 「공정 2」의 종료 후, 필요에 따라서, 재결정, 칼럼 크로마토그래피 또는 승화 등으로 정제해도 된다.Compound (9) is obtained by carrying out usual treatment after the termination of " process 1 ". If necessary, it may be purified by recrystallization, column chromatography or sublimation. Is a method for obtaining triazine compound (1) of the present invention by reacting compound (9) with compound (4) optionally in the presence of a base in the presence of a palladium catalyst, and the Suzuki- By applying the reaction conditions of a typical coupling reaction such as a Urea reaction, a Negishi reaction, a Tamao-Kumar reaction, and a Stille reaction, the desired product can be obtained in a satisfactory yield. &Quot; Process 2 " can be selected from reaction conditions similar to those described in " Process 1 ". However, the reaction conditions need not be the same as those in " Process 1 ". The triazine compound (1) can also be synthesized by adding the compound (4) to the reaction system of the "Step 1" without isolating the compound (9) as a synthetic intermediate. After completion of the " process 2 ", it may be purified by recrystallization, column chromatography or sublimation, if necessary.

계속해서, 반응식 (2)에 대해서 설명한다. 「공정 3」은 화합물(2)를, 경우에 따라서는 염기의 존재 하에, 팔라듐 촉매의 존재 하에 화합물(4)와 반응시켜, 합성 중간체인 화합물(10)을 얻는 방법이며, 스즈키-미야우라 반응 반응, 네기시 반응, 타마오-쿠마다 반응, 스틸레 반응 등의, 일반적인 커플링 반응의 반응 조건을 적용함으로써, 수율 양호하게 목적물을 얻을 수 있다. 「공정 3」은 「공정 1」에서 예시된 조건과 같은 반응 조건을 선택할 수 있다. 단, 「공정 1」과 같은 반응 조건일 필요는 없다. 「공정 3」의 종료 후, 필요에 따라서, 재결정, 칼럼 크로마토그래피 또는 승화 등으로 정제해도 된다. 「공정 4」는 화합물(10)을, 경우에 따라서는 염기의 존재 하에, 팔라듐 촉매의 존재 하에 화합물(3)과 반응시켜, 본 발명의 트라이아진 화합물(1)을 얻는 방법이며, 스즈키-미야우라 반응 반응, 네기시 반응, 타마오-쿠마다 반응, 스틸레 반응 등의, 일반적인 커플링 반응의 반응 조건을 적용함으로써, 수율 양호하게 목적물을 얻을 수 있다. 「공정 4」는 「공정 1」에서 제시된 조건과 마찬가지인 반응 조건을 선택할 수 있다. 단, 「공정 1」과 같은 반응 조건일 필요는 없다. 또 합성 중간체인 화합물(10)을 단리하지 않고 「공정 3」의 반응계 중에 화합물(3)을 추가하고, 트라이아진 화합물(1)을 합성할 수도 있다. 「공정 4」의 종료 후, 필요에 따라서, 재결정, 칼럼 크로마토그래피 또는 승화 등으로 정제해도 된다.Next, the reaction formula (2) will be described. "Step 3" is a method of reacting compound (2) with compound (4) optionally in the presence of a base in the presence of a palladium catalyst to obtain compound (10) as a synthetic intermediate, and Suzuki-Miyaura reaction By applying the reaction conditions of a typical coupling reaction such as reaction, Negishi reaction, Tamao-Kumar reaction, Stille reaction and the like, the desired product can be obtained in good yield. &Quot; Process 3 " can select reaction conditions such as those exemplified in " Process 1 ". However, the reaction conditions need not be the same as those in " Process 1 ". After completion of the " process 3 ", it may be purified by recrystallization, column chromatography or sublimation, if necessary. "Step 4" is a method for obtaining the triazine compound (1) of the present invention by reacting the compound (10) with the compound (3) in the presence of a base optionally in the presence of a palladium catalyst, By applying the reaction conditions of a typical coupling reaction such as a Urea reaction, a Negishi reaction, a Tamao-Kumar reaction, and a Stille reaction, the desired product can be obtained in a satisfactory yield. The " process 4 " can select the reaction conditions similar to the conditions shown in " process 1 ". However, the reaction conditions need not be the same as those in " Process 1 ". Alternatively, the triazine compound (1) may be synthesized by adding the compound (3) to the reaction system of the "Step 3" without isolating the compound (10) as a synthetic intermediate. After completion of the " Step 4 ", it may be purified by recrystallization, column chromatography or sublimation, if necessary.

계속해서, 반응식 (3)에 대해서 설명한다. 「공정 5」에서 이용되는 화합물(5)은, 화합물(9)로부터, 일반적인 유기금속화합물을 합성하는 반응(예를 들면 Angew.Chem.Int.Ed. 2007, 46, 5359-5363)을 이용해서 합성할 수 있다. 「공정 5」는 화합물(5)을, 경우에 따라서는 염기의 존재 하에, 팔라듐 촉매의 존재 하에 화합물(6)과 반응시켜, 본 발명의 트라이아진 화합물(1)을 얻는 방법이며, 스즈키-미야우라 반응 반응, 네기시 반응, 타마오-쿠마다 반응, 스틸레 반응 등의, 일반적인 커플링 반응의 반응 조건을 적용함으로써, 수율 양호하게 목적물을 얻을 수 있다.Next, the reaction formula (3) will be described. The compound (5) used in the " Step 5 " can be synthesized from the compound (9) by using a reaction for synthesizing a general organometallic compound (for example, Angew.Chem.Int. Ed. 2007, 46, 5359-5363) Can be synthesized. Is a method for obtaining triazine compound (1) of the present invention by reacting compound (5) with compound (6) optionally in the presence of a base in the presence of a palladium catalyst, and the Suzuki- By applying the reaction conditions of a typical coupling reaction such as a Urea reaction, a Negishi reaction, a Tamao-Kumar reaction, and a Stille reaction, the desired product can be obtained in a satisfactory yield.

「공정 5」에서 이용하는 것이 가능한 팔라듐 촉매로서는, 「공정 1」에서 제시된 것과 마찬가지의 팔라듐 촉매를 들 수 있다. 그 중에서도, 제3급 포스핀을 배위자로서 지니는 팔라듐 착체는 반응 수율이 양호한 점에서 더욱 바람직하고, 입수 용이하고, 반응 수율이 양호한 점에서, 트라이페닐포스핀을 배위자로서 지니는 팔라듐 착체가 특히 바람직하다.Examples of the palladium catalyst that can be used in " Step 5 " include palladium catalysts similar to those shown in " Step 1 ". Among them, a palladium complex having a tertiary phosphine as a ligand is more preferable from the viewpoint of a good reaction yield, and a palladium complex having triphenylphosphine as a ligand is particularly preferable in view of easy availability and good reaction yield .

제3급 포스핀을 배위자로서 지니는 팔라듐 착체는, 팔라듐염 또는 착화합물에 제3급 포스핀을 첨가하여, 반응계 중에서 조제할 수도 있다. 이때 이용하는 것이 가능한 제3급 포스핀으로서는, 「공정 1」에서 제시된 것과 마찬가지의 제3급 포스핀을 들 수 있다. 입수 용이하고, 반응 수율이 양호한 점에서, 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐 또는 트라이페닐포스핀이 바람직하다. 제3급 포스핀과 팔라듐염 또는 착화합물의 몰비는, 1:10 내지 10:1이 바람직하고, 반응 수율이 양호한 점에서 1:2 내지 5:1이 더욱 바람직하다. 「공정 5」에서 이용하는 것이 가능한 염기로서는, 「공정 1」에서 제시된 것과 마찬가지의 염기를 들 수 있다. 염기와 화합물(5)의 몰비는, 1:2로부터 10:1이 바람직하고, 수율이 양호한 점에서 1:1로부터 3:1이 더욱 바람직하다. 「공정 5」에서 이용하는 화합물(5)과 화합물(6)의 몰비는, 1:5로부터 2:1이 바람직하고, 수율이 양호한 점에서 1:1로부터 1:3이 더욱 바람직하다. 「공정 5」에서 이용하는 것이 가능한 용매로서, 「공정 1」에서 제시된 것과 마찬가지의 용매를 들 수 있다. 수율이 양호한 점에서 다이옥산 또는 THF와 물의 혼합 용매를 이용하는 것이 바람직하다. 「공정 5」는, 0℃로부터 150℃에서 적절하게 선택된 온도에서 실시할 수 있고, 수율이 양호한 점에서 50℃에서부터 100℃에서 행하는 것이 더욱 바람직하다. 「공정 5」의 종료 후, 필요에 따라서, 재결정, 칼럼 크로마토그래피 또는 승화 등으로 정제해도 된다.The palladium complex having a tertiary phosphine as a ligand can be prepared in a reaction system by adding a tertiary phosphine to a palladium salt or a complex compound. As the tertiary phosphine which can be used at this time, there is a tertiary phosphine similar to that shown in " Process 1 ". 2-dicyclohexylphosphino-2 ', 4', 6'-triisopropylbiphenyl or triphenylphosphine is preferred because it is readily available and has a good reaction yield. The molar ratio of the tertiary phosphine to the palladium salt or complex is preferably 1:10 to 10: 1, and more preferably 1: 2 to 5: 1 in terms of good reaction yield. The base usable in " Step 5 " includes bases similar to those shown in " Step 1 ". The molar ratio of the base to the compound (5) is preferably from 1: 2 to 10: 1, more preferably from 1: 1 to 3: 1 in terms of good yield. The molar ratio of the compound (5) to the compound (6) used in " Step 5 " is preferably 1: 5 to 2: 1 and more preferably 1: 1 to 1: 3 in view of good yield. As the solvent which can be used in " Process 5 ", the same solvents as those shown in " Process 1 " can be mentioned. It is preferable to use dioxane or a mixed solvent of THF and water in view of good yield. &Quot; Step 5 " can be conducted at a temperature appropriately selected from 0 DEG C to 150 DEG C, and more preferably from 50 DEG C to 100 DEG C from the viewpoint of good yield. After completion of " Step 5 ", purification may be carried out by recrystallization, column chromatography or sublimation, if necessary.

계속해서, 반응식 (4)에 대해서 설명한다. 「공정 6」에서 이용되는 화합물(7)은, 화합물(10)으로부터, 일반적인 유기 금속화합물을 합성하는 반응(예를 들면 Angew.Chem.Int.Ed. 2007, 46, 5359-5363)을 이용해서 합성할 수 있다. 「공정 6」은 화합물(7)을, 경우에 따라서는 염기의 존재 하에, 팔라듐 촉매의 존재 하에 화합물(8)과 반응시켜, 본 발명의 트라이아진 화합물(1)을 얻는 방법이며, 스즈키-미야우라 반응 반응, 네기시 반응, 타마오-쿠마다 반응, 스틸레 반응 등의, 일반적인 커플링 반응의 반응 조건을 적용함으로써, 수율 양호하게 목적물을 얻을 수 있다. 「공정 6」은, 「공정 5」에서 제시된 것과 마찬가지인 반응 조건을 선택할 수 있다. 단, 「공정 5」와 같은 반응 조건일 필요는 없다. 「공정 6」의 종료 후, 필요에 따라서, 재결정, 칼럼 크로마토그래피 또는 승화 등으로 정제해도 된다.Next, the reaction formula (4) will be described. Compound (7) used in " Step 6 " can be synthesized from compound (10) using a reaction for synthesizing a general organometallic compound (for example, Angew.Chem.Int. Ed. 2007, 46, 5359-5363) Can be synthesized. "Step 6" is a method for obtaining the triazine compound (1) of the present invention by reacting the compound (7) with the compound (8) in the presence of a base optionally in the presence of a palladium catalyst, By applying the reaction conditions of a typical coupling reaction such as a Urea reaction, a Negishi reaction, a Tamao-Kumar reaction, and a Stille reaction, the desired product can be obtained in a satisfactory yield. In " Process 6 ", reaction conditions similar to those shown in " Process 5 " can be selected. However, it need not be a reaction condition such as " Step 5 ". After completion of " Step 6 ", it may be purified by recrystallization, column chromatography or sublimation, if necessary.

본 발명의 트라이아진 화합물(1)은 유기 전계발광소자의 구성 성분의 일부로서 이용했을 때에 유효하다. 특히, 전자수송층으로서 이용한 때에, 종래의 소자보다도 장수명화, 고효율화 및 저전압화 등의 효과가 얻어진다. 또한, 본 발명의 트라이아진 화합물(1)을 유기 전계발광소자용 재료로서 이용할 때, 임의의 유기 금속종, 유기 화합물 또는 무기화합물과의 공증착 막으로서 이용하는 것도 가능하다.The triazine compound (1) of the present invention is effective when used as a part of constituent components of an organic electroluminescent device. Particularly, when used as an electron transporting layer, effects such as long lifetime, high efficiency, and low voltage can be obtained as compared with conventional devices. When the triazine compound (1) of the present invention is used as a material for an organic electroluminescence device, it can also be used as a co-deposition film with any organic metal species, organic compound or inorganic compound.

본 발명의 트라이아진 화합물(1)로 이루어진 유기 전계발광소자용 박막의 제조 방법에 특별히 제한은 없지만, 진공증착법에 의한 성막이 가능하다. 진공증착법에 의한 성막은, 범용의 진공 증착 장치를 이용함으로써 행할 수 있다. 진공증착법으로 막을 형성할 때의 진공조의 진공도는, 유기 전계발광소자 제작의 택트 타임(tact time)이나 제조 비용을 고려하면, 일반적으로 이용되는 확산펌프, 터보-분자펌프 혹은 크라이오펌프(cryopump)에 의해 달성될 수 있는 1×10-2㎩ 내지 1×10-5㎩ 정도가 바람직하다. 증착 속도는, 형성하는 막의 두께에 따르지만 0.005 내지 1.0㎚/초가 바람직하다. 또한, 본 발명의 트라이아진 화합물(1)은, 클로로포름, 다이클로로메탄, 1,2-다이클로로에탄, 클로로벤젠, 톨루엔, 아세트산 에틸 또는 테트라하이드로퓨란 등에 대한 용해도가 높기 때문에, 범용의 장치를 이용한 스핀 코트법, 잉크젯법, 주조법 또는 침지법 등에 의한 성막도 가능하다.The method for producing the thin film for an organic electroluminescence device comprising the triazine compound (1) of the present invention is not particularly limited, but it is possible to form a film by a vacuum vapor deposition method. The film formation by the vacuum vapor deposition method can be performed by using a general-purpose vacuum vapor deposition apparatus. The degree of vacuum of the vacuum chamber at the time of forming the film by the vacuum vapor deposition method may be appropriately selected depending on the tact time and manufacturing cost of the organic electroluminescent device, Is preferably about 1 x 10 < -2 > Pa to 1 x 10 < -5 > Pa. The deposition rate depends on the thickness of the film to be formed, but is preferably 0.005 to 1.0 nm / second. Since the solubility of the triazine compound (1) of the present invention is high in chloroform, dichloromethane, 1,2-dichloroethane, chlorobenzene, toluene, ethyl acetate or tetrahydrofuran, A spin coating method, an ink jet method, a casting method, a dipping method, or the like.

[도면의 간단한 설명]BRIEF DESCRIPTION OF THE DRAWINGS Fig.

도 1은 실시형태(소자 평가)에서 제작한 유기 전계발광소자의 단면도.1 is a cross-sectional view of an organic electroluminescent device manufactured in an embodiment (device evaluation).

[[ 실시예Example ]]

이하, 실시예 및 참고예를 제시해서 본 발명을 더욱 상세히 설명하지만, 본 발명은 이들로 한정해서 해석되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to examples and reference examples, but the present invention is not limited to these examples.

합성예-1Synthesis Example 1

Figure pct00044
Figure pct00044

아르곤 기류 하, 2-(3-브로모-5-클로로페닐)-4,6-다이페닐-1,3,5-트라이아진(14.8g, 34.9m㏖), 4-(2-피리딜)페닐보론산(9.04g, 45.4m㏖) 및 테트라키스트라이페닐포스핀팔라듐(808㎎, 0.699m㏖)을 테트라하이드로퓨란(250㎖)에 현탁시키고, 60℃로 가열하였다. 이것에 10% NaOH 수용액(40㎖, 105m㏖)을 천천히 적하한 후, 3시간 교반하였다. 실온까지 방랭 후, 반응 혼합물에 물(90㎖)을 첨가하고, 석출물을 여과하여 취하였다. 얻어진 석출물을 톨루엔에 의한 재결정에 의해 정제시켜, 목적물인 2-[5-클로로-4'-(2-피리딜)바이페닐-3-일]-4,6-다이페닐-1,3,5-트라이아진의 백색 고체(수득량 15.4g, 수율 88.5%)를 얻었다.(14.8 g, 34.9 mmol), 4- (2-pyridyl) -1,3,5-triazin- Phenylboronic acid (9.04 g, 45.4 mmol) and tetrakis triphenylphosphine palladium (808 mg, 0.699 mmol) were suspended in tetrahydrofuran (250 mL) and heated to 60 < 0 > C. A 10% aqueous solution of NaOH (40 ml, 105 mmol) was slowly added dropwise thereto, followed by stirring for 3 hours. After cooling to room temperature, water (90 ml) was added to the reaction mixture, and the precipitate was collected by filtration. The resultant precipitate was purified by recrystallization with toluene to obtain the desired product, 2- [5-chloro-4 '- (2-pyridyl) biphenyl-3-yl] -Triazine as a white solid (yield 15.4 g, yield 88.5%).

1H-NMR(CDCl3): 7.27(ddd, J=5.7Hz, 4.6Hz, 2.3Hz, 1H), 7.56-7.65(m, 6H), 7.77-7.85(m, 5H), 8.16(d, J=8.6Hz, 2H), 8.72-8.74(m, 2H), 8.77(dd, J=8.2Hz, 1.4Hz, 4H), 8.92 (t, J=1.6Hz, 1H). 1 H-NMR (CDCl 3 ): 7.27 (ddd, J = 5.7 Hz, 4.6 Hz, 2.3 Hz, 1H), 7.56-7.65 (m, 6H), 7.77-7.85 = 8.6 Hz, 2H), 8.72-8.74 (m, 2H), 8.77 (dd, J = 8.2 Hz, 1.4 Hz, 4H), 8.92 (t, J = 1.6 Hz, 1H).

합성예-2Synthesis Example 2

Figure pct00045
Figure pct00045

아르곤 기류 하, 2-[5-클로로-4'-(2-피리딜)바이페닐-3-일]-4,6-다이페닐-1,3,5-트라이아진(6.86g, 13.8m㏖), 비스(피나콜라토)다이보론(5.26g, 20.7m㏖), 아세트산 칼륨(4.06g, 41.4m㏖), 아세트산 팔라듐(31.0㎎, 0.138m㏖), 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(131.5㎎, 0.276m㏖)을 1,4-다이옥산(20㎖)에 현탁시키고, 100℃로 가열해서 4시간 교반하였다. 다음에, 반응 용액에 클로로폼 200㎖ 및 물 50㎖를 첨가해서 진탕시키고, 유기층만을 취출하였다. 다음에, 유기층에 황산 마그네슘을 첨가해서 탈수하고, 여과하였다. 얻어진 유기층의 저비점 성분을 증류 제거한 후, 100㎖의 클로로폼에 용해시켰다. 이것에 700㎖의 헥산을 첨가해서 1시간 교반하고, 생성한 석출물을 여과하여 취함으로써, 원하는 4,6-다이페닐-2-[4'-(2-피리딜)-5-(4,4,5,5-테트라메틸-1,3,2-다이옥사보로란-2-일)바이페닐-3-일]-1,3,5-트라이아진의 백색 고체(8.10g, 수율 99.7%)를 얻었다.To a solution of 2- [5-chloro-4 '- (2-pyridyl) biphenyl-3-yl] -4,6-diphenyl-1,3,5-triazine (6.86 g, 13.8 mmol ), Bis (pinacolato) diboron (5.26g, 20.7mmol), potassium acetate (4.06g, 41.4mmol), palladium acetate (31.0mg, 0.138mmol), 2-dicyclohexylphosphino- ', 4', 6'-triisopropylbiphenyl (131.5 mg, 0.276 mmol) was suspended in 1,4-dioxane (20 ml), and the mixture was heated to 100 ° C and stirred for 4 hours. Next, 200 ml of chloroform and 50 ml of water were added to the reaction solution and shaken, and only the organic layer was taken out. Next, magnesium sulfate was added to the organic layer, followed by dehydration and filtration. The low boiling point component of the obtained organic layer was distilled off and dissolved in 100 ml of chloroform. 700 ml of hexane was added thereto, and the mixture was stirred for 1 hour. The resultant precipitate was filtered to obtain the desired 4,6-diphenyl-2- [4 '- (2-pyridyl) -5- Yl) biphenyl-3-yl] -1,3,5-triazine (8.10 g, yield 99.7%) was obtained as a white solid .

1H-NMR(CDCl3): 1.43(s, 12H), 7.23-7.27(m, 1H), 7.56-7.64(m, 6H), 7.78(ddd, J=7.8Hz, 7.8Hz, 1.8Hz, 1H), 7.81(d, J=7.7Hz, 1H), 7.90(d, J=8.5Hz, 2H), 8.14(d, J=8.5Hz, 2H), 8.33(dd, J=1.9Hz, 1.1Hz, 1H), 8.73(ddd, J=4.8Hz, 1.7Hz, 1.1Hz, 1H), 8.81(dd, J=7.8Hz, 1.6Hz, 4H), 9.12-9.14(m, 2H). 1 H-NMR (CDCl 3) : 1.43 (s, 12H), 7.23-7.27 (m, 1H), 7.56-7.64 (m, 6H), 7.78 (ddd, J = 7.8Hz, 7.8Hz, 1.8Hz, 1H J = 8.5 Hz, 2H), 8.14 (d, J = 8.5 Hz, 2H), 8.33 (dd, J = 1.9 Hz, 1.1 Hz, 1H), 8.73 (ddd, J = 4.8Hz, 1.7Hz, 1.1Hz, 1H), 8.81 (dd, J = 7.8Hz, 1.6Hz, 4H), 9.12-9.14 (m, 2H).

합성예-3Synthesis Example 3

Figure pct00046
Figure pct00046

질소 기류 하, N-페나실피리디늄브로마이드(9.93g, 34.6m㏖), 4'-브로모칼콘(14.4g, 51.8m㏖) 및 아세트산 암모늄(53.5g, 691m㏖)을, 아세트산(500㎖) 및 다이메틸폼아마이드(500㎖)의 혼합 용매에 용해시켜, 150℃에서 19시간 교반하였다. 실온까지 방랭 후, 반응 혼합물에 물(500㎖)을 첨가하고, 석출물을 여과하여 취하였다. 여과하여 취한 석출물을 메탄올로 세정하여, 목적으로 하는 2-(4-브로모페닐)-4,6-다이페닐피리딘의 회백색 분말(수득량 10.4g, 수율 77.7%)을 얻었다.(9.93 g, 34.6 mmol), 4'-bromochalcone (14.4 g, 51.8 mmol) and ammonium acetate (53.5 g, 691 mmol) were added to a solution of acetic acid ) And dimethylformamide (500 ml), and the mixture was stirred at 150 占 폚 for 19 hours. After cooling to room temperature, water (500 ml) was added to the reaction mixture, and the precipitate was collected by filtration. The precipitate obtained by filtration was washed with methanol to obtain an objective off-white powder of 2- (4-bromophenyl) -4,6-diphenylpyridine (yield: 10.4 g, yield 77.7%).

1H-NMR(CDCl3); 8.17(d, 2H), 8.07(d, 2H), 7.88(s, 1H), 7.82(s, 1H), 7.71(d, 2H), 7.62(d, 2H), 7.52-7.44(m, 6H). 1 H-NMR (CDCl 3) ; 2H), 7.52-7.44 (m, 6H), 7.17 (d, 2H), 8.07 (d, 2H), 7.88 .

실시예-1Example-1

Figure pct00047
Figure pct00047

아르곤 기류 하, 4,6-다이페닐-2-[4'-(2-피리딜)-5-(4,4,5,5-테트라메틸-1,3,2-다이옥사보로란-2-일)바이페닐-3-일]-1,3,5-트라이아진(4.00g, 6.80m㏖), 2-(4-브로모페닐)-4,6-다이페닐피리딘(3.15g, 8.15m㏖), 아세트산 팔라듐(30.5㎎, 0.135m㏖), 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(129.6㎎, 0.271m㏖), 탄산 칼륨(2.44g, 17.7m㏖)을, 테트라하이드로퓨란(75㎖) 및 물(17㎖)의 혼합 용매에 현탁시키고, 70℃로 가열해서 19시간 교반하였다. 실온까지 방랭 후, 반응 혼합물에 물(100㎖)을 첨가하고, 석출물을 여과하여 취하였다. 얻어진 석출물을 톨루엔에 의한 재결정 및 실리카겔 크로마토그래피(전개 용매: 클로로폼 및 헥산 2:1의 혼합 용매)에 의해 정제시켜, 목적물인 4,6-다이페닐-2-[4-(4,6-다이페닐피리딘-2-일)-4"-(2-피리딜)-1,1':3',1"-터페닐-5'-일]-1,3,5-트라이아진(화합물 A-127)의 백색 고체(수득량 3.35g, 수율 64.2%)를 얻었다.Under argon stream, 4,6-diphenyl-2- [4 '- (2-pyridyl) -5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan- Yl) -1,3,5-triazine (4.00 g, 6.80 mmol) and 2- (4-bromophenyl) -4,6-diphenylpyridine (3.15 g, 8.15 2, 4 ', 6'-triisopropylbiphenyl (129.6 mg, 0.271 mmol) and potassium carbonate (2.44 g, g, 17.7 mmol) was suspended in a mixed solvent of tetrahydrofuran (75 ml) and water (17 ml), heated to 70 占 폚 and stirred for 19 hours. After cooling to room temperature, water (100 ml) was added to the reaction mixture, and the precipitate was collected by filtration. The resulting precipitate was purified by recrystallization with toluene and silica gel chromatography (developing solvent: a mixed solvent of chloroform and hexane 2: 1) to obtain the desired product, 4,6-diphenyl-2- [4- Yl) -1,3,5-triazine (compound A (1-tert-Butylpyridin-2-yl) -127) as a white solid (yield 3.35 g, yield 64.2%).

1H-NMR(CDCl3)δ(ppm): 7.26(ddd, J=6.0Hz, 4.8Hz, 1.4Hz, 1H), 7.44-7.65(m, 12H), 7.78(d, J=6.9Hz, 2H), 7.80(dd, J=7.3Hz, 1.8Hz, 1H), 7.83(d, J=7.8Hz, 1H), 7.92-7.99(m, 6H), 8.17 (t, J=1.8Hz, 1H), 8.19(d, J=8.5Hz, 2H), 8.24(dd, J=8.4Hz, 1.4Hz, 2H), 8.40(d, J=8.5Hz, 2H), 8.74(ddd, J=4.8Hz, 1.8Hz, 1.0Hz, 1H), 8.81(dd, J=8.1Hz, 1.9Hz, 4H), 9.06(dt, J=6.3Hz, 1.6Hz, 2H). 1 H-NMR (CDCl 3) δ (ppm): 7.26 (ddd, J = 6.0Hz, 4.8Hz, 1.4Hz, 1H), 7.44-7.65 (m, 12H), 7.78 (d, J = 6.9Hz, 2H ), 7.80 (dd, J = 7.3 Hz, 1.8 Hz, 1H), 7.83 (d, J = 7.8 Hz, 1H), 7.92-7.99 J = 8.5 Hz, 2H), 8.24 (dd, J = 8.4 Hz, 1.4 Hz, 2H), 8.40 , 1.0 Hz, 1H), 8.81 (dd, J = 8.1 Hz, 1.9 Hz, 4H), 9.06 (dt, J = 6.3 Hz, 1.6 Hz, 2H).

얻어진 화합물 A-127의 Tg는 134℃였다.The Tg of the obtained Compound A-127 was 134 占 폚.

합성예-4Synthesis Example 4

Figure pct00048
Figure pct00048

아르곤 기류 하, 2-(3-브로모-5-클로로페닐)-4,6-다이페닐-1,3,5-트라이아진(25.0g, 59.1m㏖), 3-피리딘보론산(12.0g, 97.6m㏖) 및 테트라키스트라이페닐포스핀팔라듐(2.05g, 1.77m㏖), 탄산 칼륨(24.5g, 177m㏖)을, 테트라하이드로퓨란(500㎖) 및 물(177㎖)의 혼합 용매에 현탁시키고, 70℃로 가열해서 18시간 교반하였다. 다음에, 반응 용매를 증류 제거하고, 클로로폼 및 물을 첨가하고 다시 용해시켰다. 유기층만을 취출하고, 황산 마그네슘을 첨가하고 탈수한 후, 여과하였다. 얻어진 유기층의 저비점 성분을 증류 제거해서 얻어진 회백색 고체를, 톨루엔에 의한 재결정에 의해 정제시켜, 목적물인 2-[5-클로로-3-(3-피리딜)페닐]-4,6-다이페닐-1,3,5-트라이아진의 회백색 고체(수득량 22.6g, 수율 90.9%)를 얻었다.(25.0 g, 59.1 mmol) and 3-pyridine boronic acid (12.0 g, 59.1 mmol) were added to a solution of 2- , Tetrakis triphenylphosphine palladium (2.05 g, 1.77 mmol) and potassium carbonate (24.5 g, 177 mmol) were dissolved in a mixed solvent of tetrahydrofuran (500 ml) and water (177 ml) Suspended, heated to 70 캜 and stirred for 18 hours. Next, the reaction solvent was distilled off, and chloroform and water were added and dissolved again. Only the organic layer was taken out, magnesium sulfate was added, dehydrated, and then filtered. The off-white solid obtained by distilling off the low-boiling point component of the obtained organic layer was purified by recrystallization with toluene to obtain the objective 2- [5-chloro-3- (3-pyridyl) phenyl] 1,3,5-triazine as an off-white solid (yield 22.6 g, yield 90.9%).

1H-NMR(CDCl3): 7.45(dd, J=7.6Hz, 4.8Hz, 1H), 7.56-7.65(m, 6H), 7.78 (t, J=1.9Hz, 1H), 7.99(d, J=7.9Hz, 1H), 8.68(dd, J=4.8Hz, 1.6Hz, 1H), 8.74-8.76(m, 1H), 8.76(d, J=6.5Hz, 4H), 8.86(brs, 1H), 8.99(d, J=2.2Hz, 1H). 1 H-NMR (CDCl 3 ): 7.45 (dd, J = 7.6 Hz, 4.8 Hz, 1H), 7.56-7.65 = 7.9 Hz, 1H), 8.68 (dd, J = 4.8 Hz, 1.6 Hz, 1H), 8.74-8.76 (m, 1H), 8.76 (d, J = 6.5 Hz, 4H), 8.86 8.99 (d, J = 2.2 Hz, 1 H).

합성예-5Synthesis Example 5

Figure pct00049
Figure pct00049

아르곤 기류 하, 2-[5-클로로-3-(3-피리딜)페닐]-4,6-다이페닐-1,3,5-트라이아진(10.0g, 23.8m㏖), 비스(피나콜라토)다이보론(9.07g, 35.7m㏖), 아세트산 칼륨(7.01g, 71.4m㏖), 아세트산 팔라듐(53.4㎎, 0.238m㏖), 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(227㎎, 0.476m㏖)을 1,4-다이옥산(400㎖)에 현탁시키고, 100℃로 가열해서 18시간 교반하였다. 다음에, 반응 용액에 클로로폼 500㎖ 및 물 100㎖를 첨가해서 진탕시키고, 유기층만을 취출하였다. 유기층에 황산 마그네슘을 첨가해서 탈수하고, 여과하였다. 얻어진 유기층의 저비점 성분을 증류 제거한 후, 150㎖의 클로로폼에 용해시켰다. 이것에 1000㎖의 헥산을 첨가해서 1시간 교반하고, 생성한 석출물을 여과하여 취함으로써, 원하는 4,6-다이페닐-2-[3-(3-피리딜)-5-(4,4,5,5-테트라메틸-1,3,2-다이옥사보로란-2-일)페닐]-1,3,5-트라이아진의 백색 고체(9.58g, 수율 78.6%)를 얻었다.A solution of 2- [5-chloro-3- (3-pyridyl) phenyl] -4,6-diphenyl-1,3,5-triazine (10.0 g, 23.8 mmol), bis 2-dicyclohexylphosphino-2 ', 4 ', 6 ', 6,7-dimethoxybenzoic acid (1.0 g, 35.7 mmol), potassium acetate (7.01 g, 71.4 mmol), palladium acetate '-Triisopropylbiphenyl (227 mg, 0.476 mmol) was suspended in 1,4-dioxane (400 ml), and the mixture was heated to 100 ° C and stirred for 18 hours. Next, 500 ml of chloroform and 100 ml of water were added to the reaction solution and shaken, and only the organic layer was taken out. The organic layer was dehydrated by adding magnesium sulfate and filtered. The low boiling point component of the obtained organic layer was distilled off, and then dissolved in 150 ml of chloroform. 1000 ml of hexane was added thereto and the mixture was stirred for 1 hour and the resultant precipitate was collected by filtration to obtain the desired 4,6-diphenyl-2- [3- (3-pyridyl) -5- 5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl] -1,3,5-triazine as a white solid (9.58 g, yield 78.6%).

1H-NMR(CDCl3)δ(ppm): 1.42(s, 12H), 7.43(ddd, J=7.8Hz, 4.8Hz, 0.7Hz, 1H), 7.56-7.64(m, 6H), 8.06(ddd, J=7.8Hz, 2.3Hz, 1.6Hz, 1H), 8.23(dd, J=2.1Hz, 1.0Hz, 1H), 8.65(dd, J=4.9Hz, 1.6Hz, 1H), 8.79(dd, J=8.0Hz, 1.4Hz, 4H), 9.04(dd, J=2.5Hz, 0.8Hz, 1H), 9.08 (t, J=1.9Hz, 1H), 9.16(dd, J=1.7Hz, 1.1Hz, 1H). 1 H-NMR (CDCl 3 )? (Ppm): 1.42 (s, 12H), 7.43 (ddd, J = 7.8Hz, 4.8Hz, 0.7Hz, 1H), 7.56-7.64 J = 7.8 Hz, 2.3 Hz, 1.6 Hz, 1H), 8.23 (dd, J = 2.1 Hz, 1.0 Hz, 1H), 8.65 (dd, J = 4.9 Hz, 1.6 Hz, 1H) = 8.0 Hz, 1.4 Hz, 4H), 9.04 (dd, J = 2.5 Hz, 0.8 Hz, 1H), 9.08 (t, J = 1.9 Hz, 1H), 9.16 ).

실시예-2Example-2

Figure pct00050
Figure pct00050

아르곤 기류 하, 4,6-다이페닐-2-[3-(3-피리딜)-5-(4,4,5,5-테트라메틸-1,3,2-다이옥사보로란-2-일)페닐]-1,3,5-트라이아진(3.00g, 5.85m㏖), 2-(4-브로모페닐)-4,6-다이페닐피리딘(2.71g, 7.03m㏖), 아세트산 팔라듐(13.1㎎, 0.058m㏖), 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(55.8㎎, 0.117m㏖), 탄산 칼륨(2.10g, 15.2m㏖)을, 테트라하이드로퓨란(35㎖) 및 물(15㎖)의 혼합 용매에 현탁시키고, 70℃로 가열해서 20시간 교반하였다. 실온까지 방랭 후, 반응 혼합물에 물(50㎖)을 첨가하고, 석출물을 여과하여 취하였다. 얻어진 석출물을 실리카겔 크로마토그래피(전개 용매:클로로폼) 및 톨루엔에 의한 재결정에 의해 정제시켜, 목적물인 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(3-피리딜)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-37)의 백색 고체(수득량 2.66g, 수율 65.8%)를 얻었다.To a solution of 4,6-diphenyl-2- [3- (3-pyridyl) -5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan- Phenyl) -1,3,5-triazine (3.00 g, 5.85 mmol), 2- (4-bromophenyl) -4,6-diphenylpyridine (2.71 g, 7.03 mmol) 2-dicyclohexylphosphino-2 ', 4', 6'-triisopropylbiphenyl (55.8 mg, 0.117 mmol) and potassium carbonate (2.10 g, 15.2 mmol) Was suspended in a mixed solvent of tetrahydrofuran (35 ml) and water (15 ml), and the mixture was heated to 70 캜 and stirred for 20 hours. After cooling to room temperature, water (50 ml) was added to the reaction mixture, and the precipitate was collected by filtration. The obtained precipitate was purified by recrystallization with silica gel chromatography (developing solvent: chloroform) and toluene to obtain the desired product, 4,6-diphenyl-2- [4 '- (4,6- (Yield: 2.66 g, yield 65.8%) of 5- (3-pyridyl) -biphenyl-3-yl] -1,3,5-triazine (Compound A-37).

1H-NMR(CDCl3)δ(ppm): 7.46-7.67(m, 13H), 7.80(dd, J=8.3Hz, 1.4Hz, 2H), 7.94(d, J=1.4Hz, 1H), 7.96(d, J=8.5Hz, 2H), 8.00(d, J=1.4Hz, 1H), 8.11 (t, J=1.8Hz, 1H), 8.12(ddd, J=7.2Hz, 2.3Hz, 1.7Hz, 1H), 8.26(dd, J=8.3Hz, 1.3Hz, 2H), 8.42(d, J=8.5Hz, 2H), 8.72(dd, J=4.8Hz, 1.6Hz, 1H), 8.82(dd, J=8.2Hz, 1.4Hz, 4H), 9.01 (t, J=1.6Hz, 1H), 9.11(d, J=2.2Hz, 1H), 9.12 (t, J=5.0Hz, 1H). 1 H-NMR (CDCl 3 )? (Ppm): 7.46-7.67 (m, 13H), 7.80 (dd, J = 8.3 Hz, 1.4 Hz, 2H) (t, J = 1.8 Hz, 1H), 8.12 (ddd, J = 7.2 Hz, 2.3 Hz, 1.7 Hz, 1H) J = 8.3 Hz, 1.3 Hz, 2H), 8.42 (d, J = 8.5 Hz, 2H), 8.72 (dd, J = 4.8 Hz, 1.6 Hz, 1H), 8.82 = 8.2 Hz, 1.4 Hz, 4H), 9.01 (t, J = 1.6 Hz, 1H), 9.11 (d, J = 2.2 Hz, 1H), 9.12 (t, J = 5.0 Hz, 1H).

얻어진 화합물 A-37의 Tg는 122℃였다.The Tg of the obtained Compound A-37 was 122 占 폚.

합성예-6Synthesis Example 6

Figure pct00051
Figure pct00051

아르곤 기류 하, 2-(3-브로모-5-클로로페닐)-4,6-다이페닐-1,3,5-트라이아진(70.0g, 0.166㏖), 9-페난트렌보론산(38.6g, 0.174㏖), 테트라키스(트라이페닐포스핀)팔라듐(3.83g, 3.31m㏖)을 테트라하이드로퓨란(1000㎖)에 현탁시키고 4.0M-수산화나트륨 수용액(124㎖,0.497㏖)에 적하하였다. 얻어진 혼합물을 70℃에서 24시간 교반하였다. 방랭 후, 물(550㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 재결정(톨루엔)시킴으로써, 반응 중간체인 2-[3-클로로-5-(9-페난트릴)페닐]-4,6-다이페닐-1,3,5-트라이아진의 백색 고체(수득량 78.9g, 수율 92%)를 얻었다.(70.0 g, 0.166 mol) and 9-phenanthreneboronic acid (38.6 g, 0.166 mol) in a stream of argon were added to a solution of 2- (3-bromo-5-chlorophenyl) , 0.174 mol) and tetrakis (triphenylphosphine) palladium (3.83 g, 3.31 mmol) were suspended in tetrahydrofuran (1000 ml) and added dropwise to 4.0 M aqueous sodium hydroxide solution (124 ml, 0.497 mol). The resulting mixture was stirred at 70 占 폚 for 24 hours. After cooling, water (550 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. (Toluene), a white solid of the reaction intermediate 2- [3-chloro-5- (9-phenanthryl) phenyl] -4,6-diphenyl-1,3,5-triazine (yield 78.9 g , Yield: 92%).

합성예-7Synthesis Example-7

Figure pct00052
Figure pct00052

아르곤 기류 하, 합성예-6에서 얻어진 2-[3-클로로-5-(9-페난트릴)페닐]-4,6-다이페닐-1,3,5-트라이아진(5.20g, 10m㏖), 비스피나콜라토 다이보론(3.81g, 15m㏖), 아세트산 팔라듐(22.5㎎, 0.10m㏖), 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(95.4㎎, 0.20m㏖), 아세트산 칼륨(2.95g, 30m㏖)을 1,4-다이옥산(200㎖)에 현탁시키고, 100℃에서 4시간 교반하였다. 방랭 후, 여과에 의해 침전 성분을 제거하였다. 클로로폼(200㎖), 물(100㎖)을 첨가해서 교반한 후, 수층과 유기층을 분리하였다. 또한, 수층을 클로로폼(50㎖)으로 3회 추출하고, 유기층과 합하였다. 유기층으로부터 저비점 성분을 감압 농축, 건조 고형화시켜 조질의 생성물을 얻었다. 헥산을 첨가하고 0℃로 냉각하면서 교반·현탁시켜, 얻어진 고체를 여과하여 취하였다. 얻어진 고체를 감압 건조시킴으로써, 2-[3-{(4,4,5,5-테트라메틸-1,3,2-다이옥사보로란-2-일)페닐}-5-(9-페난트릴)페닐]-4,6-다이페닐-1,3,5-트라이아진의 유백색 분말(수득량 6.07g, 수율 99%)을 얻었다.2- (3-chloro-5- (9-phenanthryl) phenyl] -4,6-diphenyl-1,3,5-triazine (5.20 g, 10 mmol) , Bispinacolato diboron (3.81 g, 15 mmol), palladium acetate (22.5 mg, 0.10 mmol), 2-dicyclohexylphosphino-2 ', 4', 6'-triisopropylbiphenyl And potassium acetate (2.95 g, 30 mmol) were suspended in 1,4-dioxane (200 ml), and the mixture was stirred at 100 ° C for 4 hours. After cooling, the precipitated component was removed by filtration. Chloroform (200 ml) and water (100 ml) were added and stirred, followed by separation of the aqueous layer and the organic layer. Further, the aqueous layer was extracted three times with chloroform (50 ml) and combined with the organic layer. From the organic layer, the low boiling point component was concentrated under reduced pressure, dried and solidified to obtain a crude product. Hexane was added thereto, and the mixture was stirred and cooled while being cooled to 0 deg. C, and the obtained solid was collected by filtration. The resulting solid was dried under reduced pressure to give 2- [3 - {(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl} ) Phenyl] -4,6-diphenyl-1,3,5-triazine (yield 6.07 g, yield 99%).

1H-NMR(CDCl3)δ(ppm): 1.43(s, 12H), 7.51-7.75(m, 10H), 7.82(s, 1H), 7.89-7.98(m, 2H), 8.23(brs, 1H), 8.75-8.81(m, 5H), 8.83(brd, J=8.2Hz, 1H), 9.01(brs, 1H), 9.24(brs, 1H). 1 H-NMR (CDCl 3 )? (Ppm): 1.43 (s, 12H), 7.51-7.75 (m, 10H), 7.82 ), 8.75-8.81 (m, 5H), 8.83 (brd, J = 8.2 Hz, 1H), 9.01 (brs, 1H), 9.24 (brs, 1H).

실시예-3Example-3

Figure pct00053
Figure pct00053

질소 기류 하, 합성예-7에서 얻어진 2-[3-{(4,4,5,5-테트라메틸-1,3,2-다이옥사보로란-2-일)페닐}-5-(9-페난트릴)페닐]-4,6-다이페닐-1,3,5-트라이아진(1.58g, 2.59m㏖), 2-(4-브로모페닐)-4,6-다이페닐피리딘(1.00g, 2.59m㏖), 테트라키스트라이페닐포스핀팔라듐(89.8㎎, 0.078m㏖), 10% NaOH 수용액(2.25g, 7.77m㏖), 테트라하이드로퓨란(30㎖)을 100㎖ 4구 플라스크에 가하고, 70℃에서 2시간 교반하였다. 실온까지 방랭 후, 반응 혼합물에 물(50㎖)을 첨가하고, 석출물을 여과하여 취하였다. 여과하여 취한 석출물을 순수, 메탄올, 헥산으로 순차 세정하여, 회색 분말을 얻었다. 얻어진 회색 분말을 톨루엔으로 재결정함으로써 정제시켜, 목적물인 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(9-페난트릴)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-165)의 회백색 분말(수득량 1.53g, 수율 74.6%,)을 얻었다.A solution of 2- [3 - {(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl} -5- (9 (1.58 g, 2.59 mmol), 2- (4-bromophenyl) -4,6-diphenylpyridine (1.00 g, 2.59 mmol), tetrakis triphenylphosphine palladium (89.8 mg, 0.078 mmol), 10% aqueous NaOH solution (2.25 g, 7.77 mmol) and tetrahydrofuran And the mixture was stirred at 70 ° C for 2 hours. After cooling to room temperature, water (50 ml) was added to the reaction mixture, and the precipitate was collected by filtration. The precipitate obtained by filtration was washed successively with pure water, methanol and hexane to obtain a gray powder. The obtained gray powder was purified by recrystallization with toluene to obtain 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridin-2-yl) -5- (9-phenanthryl) Phenyl-3-yl] -1,3,5-triazine (Compound A-165) (yield 1.53 g, yield 74.6%).

1H-NMR(CDCl3)δ(ppm): 7.43-7.62(m, 13H), 7.66 (t, J=7.2Hz, 1H), 7.72 (t, J=7.8Hz, 2H), 7.77(dd, J=8.5Hz, 1.4Hz, 2H), 7.91(d, J=7.4Hz, 2H), 7.98(d, J=8.2Hz, 4H), 8.04(dd, J=8.3Hz, 1.0Hz, 1H), 8.09 (t, J=1.8Hz, 1H), 8.23(dd, J=8.2Hz, 1.4Hz, 2H), 8.38(d, J=8.6Hz, 2H), 8.78(dd, J=8.3Hz, 1.5Hz, 4H), 8.77-8.79(m, 1H), 8.84(d, J=8.0Hz, 1H), 8.94 (t, J=1.6Hz, 1H), 9.19(t, 1.7Hz, 1H). 1 H-NMR (CDCl 3) δ (ppm): 7.43-7.62 (m, 13H), 7.66 (t, J = 7.2Hz, 1H), 7.72 (t, J = 7.8Hz, 2H), 7.77 (dd, J = 8.5 Hz, 1.4 Hz, 2H), 7.91 (d, J = 7.4 Hz, 2H), 7.98 (d, J = 8.2 Hz, 4H), 8.04 (dd, J = 8.3 Hz, 1.0 Hz, 1H) J = 8.0 Hz, 1H), 8.23 (dd, J = 8.2 Hz, 1.4 Hz, 2H), 8.38 (d, J = 8.6 Hz, 2H), 8.78 J = 8.0 Hz, 1H), 8.94 (t, J = 1.6 Hz, 1H), 9.19 (t, 1.7 Hz, 1H).

얻어진 화합물 A-165의 Tg는 152℃였다.The Tg of the obtained Compound A-165 was 152 占 폚.

합성예-8Synthesis Example-8

Figure pct00054
Figure pct00054

아르곤 기류 하, 합성예-3에서 얻어진 2-(4-브로모페닐)-4,6-다이페닐피리딘(15g, 38.8m㏖)을 테트라하이드로퓨란(195㎖)에 용해시켜, -78℃로 냉각시켰다. 얻어진 용액에, 1.64M의 n-뷰틸리튬/헥산 용액(25.9㎖, 42.7m㏖)을 천천히 적하한 후, 0.5시간 교반하였다. 얻어진 용액에, 붕산 트라이아이소프로필(11.7㎖, 50.5m㏖)을 천천히 적하하고, 1시간 교반하였다. 얻어진 용액을 실온까지 승온시키고, 18시간 교반하였다. 얻어진 용액에, 1.5M의 수산화나트륨 수용액(68㎖, 101m㏖)을 첨가해서 교반한 후, 석출물을 여과 분별하였다. 석출물을 물 및 헥산으로 세정한 후, 진공건조시킴으로써 목적 중간체인 4-(4,6-다이페닐피리딘-2-일)페닐보론산(12.8g, 수율 93.7%)을 얻었다.2- (4-bromophenyl) -4,6-diphenylpyridine (15 g, 38.8 mmol) obtained in Synthetic Example 3 was dissolved in tetrahydrofuran (195 ml) under an argon stream, Lt; / RTI > To the obtained solution, 1.64M n-butyllithium / hexane solution (25.9 ml, 42.7 mmol) was slowly added dropwise, followed by stirring for 0.5 hours. To the obtained solution, triisopropyl borate (11.7 ml, 50.5 mmol) was slowly added dropwise and the mixture was stirred for 1 hour. The resulting solution was warmed to room temperature and stirred for 18 hours. To the obtained solution, 1.5 M aqueous sodium hydroxide (68 ml, 101 mmol) was added and stirred, and the precipitate was filtered off. The precipitate was washed with water and hexane and then dried in vacuo to obtain 4- (4,6-diphenylpyridin-2-yl) phenylboronic acid as a target intermediate (12.8 g, yield 93.7%).

합성예-9Synthesis Example-9

Figure pct00055
Figure pct00055

아르곤 기류 하, 2-(3-브로모-5-클로로페닐)-4,6-다이페닐-1,3,5-트라이아진(10.0g, 23.73m㏖), 합성예-8에서 얻어진 4-(4,6-다이페닐피리딘-2-일)페닐보론산(10.0g, 28.5m㏖), 테트라키스(트라이페닐포스핀)팔라듐(823㎎, 0.711m㏖) 및 탄산 칼륨(9.84g, 71.2m㏖)을, 테트라하이드로퓨란(261㎖) 및 물(71㎖)의 혼합 용매에 현탁시켰다. 얻어진 혼합물을 70℃에서 23시간 교반하였다. 방랭 후, 물(500㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써, 목적 중간체인 2-[5-클로로-4'-(4,6-다이페닐피리딘-2-일)바이페닐-3-일]-4,6-다이페닐-1,3,5-트라이아진의 회백색 고체(수득량 13.7g, 수율 89.1%)를 얻었다.2- (3-bromo-5-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (10.0 g, 23.73 mmol) (10.0 g, 28.5 mmol), tetrakis (triphenylphosphine) palladium (823 mg, 0.711 mmol) and potassium carbonate (9.84 g, 71.2 mmol) was suspended in a mixed solvent of tetrahydrofuran (261 ml) and water (71 ml). The resulting mixture was stirred at 70 占 폚 for 23 hours. After cooling, water (500 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The resulting solid was recrystallized (toluene) to obtain the desired intermediate 2- [5-chloro-4 '- (4,6-diphenylpyridin-2- 1,3,5-triazine as an off-white solid (yield 13.7 g, yield 89.1%).

1H-NMR(CDCl3)δ(ppm): 7,44-7.65(m, 12H), 7.77(dd, J=8.4Hz, 1.4Hz, 2H), 7.85-7.88(m, 3H), 7.92(d, J=1.4Hz, 1H), 7.97(d, J=1.4Hz, 1H), 8.23(brd, J=7.2Hz, 2H), 8.38(d, J=8.4Hz, 2H), 8.74(dd, J=2.0Hz, 1.5Hz, 1H), 8.79(dd, J=8.0Hz, 1.8Hz, 4H), 8.95 (t, J=1.6Hz, 1H). 1 H-NMR (CDCl 3 )? (Ppm): 7,44-7.65 (m, 12H), 7.77 (dd, J = 8.4 Hz, 1.4 Hz, 2H), 7.85-7.88 (dd, J = 1.4 Hz, 1H), 7.97 (d, J = 1.4 Hz, 1H), 8.23 (brd, J = 7.2 Hz, 2H), 8.38 J = 2.0Hz, 1.5Hz, 1H), 8.79 (dd, J = 8.0Hz, 1.8Hz, 4H), 8.95 (t, J = 1.6Hz, 1H).

합성예-10Synthesis Example-10

Figure pct00056
Figure pct00056

질소 기류 하, 2-(3-브로모-5-클로로페닐)-4,6-다이페닐-1,3,5-트라이아진(12.0g, 28.3m㏖) 및 페닐보론산(4.5g, 36.8m㏖)을 1,2-다이메톡시에탄(120㎖)에 현탁시키고, 이것에 10% NaOH 수용액(34.0g, 85.1m㏖)을 3분에 걸쳐서 적하하였다. 얻어진 혼합물에 테트라키스트라이페닐포스핀팔라듐(655㎎, 0.56m㏖)을 첨가하고, 80℃에서 14시간 교반하였다. 실온까지 방랭 후, 반응 혼합물에 물(150㎖)을 첨가하고, 석출물을 여과하여 취하였다. 얻어진 고체를 물, 메탄올, 헥산으로 세정하였다. 고체를 재결정(톨루엔)시킴으로써, 목적물인 2-(5-클로로바이페닐-3-일)-4,6-다이페닐-1,3,5-트라이아진의 백색 고체(수득량 11.5g, 수율 96%)를 얻었다.(12.0 g, 28.3 mmol) and phenylboronic acid (4.5 g, 36.8 mmol) were added to a solution of 2- (3-bromo-5-chlorophenyl) m mol) was suspended in 1,2-dimethoxyethane (120 ml), and 10% aqueous NaOH solution (34.0 g, 85.1 mmol) was added dropwise thereto over 3 minutes. Tetrakis triphenylphosphine palladium (655 mg, 0.56 mmol) was added to the resulting mixture, and the mixture was stirred at 80 占 폚 for 14 hours. After cooling to room temperature, water (150 ml) was added to the reaction mixture, and the precipitate was collected by filtration. The resulting solid was washed with water, methanol, and hexane. The solid was recrystallized (toluene) to obtain a white solid of the objective product, 2- (5-chlorobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine (yield 11.5 g, yield 96 %).

실시예-4Example-4

Figure pct00057
Figure pct00057

아르곤 기류 하, 합성예-10에서 얻어진 2-(5-클로로바이페닐-3-일)-4,6-다이페닐-1,3,5-트라이아진(1.5g, 3.57m㏖), 합성예-8에서 얻어진 4-(4,6-다이페닐피리딘-2-일)페닐보론산(1.63g, 4.64m㏖), 아세트산 팔라듐(16.0㎎, 0.07m㏖), 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(68.1㎎, 0.142m㏖) 및 탄산 칼륨(1.48g, 10.7m㏖)을, 테트라하이드로퓨란(50㎖) 및 물(10㎖)의 혼합 용매에 현탁시켰다. 얻어진 혼합물을 70℃에서 19시간 교반하였다. 방랭 후, 물(50㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써, 목적물인 4,6-다이페닐-2-[4-(4,6-다이페닐피리딘-2-일)-1,1':3',1"-터페닐-5'-일]-1,3,5-트라이아진(A-1)의 회백색 고체(수득량 2.22g, 수율 90.1%)를 얻었다.2- (5-chlorobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine (1.5 g, 3.57 mmol) obtained in Synthesis Example-10, 4- (4,6-diphenylpyridin-2-yl) phenylboronic acid (1.63 g, 4.64 mmol), palladium acetate (16.0 mg, 0.07 mmol), 2- dicyclohexylphosphino- (68.1 mg, 0.142 mmol) and potassium carbonate (1.48 g, 10.7 mmol) were added to a mixture of tetrahydrofuran (50 ml) and water (10 ml) And suspended in a solvent. The resulting mixture was stirred at 70 占 폚 for 19 hours. After cooling, water (50 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The resulting solid was recrystallized (toluene) to obtain the objective product, 4,6-diphenyl-2- [4- (4,6-diphenylpyridin- -5'-yl] -1,3,5-triazine (A-1) as a white solid (yield: 2.22 g, yield 90.1%).

1H-NMR(CDCl3)δ(ppm): 7.43-7.64(m, 15H), 7.78(dd, J=8.5Hz, 1.5Hz, 2H), 7.82(dd, J=8.2Hz, 1.3Hz, 2H), 7.93(dd, J=8.5Hz, 1.4Hz, 2H), 7.97(J=8.7Hz, 1.4Hz, 2H), 8.11 (t, J=1.8Hz, 1H), 8.24(dd, J=8.4Hz, 1.4Hz, 2H), 8.39(d, J=8.5Hz, 2H), 8.81(dd, J=7.9Hz, 1.5Hz, 4H), 8.99 (t, J=1.6Hz, 1H), 9.05 (t, J=1.6Hz, 1H). 1 H-NMR (CDCl 3) δ (ppm): 7.43-7.64 (m, 15H), 7.78 (dd, J = 8.5Hz, 1.5Hz, 2H), 7.82 (dd, J = 8.2Hz, 1.3Hz, 2H J = 8.7 Hz, 1.4 Hz, 2H), 8.11 (t, J = 1.8 Hz, 1H), 8.24 (dd, J = 8.4 Hz, (D, J = 7.9 Hz, 1.5 Hz, 4H), 8.99 (t, J = 1.6 Hz, 1H), 9.05 J = 1.6 Hz, 1H).

얻어진 화합물 A-1의 Tg는 117℃였다.The Tg of the obtained compound A-1 was 117 占 폚.

합성예-11Synthesis Example-11

Figure pct00058
Figure pct00058

아르곤 기류 하, 2-(3-브로모-5-클로로페닐)-4,6-다이페닐-1,3,5-트라이아진(8.46g, 20.0m㏖) 및 4-바이페닐보론산(4.36g, 22.0m㏖) 및 테트라키스트라이페닐포스핀팔라듐(462㎎, 0.40m㏖)을 테트라하이드로퓨란(100㎖)에 현탁시키고, 이것에 4N의 NaOH 수용액(15.0㎖,60m㏖)을 3분에 걸쳐서 적하하였다. 얻어진 혼합물을 75℃에서 16시간 교반하였다. 실온까지 방랭 후, 반응 혼합물에 물(150㎖)을 첨가하고, 석출물을 여과하여 취하였다. 얻어진 고체를 물, 메탄올, 헥산으로 세정하였다. 고체를 재결정(톨루엔)시킴으로써, 목적물인 2-(5-클로로-1,1':4',1"-터페닐-3-일)-4,6-다이페닐-1,3,5-트라이아진의 백색 고체(수득량 9.48g, 수율 95.6%)를 얻었다.2- (3-bromo-5-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (8.46 g, 20.0 mmol) and 4-biphenylboronic acid g, 22.0 mmol) and tetrakis triphenylphosphine palladium (462 mg, 0.40 mmol) were suspended in tetrahydrofuran (100 ml), and 4N NaOH aqueous solution (15.0 ml, 60 mmol) Lt; / RTI > The resulting mixture was stirred at 75 占 폚 for 16 hours. After cooling to room temperature, water (150 ml) was added to the reaction mixture, and the precipitate was collected by filtration. The resulting solid was washed with water, methanol, and hexane. The solids were recrystallized (toluene) to give the desired product 2- (5-chloro-1,1 ': 4', 1 "-terphenyl- Azine as a white solid (yield 9.48 g, yield 95.6%).

실시예-5Example 5

Figure pct00059
Figure pct00059

아르곤 기류 하, 합성예-11에서 얻어진 2-(5-클로로-1,1':4',1"-터페닐-3-일)-4,6-다이페닐-1,3,5-트라이아진(1.5g, 3.02m㏖), 합성예-8에서 얻어진 4-(4,6-다이페닐피리딘-2-일)페닐보론산(1.27g, 3.63m㏖), 아세트산 팔라듐(13.6㎎, 0.060m㏖), 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(57.6㎎, 0.120m㏖) 및 탄산 칼륨(1.25g, 9.07m㏖)을, 테트라하이드로퓨란(50㎖) 및 물(9㎖)의 혼합 용매에 현탁시켰다. 얻어진 혼합물을 70℃에서 19시간 교반하였다. 방랭 후, 물(50㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써, 목적물인4,6-다이페닐-2-[4-(4,6-다이페닐피리딘-2-일)-1,1':3',1":4",1"'-쿼터페닐-5'-일]-1,3,5-트라이아진(A-109)의 회백색 고체(수득량 2.16g, 수율 93.0%)를 얻었다.(5-chloro-1,1 ': 4', 1 "-terphenyl-3-yl) -4,6-diphenyl-1,3,5-tri Azine (1.5 g, 3.02 mmol), 4- (4,6-diphenylpyridin-2-yl) phenylboronic acid (1.27 g, 3.63 mmol) obtained in Synthesis Example-8, palladium acetate (13.6 mg, 2, 4 ', 6'-triisopropylbiphenyl (57.6 mg, 0.120 mmol) and potassium carbonate (1.25 g, 9.07 mmol) were dissolved in tetrahydrofuran (50 ml) and water (9 ml) .The obtained mixture was stirred for 19 hours at 70 DEG C. After cooling, water (50 ml) was added, the precipitated solid was filtered off, The resulting solid was recrystallized (toluene) to obtain the desired product, 4,6-diphenyl-2- [4- (4,6-diphenylpyridin-2-yl) (Yield 2.16 g, yield 93.0%) of 3 ', 1 ": 4", 1 "' -tetraphenyl-5'- yl] -1,3,5- .

1H-NMR(CDCl3)δ(ppm): 7.38 (t, J=7.4Hz, 1H), 7.44-7.65(m, 14H), 7.70(dd, J=8.3Hz, 1.3Hz, 2H), 7.77-7.80(m, 4H), 7.90(d, J=8.4Hz, 2H), 7.92(d, J=1.4Hz, 1H), 7.96(d, J=8.6Hz, 2H), 7.99(d, J=1.5Hz, 1H), 8.16 (t, J=1.7Hz, 1H), 8.24(dd, J=8.4Hz, 1.5Hz, 2H), 8.40(d, J=8.5Hz, 2H), 8.81(dd, J=8.2Hz, 1.5Hz, 4H), 9.05(d, J=9.2Hz, 2H). 1 H-NMR (CDCl 3) δ (ppm): 7.38 (t, J = 7.4Hz, 1H), 7.44-7.65 (m, 14H), 7.70 (dd, J = 8.3Hz, 1.3Hz, 2H), 7.77 J = 8.6 Hz, 2H), 7.99 (d, J = 8.4 Hz, 2H), 7.92 (d, J = (T, J = 1.7 Hz, 1H), 8.24 (dd, J = 8.4 Hz, 1.5 Hz, 2H), 8.40 = 8.2 Hz, 1.5 Hz, 4H), 9.05 (d, J = 9.2 Hz, 2H).

얻어진 화합물 A-109의 Tg는 129℃였다.The obtained Compound A-109 had a Tg of 129 占 폚.

합성예-12Synthesis Example-12

Figure pct00060
Figure pct00060

질소 기류 하, 페나실피리디늄브로마이드(5.00g, 17.4m㏖), 4-브로모칼콘(7.26g, 26.1m㏖) 및 아세트산 암모늄(32.3g, 420m㏖)을, 아세트산(250㎖) 및 다이메틸폼아마이드(250㎖)의 혼합 용매에 용해시켜, 150℃에서 23시간 교반하였다. 실온까지 방랭 후, 반응 혼합물에 물(500㎖)을 첨가하고, 석출물을 여과하여 취하였다. 여과하여 취한 석출물을 메탄올로 세정하여, 목적으로 하는 4-(4-브로모페닐)-2,6-다이페닐피리딘의 회백색 분말(수득량 1.14g, 수율 35.2%)을 얻었다.(7.26 g, 26.1 mmol) and ammonium acetate (32.3 g, 420 mmol) were dissolved in acetic acid (250 ml) and a solution of diisobutylaluminum bromide Methyl formamide (250 ml), and the mixture was stirred at 150 占 폚 for 23 hours. After cooling to room temperature, water (500 ml) was added to the reaction mixture, and the precipitate was collected by filtration. The precipitate obtained by filtration was washed with methanol to obtain an objective off-white powder of the objective 4- (4-bromophenyl) -2,6-diphenylpyridine (yield: 1.14 g, yield: 35.2%).

1H-NMR(CDCl3)δ(ppm): 7.44 (t, J=7.5Hz, 2H), 7.51 (m, J=7.5Hz, 4H), 7.60(d, J=8.6Hz, 2H), 7.65(d, J=8.8Hz, 2H), 7.83(s, 2H), 8.18(dd, J=8.5Hz, 1.5Hz, 4H). 1 H-NMR (CDCl 3) δ (ppm): 7.44 (t, J = 7.5Hz, 2H), 7.51 (m, J = 7.5Hz, 4H), 7.60 (d, J = 8.6Hz, 2H), 7.65 (d, J = 8.8 Hz, 2H), 7.83 (s, 2H), 8.18 (dd, J = 8.5 Hz, 1.5 Hz, 4H).

합성예-13Synthesis Example-13

Figure pct00061
Figure pct00061

아르곤 기류 하, 합성예-12에서 얻어진 4-(4-브로모페닐)-2,6-다이페닐피리딘(4.9g, 12.7m㏖)을 테트라하이드로퓨란(64㎖)에 용해시켜, -78℃로 냉각시켰다. 얻어진 용액에, 1.65M의 n-뷰틸리튬/헥산 용액(8.45㎖, 14.0m㏖)을 천천히 적하한 후, 0.5시간 교반하였다. 얻어진 용액에, 붕산 트라이아이소프로필(3.80㎖, 16.5m㏖)을 천천히 적하하고, 1시간 교반하였다. 얻어진 용액을 실온까지 승온시키고, 17시간 교반하였다. 얻어진 용액에, 1.5M의 수산화나트륨 수용액(45㎖,33.0m㏖)을 첨가해서 교반한 후, 석출물을 여과 분별하였다. 석출물을 물 및 헥산으로 세정한 후, 진공건조시킴으로써 목적 중간체인 4-(2,6-다이페닐피리딘-4-일)페닐보론산(3.70g, 수율 83.0%)을 얻었다.4- (4-bromophenyl) -2,6-diphenylpyridine (4.9 g, 12.7 mmol) obtained in Synthesis Example-12 was dissolved in tetrahydrofuran (64 ml) under an argon stream, Lt; / RTI > To the obtained solution, 1.65M n-butyllithium / hexane solution (8.45 ml, 14.0 mmol) was slowly added dropwise, followed by stirring for 0.5 hours. To the obtained solution, triisopropyl borate (3.80 ml, 16.5 mmol) was slowly added dropwise and the mixture was stirred for 1 hour. The resulting solution was warmed to room temperature and stirred for 17 hours. To the obtained solution, 1.5 M aqueous sodium hydroxide (45 ml, 33.0 mmol) was added and stirred, and the precipitate was filtered off. The precipitate was washed with water and hexane and then dried in vacuo to obtain 4- (2,6-diphenylpyridin-4-yl) phenylboronic acid as a target intermediate (3.70 g, yield 83.0%).

실시예-6Example-6

Figure pct00062
Figure pct00062

아르곤 기류 하, 합성예-1에서 얻어진 2-[5-클로로-4'-(2-피리딜)바이페닐-3-일]-4,6-다이페닐-1,3,5-트라이아진(1.50g, 3.02m㏖), 합성예-13에서 얻어진 4-(2,6-다이페닐피리딘-4-일)페닐보론산(1.27g, 3.62m㏖), 아세트산 팔라듐(13.6㎎, 0.060m㏖), 탄산 칼륨(1.25g, 9.05m㏖) 및 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(57.5㎎, 0.12m㏖)을, 테트라하이드로퓨란(50㎖) 및 물(9㎖)의 혼합 용매에 현탁시켰다. 얻어진 혼합물을 70℃에서 21시간 교반하였다. 방랭 후, 물(50㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써 목적물인 4,6-다이페닐-2-[4-(2,6-다이페닐피리딘-4-일)-4"-(2-피리딜)-1,1':3',1"-터페닐-5'-일]-1,3,5-트라이아진(A-136)의 회백색 고체(수득량 1.26g, 수율 54.4%)를 얻었다.Under argon stream, a solution of 2- [5-chloro-4 '- (2-pyridyl) biphenyl-3-yl] -4,6-diphenyl-1,3,5-triazine 1.56 g, 3.02 mmol), 4- (2,6-diphenylpyridin-4-yl) phenylboronic acid (1.27 g, 3.62 mmol) obtained in Synthesis Example-13, and palladium acetate (13.6 mg, 0.060 mmol ), Potassium carbonate (1.25 g, 9.05 mmol) and 2-dicyclohexylphosphino-2 ', 4', 6'-triisopropylbiphenyl (57.5 mg, 0.12 mmol) were dissolved in tetrahydrofuran Ml) and water (9 ml). The resulting mixture was stirred at 70 占 폚 for 21 hours. After cooling, water (50 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The resulting solid was recrystallized (toluene) to obtain the desired product, 4,6-diphenyl-2- [4- (2,6-diphenylpyridin- : An off-white solid (yield 1.26 g, yield 54.4%) of 3 ', 1 "-terphenyl-5'- yl] -1,3,5-triazine (A-136) was obtained.

1H-NMR(CDCl3)δ(ppm): 7.25-7.29(m, 1H), 7.45 (t, J=7.6Hz, 2H), 7.50-7.55(m, 4H), 7.57-7.63(m, 6H), 7.80 (t, J=8.3Hz, 1H), 7.84(brd, J=7.8Hz, 1H), 7.94(dd, J=8.3Hz, 2.1Hz, 4H), 7.97-8.00(m, 4H), 8.16 (t, J=1.8Hz, 1H), 8.20(J=8.5Hz, 2H), 8.24(dd, J=8.3Hz, 1.4Hz, 4H), 8.74(ddd, J=4.8Hz, 1.8Hz, 1.1Hz, 1H), 8.81(dd, J=8.1Hz, 1.9Hz, 4H), 9.06(dt, J=7.7Hz, 1.8Hz, 2H). 1 H-NMR (CDCl 3) δ (ppm): 7.25-7.29 (m, 1H), 7.45 (t, J = 7.6Hz, 2H), 7.50-7.55 (m, 4H), 7.57-7.63 (m, 6H ), 7.80 (t, J = 8.3 Hz, 1H), 7.84 (brd, J = 7.8 Hz, 1H), 7.94 (dd, J = 8.3 Hz, 2.1 Hz, 4H), 7.97-8.00 8.14 (d, J = 8.3 Hz, 1.4 Hz, 4H), 8.74 (ddd, J = 4.8 Hz, 1.8 Hz, 1.1 Hz, 1H), 8.81 (dd, J = 8.1 Hz, 1.9 Hz, 4H), 9.06 (dt, J = 7.7 Hz, 1.8 Hz, 2H).

얻어진 화합물 A-136의 Tg는 134℃였다.The Tg of the obtained Compound A-136 was 134 占 폚.

실시예-7Example-7

Figure pct00063
Figure pct00063

아르곤 기류 하, 합성예-9에서 얻어진 2-[5-클로로-4'-(4,6-다이페닐피리딘-2-일)바이페닐-3-일]-4,6-다이페닐-1,3,5-트라이아진(1.50g, 2.31m㏖), 3-퀴놀린 보론산(480㎎, 2.77m㏖), 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(44.0㎎, 0.092m㏖), 아세트산 팔라듐(10.4㎎, 0.046m㏖) 및 탄산 칼륨(958㎎, 6.93m㏖)을, 테트라하이드로퓨란(60㎖) 및 물(7㎖)의 혼합 용매에 현탁시켰다. 얻어진 혼합물을 70℃에서 17시간 교반하였다. 방랭 후, 물(70㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써, 목적물인 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(3-퀴놀릴)-바이페닐-3-일]-1,3,5-트라이아진(A-180)의 회백색 고체(수득량 1.35g, 수율 78.6%)를 얻었다.2- [5-chloro-4 '- (4,6-diphenylpyridin-2-yl) biphenyl-3-yl] -4,6-diphenyl- (1.50 g, 2.31 mmol), 3-quinolinic acid (480 mg, 2.77 mmol), 2-dicyclohexylphosphino-2 ', 4', 6'-triisopropylbiphenyl To a mixture of phenyl (44.0 mg, 0.092 mmol), palladium acetate (10.4 mg, 0.046 mmol) and potassium carbonate (958 mg, 6.93 mmol) in tetrahydrofuran (60 mL) and water (7 mL) Lt; / RTI > The resulting mixture was stirred at 70 占 폚 for 17 hours. After cooling, water (70 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The resulting solid was recrystallized (toluene) to obtain the desired product, 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridin-2-yl) -5- (3-quinolyl) 3-yl] -1,3,5-triazine (A-180) as an off-white solid (yield 1.35 g, yield 78.6%).

1H-NMR(CDCl3)δ(ppm): 7.44-7.66(m, 13H), 7.76(dd, J=8.2Hz, 1.4Hz, 1H), 7.78(dd, J=7.1Hz, 1.4Hz, 2H), 7.93(d, J=1.4Hz, 1H), 7.97-8.00(m, 4H), 8.20-8.25(m, 4H), 8.42(d, J=8.5Hz, 2H), 8.54(d, J=2.3Hz, 1H), 8.82(dd, J=8.1Hz, 1.9Hz, 4H), 9.13(dt, J=6.8Hz, 1.7Hz, 2H), 9.43(d, J=2.2Hz, 1H). 1 H-NMR (CDCl 3) δ (ppm): 7.44-7.66 (m, 13H), 7.76 (dd, J = 8.2Hz, 1.4Hz, 1H), 7.78 (dd, J = 7.1Hz, 1.4Hz, 2H ), 7.93 (d, J = 1.4 Hz, 1H), 7.97-8.00 (m, 4H), 8.20-8.25 (m, 4H), 8.42 (Dt, J = 6.8 Hz, 1.7 Hz, 2H), 9.43 (d, J = 2.2 Hz, 1H), 8.82 (dd, J = 8.1 Hz, 1.9 Hz, 4H), 9.13

얻어진 화합물 A-180의 Tg는 128℃였다.The Tg of the obtained Compound A-180 was 128 占 폚.

실시예-8Example-8

Figure pct00064
Figure pct00064

아르곤 기류 하, 합성예-9에서 얻어진 2-[5-클로로-4'-(4,6-다이페닐피리딘-2-일)바이페닐-3-일]-4,6-다이페닐-1,3,5-트라이아진(300㎎, 0.46m㏖), 탄산 칼륨(141㎎, 0.55m㏖) 및 4-(4,4,5,5-테트라메틸-1,3,2-다이옥사보로란-2-일)ISO 퀴놀린(141.5㎎, 0.554m㏖)을, 테트라하이드로퓨란(8㎖) 및 물(1㎖)의 혼합 용매에 현탁시켜서 70℃로 가열하였다. 얻어진 혼합물에, 아세트산 팔라듐(2.07㎎, 0.0092m㏖) 및 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(8.80㎎, 0.018m㏖)을 THF(5㎖)에 용해시킨 용액을 첨가하고, 70℃에서 24시간 교반하였다. 방랭 후, 물(10㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써, 목적물인 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(4-아이소퀴놀릴)-바이페닐-3-일]-1,3,5-트라이아진(A-173)의 회백색 고체(수득량 309㎎, 수율 90.0%)를 얻었다.2- [5-chloro-4 '- (4,6-diphenylpyridin-2-yl) biphenyl-3-yl] -4,6-diphenyl- (300 mg, 0.46 mmol), potassium carbonate (141 mg, 0.55 mmol) and 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolane -2-yl) ISOquinoline (141.5 mg, 0.554 mmol) was suspended in a mixed solvent of tetrahydrofuran (8 ml) and water (1 ml) and heated to 70 占 폚. To the obtained mixture, palladium acetate (2.07 mg, 0.0092 mmol) and 2-dicyclohexylphosphino-2 ', 4', 6'- triisopropylbiphenyl (8.80 mg, 0.018 mmol) ), And the mixture was stirred at 70 占 폚 for 24 hours. After cooling, water (10 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The resulting solid was recrystallized (toluene) to obtain the objective product, 4,6-diphenyl-2- [4 '- (4,6- diphenylpyridin- Yl] -1,3,5-triazine (A-173) as a white solid (Yield 309 mg, yield 90.0%).

1H-NMR(CDCl3)δ(ppm): 7.45-7.61(m, 12H), 7.68-7.79(m, 4H), 7.92(d, J=1.4Hz, 1H), 7.95-7.98(m, 3H), 8.05(brd, J=6.8Hz, 1H), 8.03 (t, J=1.6Hz, 1H), 8.12(brd, J=7.8Hz, 1H), 8.23(dd, J=8.8Hz, 1.4Hz, 2H), 8.39(d, J=8.6Hz, 2H), 8.71(s, 1H), 8.78(dd, J=8.4Hz, 1.6Hz, 4H), 8.91 (t, J=1.6Hz, 1H), 9.19 (t, J=1.7Hz, 1H), 9.36(brs, 1H). 1 H-NMR (CDCl 3 )? (Ppm): 7.45-7.61 (m, 12H), 7.68-7.79 (m, 4H), 7.92 J = 7.8 Hz, 1H), 8.23 (dd, J = 8.8 Hz, 1.4 Hz, 1H), 8.05 (brd, J = 6.8 Hz, (D, J = 8.4 Hz, 1.6 Hz, 4H), 8.91 (t, J = 1.6 Hz, 1H), 9.19 (t, J = 1.7 Hz, 1H), 9.36 (brs, 1H).

얻어진 화합물 A-173의 Tg는 137℃였다.The Tg of the obtained Compound A-173 was 137 占 폚.

실시예-9Example-9

Figure pct00065
Figure pct00065

아르곤 기류 하, 합성예-9에서 얻어진 2-[5-클로로-4'-(4,6-다이페닐피리딘-2-일)바이페닐-3-일]-4,6-다이페닐-1,3,5-트라이아진(1.50g, 2.31m㏖), 탄산 칼륨(958㎎, 6.93m㏖) 및 4-(3-피리딜)페닐보론산(552㎎, 2.77m㏖)을, 테트라하이드로퓨란(30㎖) 및 물(6㎖)의 혼합 용매에 현탁시켜서 70℃로 가열하였다. 얻어진 혼합물에, 아세트산 팔라듐(10.4㎎, 0.046m㏖) 및 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(44.0㎎, 0.092m㏖)을 THF(5㎖)에 용해시킨 용액을 첨가하고, 70℃에서 18시간 교반하였다. 방랭 후, 물(30㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써 목적물인 4,6-다이페닐-2-[4-(4,6-다이페닐피리딘-2-일)-4"-(3-피리딜)-1,1':3',1"-터페닐-5'-일]-1,3,5-트라이아진(A-145)의 회백색 고체(수득량 1.64g, 수율 92.4%)를 얻었다.2- [5-chloro-4 '- (4,6-diphenylpyridin-2-yl) biphenyl-3-yl] -4,6-diphenyl- (952 mg, 6.93 mmol) and 4- (3-pyridyl) phenylboronic acid (552 mg, 2.77 mmol) were dissolved in tetrahydrofuran (30 ml) and water (6 ml) and heated to 70 ° C. To the obtained mixture, palladium acetate (10.4 mg, 0.046 mmol) and 2-dicyclohexylphosphino-2 ', 4', 6'- triisopropylbiphenyl (44.0 mg, 0.092 mmol) ), And the mixture was stirred at 70 占 폚 for 18 hours. After cooling, water (30 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The resulting solid was recrystallized (toluene) to obtain the desired product, 4,6-diphenyl-2- [4- (4,6-diphenylpyridin-2-yl) : An off-white solid (1.64 g, yield 92.4%) of 3 ', 1 "-terphenyl-5'-yl] -1,3,5-triazine (A-145) was obtained.

1H-NMR(CDCl3)δ(ppm): 7.41(ddd, J=7.6Hz, 4.8Hz, 0.8Hz, 1H), 7.44-7.65(m, 12H), 7.78(d, J=8.5Hz, 4H), 7.92-7.99(m, 7H), 8.15 (t, J=1.7Hz, 1H), 8.24(dd, J=8.3Hz, 1.4Hz, 2H), 8.40(d, J=8.4Hz, 2H), 8.63(dd, J=4.7Hz, 1.6Hz, 1H), 8.81(dd, J=8.0Hz, 1.9Hz, 4H), 8.96(dd, J=2.4Hz, 0.7Hz, 1H), 9.04 (t, J=1.6Hz, 1H), 9.08 (t, J=1.6Hz, 1H). 1 H-NMR (CDCl 3) δ (ppm): 7.41 (ddd, J = 7.6Hz, 4.8Hz, 0.8Hz, 1H), 7.44-7.65 (m, 12H), 7.78 (d, J = 8.5Hz, 4H ), 7.92-7.99 (m, 7H), 8.15 (t, J = 1.7 Hz, 1H), 8.24 (dd, J = 8.3 Hz, 1.4 Hz, 2H) 8.63 (dd, J = 4.7 Hz, 1.6 Hz, 1H), 8.81 (dd, J = 8.0 Hz, 1.9 Hz, 4H) = 1.6 Hz, 1H), 9.08 (t, J = 1.6 Hz, 1H).

얻어진 화합물 A-145의 Tg는 133℃였다.The obtained Compound A-145 had a Tg of 133 캜.

실시예-10Example-10

Figure pct00066
Figure pct00066

아르곤 기류 하, 합성예-9에서 얻어진 2-[5-클로로-4'-(4,6-다이페닐피리딘-2-일)바이페닐-3-일]-4,6-다이페닐-1,3,5-트라이아진(200㎎, 0.31m㏖), 2-나프탈렌보론산(63.6㎎, 0.37m㏖), 탄산 칼륨(128㎎, 0.92m㏖), 아세트산 팔라듐(1.38㎎, 0.0061m㏖) 및 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(5.87㎎, 0.012m㏖)을, 테트라하이드로퓨란(5㎖) 및 물(1㎖)의 혼합 용매에 현탁시켰다. 얻어진 혼합물을 70℃에서 21시간 교반하였다. 방랭 후, 물(5㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정함으로써 목적물인 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(2-나프틸)-바이페닐-3-일]-1,3,5-트라이아진(A-164)의 회백색 고체(수득량 224.8㎎, 수율 98.5%)를 얻었다.2- [5-chloro-4 '- (4,6-diphenylpyridin-2-yl) biphenyl-3-yl] -4,6-diphenyl- 2-naphthaleneboronic acid (63.6 mg, 0.37 mmol), potassium carbonate (128 mg, 0.92 mmol), palladium acetate (1.38 mg, 0.0061 mmol) (5.87 mg, 0.012 mmol) was added to a mixed solvent of tetrahydrofuran (5 mL) and water (1 mL), and the mixture was stirred at room temperature for 2 hours. Lt; / RTI > The resulting mixture was stirred at 70 占 폚 for 21 hours. After cooling, water (5 ml) was added, and the precipitated solid was separated by filtration, and the solid was washed with water, methanol and hexane to obtain 4,6-diphenyl-2- [4 ' Yl) -1,3,5-triazine (A-164) as a white solid (Yield: 224.8 mg, yield 98.5 %).

1H-NMR(CDCl3)δ(ppm): 7.45-7.65(m, 14H), 7.78(dd, J=8.3Hz, 1.6Hz, 2H), 7.91-8.04(m, 8H), 8.23-8.26(m, 4H), 8.41(d, J=8.5Hz, 2H), 8.82(dd, J=8.2Hz, 2.1Hz, 4H), 9.09(dt, J=6.1Hz, 1.4Hz, 2H). 1 H-NMR (CDCl 3) δ (ppm): 7.45-7.65 (m, 14H), 7.78 (dd, J = 8.3Hz, 1.6Hz, 2H), 7.91-8.04 (m, 8H), 8.23-8.26 ( m, 4H), 8.41 (d, J = 8.5 Hz, 2H), 8.82 (dd, J = 8.2 Hz, 2.1 Hz, 4H), 9.09 (dt, J = 6.1 Hz, 1.4 Hz, 2H).

얻어진 화합물 A-164의 Tg는 122℃였다.The obtained Compound A-164 had a Tg of 122 占 폚.

합성예-14Synthesis Example-14

Figure pct00067
Figure pct00067

아르곤 기류 하, 2-(3-브로모-5-클로로페닐)-4,6-다이페닐-1,3,5-트라이아진(3.00g, 7.10m㏖), 1-나프탈렌보론산(1.46g, 8.52m㏖), 탄산 칼륨(2.94g, 21.3m㏖) 및 테트라키스(트라이페닐포스핀)팔라듐(246㎎, 0.21m㏖)을 테트라하이드로퓨란(60㎖)에 현탁시키고, 70℃에서 24시간 교반하였다. 방랭 후, 물(100㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 조질체를 실리카겔 칼럼 크로마토그래피(전개 용매:클로로폼) 및 재결정(톨루엔)에 의해 정제하고, 반응 중간체인 2-[3-클로로-5-(1-나프틸)페닐]-4,6-다이페닐-1,3,5-트라이아진의 백색 고체(수득량 2.88g, 수율 86.5%)를 얻었다.(3.00 g, 7.10 mmol) and 1-naphthaleneboronic acid (1.46 g, 7.10 mmol) were added to a solution of 2- , Potassium carbonate (2.94 g, 21.3 mmol) and tetrakis (triphenylphosphine) palladium (246 mg, 0.21 mmol) were suspended in tetrahydrofuran (60 ml) Lt; / RTI > After cooling, water (100 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The resulting crude product was purified by silica gel column chromatography (eluent: chloroform) and recrystallization (toluene) to obtain 2- [3-chloro-5- (1- Diphenyl-l, 3,5-triazine (yield: 2.88 g, yield 86.5%).

1H-NMR(CDCl3)δ(ppm): 7.48-7.64(m, 10H), 7.73(dd, J=2.1Hz, 1.6Hz, 1H), 7.91(brd, J=8.6Hz, 1H), 7.96(brd, J=4.0Hz, 1H), 7.98(brd, J=3.6Hz, 1H), 8.74-8.78(m, 5H), 8.83(dd, J=2.3Hz, 1.6Hz, 1H). 1 H-NMR (CDCl 3 )? (Ppm): 7.48-7.64 (m, 10H), 7.73 (dd, J = 2.1 Hz, 1.6 Hz, 1H), 7.91 (brd, J = 8.6 Hz, 1H) (brd, J = 4.0 Hz, 1H), 7.98 (brd, J = 3.6 Hz, 1H), 8.74-8.78 (m, 5H), 8.83 (dd, J = 2.3 Hz, 1.6 Hz, 1H).

실시예-11Example-11

Figure pct00068
Figure pct00068

아르곤 기류 하, 합성예-14에서 얻어진 2-[3-클로로-5-(1-나프틸)페닐]-4,6-다이페닐-1,3,5-트라이아진(1.30g, 2.77m㏖), 합성예-8에서 얻어진 4-(4,6-다이페닐피리딘-2-일)페닐보론산(1.17g, 3.32m㏖), 아세트산 팔라듐(12.4㎎, 0.055m㏖), 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(52.7㎎, 0.11m㏖) 및 탄산 칼륨(1.15g, 8.30m㏖)을, 테트라하이드로퓨란(60㎖) 및 물(8㎖)의 혼합 용매에 현탁시켰다 얻어진 혼합물을 70℃에서 22시간 교반하였다. 방랭 후, 물(50㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써, 목적물인 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(1-나프틸)-바이페닐-3-일]-1,3,5-트라이아진(A-163)의 회백색 고체(수득량 1.81g, 수율 88.1%)를 얻었다.2- [3-chloro-5- (1-naphthyl) phenyl] -4,6-diphenyl-1,3,5-triazine obtained in Synthesis Example-14 (1.30 g, 2.77 mmol ), 4- (4,6-diphenylpyridin-2-yl) phenylboronic acid (1.17 g, 3.32 mmol) obtained in Synthesis Example-8, palladium acetate (12.4 mg, 0.055 mmol) (52.7 mg, 0.11 mmol) and potassium carbonate (1.15 g, 8.30 mmol) were dissolved in tetrahydrofuran (60 ml) and water (8 ml) Ml). The resulting mixture was stirred at 70 占 폚 for 22 hours. After cooling, water (50 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The resulting solid was recrystallized (toluene) to obtain the desired product, 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridin-2-yl) -5- (1-naphthyl) 3-yl] -1,3,5-triazine (A-163) (yield 1.81 g, yield 88.1%).

1H-NMR(CDCl3)δ(ppm): 7.45-7.60(m, 16H), 7.79(brd, J=6.8Hz, 2H), 7.93(d, J=1.4Hz, 1H), 7.97-8.07(m, 7H), 8.25(brd, J=6.8Hz, 2H), 8.40(d, J=8.5Hz, 2H), 8.80(dd, J=8.4Hz, 1.7Hz, 4H), 8.91 (t, J=1.7Hz, 1H), 9.18 (t, J=1.8Hz, 1H). 1 H-NMR (CDCl 3) δ (ppm): 7.45-7.60 (m, 16H), 7.79 (brd, J = 6.8Hz, 2H), 7.93 (d, J = 1.4Hz, 1H), 7.97-8.07 ( J = 8.8 Hz, 2H), 8.80 (d, J = 8.5 Hz, 2H) 1.7 Hz, 1 H), 9.18 (t, J = 1.8 Hz, 1 H).

얻어진 화합물 A-163의 Tg는 134℃였다.The Tg of the obtained Compound A-163 was 134 占 폚.

실시예-12Example-12

Figure pct00069
Figure pct00069

아르곤 기류 하, 합성예-4에서 얻어진 2-[5-클로로-3-(3-피리딜)페닐]-4,6-다이페닐-1,3,5-트라이아진(1.30g, 3.09m㏖), 합성예-13에서 얻어진 4-(2,6-다이페닐피리딘-4-일)페닐보론산(1.30g, 3.71m㏖), 아세트산 팔라듐(13.9㎎, 0.061m㏖), 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(58.9㎎, 0.12m㏖) 및 탄산 칼륨(1.28g, 9.27m㏖)을, 테트라하이드로퓨란(45㎖) 및 물(9㎖)의 혼합 용매에 현탁시켰다. 얻어진 혼합물을 70℃에서 21시간 교반하였다. 방랭 후, 물(50㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써, 목적물인 4,6-다이페닐-2-[4'-(2,6-다이페닐피리딘-4-일)-5-(3-피리딜)-바이페닐-3-일]-1,3,5-트라이아진(A-46)의 회백색 고체(수득량 1.70g, 수율 79.4%)를 얻었다.2- [5-chloro-3- (3-pyridyl) phenyl] -4,6-diphenyl-1,3,5-triazine obtained in Synthetic Example 4 (1.30 g, 3.09 mmol ), 4- (2,6-diphenylpyridin-4-yl) phenylboronic acid (1.30 g, 3.71 mmol) obtained in Synthesis Example-13, palladium acetate (13.9 mg, 0.061 mmol) (58.9 mg, 0.12 mmol) and potassium carbonate (1.28 g, 9.27 mmol) were dissolved in tetrahydrofuran (45 ml) and water (9 ml) Ml). The resulting mixture was stirred at 70 占 폚 for 21 hours. After cooling, water (50 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The resulting solid was recrystallized (toluene) to obtain the desired product, 4,6-diphenyl-2- [4 '- (2,6-diphenylpyridin-4-yl) -5- (3-pyridyl) 3-yl] -1,3,5-triazine (A-46) (yield 1.70 g, yield 79.4%).

1H-NMR(CDCl3)δ(ppm): 7.46-7.57(m, 7H), 7.59-7.68(m, 6H), 7.95-7.99(m, 4H), 8.00(s, 2H), 8.10 (t, J=1.7Hz, 1H), 8.13(ddd, J=7.8Hz, 2.3Hz, 1.6Hz, 1H), 8.25(dd, J=8.6Hz, 1.4Hz, 4H), 7.23(dd, J=5.0Hz, 1.4Hz, 1H), 8.82(dd, J=8.2Hz, 2.0Hz, 4H), 9.03 (t, J=1.6Hz, 1H), 9.11 (t, J=1.6Hz, 2H). 1 H-NMR (CDCl 3 )? (Ppm): 7.46-7.57 (m, 7H), 7.59-7.68 (m, 6H), 7.95-7.99 (m, 4H), 8.00 J = 7.7 Hz, 1H), 8.13 (ddd, J = 7.8 Hz, 2.3 Hz, 1.6 Hz, 1H), 8.25 (dd, J = 8.6 Hz, 1.4 Hz, , 1.4 Hz, 1H), 8.82 (dd, J = 8.2 Hz, 2.0 Hz, 4H), 9.03 (t, J = 1.6 Hz, 1H), 9.11 (t, J = 1.6 Hz, 2H).

얻어진 화합물 A-46의 Tg는 123℃였다.The Tg of the obtained Compound A-46 was 123 占 폚.

실시예-13Example-13

Figure pct00070
Figure pct00070

아르곤 기류 하, 합성예-10에서 얻어진 2-(5-클로로바이페닐-3-일)-4,6-다이페닐-1,3,5-트라이아진(1.30g, 3.10m㏖), 합성예-13에서 얻어진 4-(2,6-다이페닐피리딘-4-일)페닐보론산(1.30g, 3.72m㏖), 아세트산 팔라듐(13.9㎎, 0.061m㏖), 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(59.0㎎, 0.12m㏖) 및 탄산 칼륨(1.28g, 9.29m㏖)을, 테트라하이드로퓨란(45㎖) 및 물(9㎖)의 혼합 용매에 현탁시켰다. 얻어진 혼합물을 70℃에서 22시간 교반하였다. 방랭 후, 물(50㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써, 목적물인 4,6-다이페닐-2-[4-(2,6-다이페닐피리딘-4-일)-1,1':3',1"-터페닐-5'-일]-1,3,5-트라이아진(A-10)의 회백색 고체(수득량 1.55g, 수율 72.7%)를 얻었다.2- (5-chlorobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine (1.30 g, 3.10 mmol) obtained in Synthesis Example-10, (1.30 g, 3.72 mmol), palladium acetate (13.9 mg, 0.061 mmol), and 2-dicyclohexylphosphino- A mixture of 2 ', 4', 6'-triisopropylbiphenyl (59.0 mg, 0.12 mmol) and potassium carbonate (1.28 g, 9.29 mmol) in tetrahydrofuran (45 mL) And suspended in a solvent. The resulting mixture was stirred at 70 占 폚 for 22 hours. After cooling, water (50 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The resulting solid was recrystallized (toluene) to give the desired product, 4,6-diphenyl-2- [4- (2,6-diphenylpyridin-4-yl) -1,1 ': 3' Yl] -1,3,5-triazine (A-10) (yield 1.55 g, yield 72.7%).

1H-NMR(CDCl3)δ(ppm): 7.46-7.67(m, 15H), 7.84(dd, J=8.2Hz, 1.4Hz, 2H), 7.94-7.98(m, 4H), 8.00(s, 2H), 8.12 (t, J=1.9Hz, 1H), 8.25(dd, J=8.5Hz, 1.4Hz, 4H), 8.83(dd, J=7.9Hz, 1.9Hz, 4H), 9.03 (t, J=1.4Hz, 1H), 9.06 (t, J=1.7Hz, 1H). 1 H-NMR (CDCl 3) δ (ppm): 7.46-7.67 (m, 15H), 7.84 (dd, J = 8.2Hz, 1.4Hz, 2H), 7.94-7.98 (m, 4H), 8.00 (s, J = 7.9 Hz, 1.9 Hz, 4H), 9.03 (t, J), 8.25 (dd, J = = 1.4 Hz, 1H), 9.06 (t, J = 1.7 Hz, 1H).

얻어진 화합물 A-10의 Tg는 121℃였다.The Tg of the obtained Compound A-10 was 121 占 폚.

실시예-14Example-14

Figure pct00071
Figure pct00071

아르곤 기류 하, 합성예-11에서 얻어진 2-(5-클로로-1,1':4',1"-터페닐-3-일)-4,6-다이페닐-1,3,5-트라이아진(1.30g, 2.62m㏖), 합성예-13에서 얻어진 4-(2,6-다이페닐피리딘-4-일)페닐보론산(1.10g, 3.15m㏖), 아세트산 팔라듐(11.8㎎, 0.052m㏖), 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(50.0㎎, 0.10m㏖) 및 탄산 칼륨(1.09g, 7.86m㏖)을, 테트라하이드로퓨란(35㎖) 및 물(7㎖)의 혼합 용매에 현탁시켰다. 얻어진 혼합물을 70℃에서 23시간 교반하였다. 방랭 후, 물(50㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써, 목적물인 4,6-다이페닐-2-[4-(2,6-다이페닐피리딘-4-일)-1,1':3',1":4",1"'-쿼터페닐-5'-일]-1,3,5-트라이아진(A-118)의 회백색 고체(수득량 1.75g, 수율 86.8%)를 얻었다.(5-chloro-1,1 ': 4', 1 "-terphenyl-3-yl) -4,6-diphenyl-1,3,5-tri Azine (1.30 g, 2.62 mmol), 4- (2,6-diphenylpyridin-4-yl) phenylboronic acid (1.10 g, 3.15 mmol) obtained in Synthesis Example-13, palladium acetate (11.8 mg, dicyclohexylphosphino-2 ', 4', 6'-triisopropylbiphenyl (50.0 mg, 0.10 mmol) and potassium carbonate (1.09 g, 7.86 mmol) were dissolved in tetrahydrofuran (35 ml) and water (7 ml) .The obtained mixture was stirred for 23 hours at 70 DEG C. After cooling, water (50 ml) was added, the precipitated solid was filtered off, The resulting solid was recrystallized (toluene) to obtain the desired product, 4,6-diphenyl-2- [4- (2,6-diphenylpyridin-4-yl) (Yield 1.75 g, yield 86.8%) of 3 ', 1 ": 4", 1 "' -tetraphenyl-5'- yl] -1,3,5- .

1H-NMR(CDCl3)δ(ppm): 7.41 (t, J=7.5Hz, 1H), 7.46-7.67(m, 14H), 7.72(dd, J=8.3Hz, 1.4Hz, 2H), 7.81(d, J=8.5Hz, 2H), 7.91-8.00(m, 8H), 8.16 (t, J=1.8Hz, 1H), 8.25(dd, J=8.6Hz, 1.4Hz, 4H), 8.83(dd, J=8.1Hz, 1.9Hz, 4H), 9.07(ddd, J=4.9Hz, 1.8Hz, 1.7Hz, 2H). 1 H-NMR (CDCl 3) δ (ppm): 7.41 (t, J = 7.5Hz, 1H), 7.46-7.67 (m, 14H), 7.72 (dd, J = 8.3Hz, 1.4Hz, 2H), 7.81 (d, J = 8.5 Hz, 2H), 7.91-8.00 (m, 8H), 8.16 (t, J = 1.8 Hz, 1H), 8.25 (dd, J = 8.6 Hz, 1.4 Hz, 4H), 8.83 , J = 8.1 Hz, 1.9 Hz, 4H), 9.07 (ddd, J = 4.9 Hz, 1.8 Hz, 1.7 Hz, 2H).

얻어진 화합물 A-118의 Tg는 131℃였다.The Tg of the obtained Compound A-118 was 131 占 폚.

합성예-15Synthesis Example-15

Figure pct00072
Figure pct00072

아르곤 기류 하, 2-(3-브로모-5-클로로페닐)-4,6-다이페닐-1,3,5-트라이아진(5.00g, 11.8m㏖), 합성예-13에서 얻어진 4-(2,6-다이페닐피리딘-4-일)페닐보론산(6.23g, 17.7m㏖), 테트라키스(트라이페닐포스핀)팔라듐(410㎎, 0.354m㏖) 및 탄산 칼륨(4.90g, 35.5m㏖)을, 테트라하이드로퓨란(240㎖) 및 물(35㎖)의 혼합 용매에 현탁시켰다. 얻어진 혼합물을 70℃에서 20시간 교반하였다. 방랭 후, 물(200㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써, 목적 중간체인 2-[5-클로로-4'-(2,6-다이페닐피리딘-4-일)바이페닐-3-일]-4,6-다이페닐-1,3,5-트라이아진의 회백색 고체(수득량 4.17g, 수율 54.2%)를 얻었다.2- (3-bromo-5-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (5.00 g, 11.8 mmol) (6.25 g, 17.7 mmol), tetrakis (triphenylphosphine) palladium (410 mg, 0.354 mmol) and potassium carbonate (4.90 g, 35.5 mmol) was suspended in a mixed solvent of tetrahydrofuran (240 ml) and water (35 ml). The resulting mixture was stirred at 70 占 폚 for 20 hours. After cooling, water (200 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The resulting solid was recrystallized (toluene) to obtain the desired intermediate 2- [5-chloro-4 '- (2,6-diphenylpyridin-4-yl) biphenyl- An off-white solid of 1,3,5-triazine (yield 4.17 g, yield 54.2%) was obtained.

1H-NMR(CDCl3)δ(ppm): 7.46-7.67(m, 12H), 7.88-7.95(m, 5H), 7.98(s, 2H), 8.25(brd, J=7.4Hz, 4H), 8.77(brt, J=1.8Hz, 1H), 8.80(dd, J=8.1Hz, 1.5Hz, 4H), 8.95(brt, J=1.7Hz, 1H). 1 H-NMR (CDCl 3) δ (ppm): 7.46-7.67 (m, 12H), 7.88-7.95 (m, 5H), 7.98 (s, 2H), 8.25 (brd, J = 7.4Hz, 4H), 8.77 (brt, J = 1.8 Hz, 1H), 8.80 (dd, J = 8.1 Hz, 1.5 Hz, 4H), 8.95 (brt, J = 1.7 Hz, 1H).

실시예-15Example-15

Figure pct00073
Figure pct00073

아르곤 기류 하, 합성예-15에서 얻어진 2-[5-클로로-4'-(2,6-다이페닐피리딘-4-일)바이페닐-3-일]-4,6-다이페닐-1,3,5-트라이아진(1.50g, 2.31m㏖), 탄산 칼륨(958㎎, 6.93m㏖) 및 4-피리딘보론산(340㎎, 2.77m㏖)을, 테트라하이드로퓨란(75㎖) 및 물(6㎖)의 혼합 용매에 현탁시켜서 70℃까지 승온시켰다. 다음에, 얻어진 혼합물에, 아세트산 팔라듐(10.4㎎, 0.046m㏖) 및 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(44.0㎎, 0.092m㏖)의 테트라하이드로퓨란(25㎖) 용액을 첨가하고, 70℃에서 19시간 교반하였다. 방랭 후, 물(100㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써, 목적물인 4,6-다이페닐-2-[4'-(2,6-다이페닐피리딘-4-일)-5-(4-피리딜)-바이페닐-3-일]-1,3,5-트라이아진(A-64)의 회백색 고체(수득량 1.09g, 수율 68.2%)를 얻었다.4-yl) biphenyl-3-yl] -4,6-diphenyl-1, 2-dicarboxylic acid obtained in Synthesis Example- (75 mg) was added to a solution of 3,5-triazine (1.50 g, 2.31 mmol), potassium carbonate (958 mg, 6.93 mmol) and 4-pyridineboronic acid (340 mg, 2.77 mmol) in tetrahydrofuran (6 ml), and the temperature was raised to 70 占 폚. Next, to the resulting mixture was added a solution of tetra (2-pyridyl) -1,3-dioxolane in the presence of palladium acetate (10.4 mg, 0.046 mmol) and 2-dicyclohexylphosphino-2 ', 4' (25 ml), and the mixture was stirred at 70 占 폚 for 19 hours. After cooling, water (100 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The resulting solid was recrystallized (toluene) to obtain the desired product, 4,6-diphenyl-2- [4 '- (2,6-diphenylpyridin- 3-yl] -1,3,5-triazine (A-64) as a white solid (Yield 1.09 g, yield 68.2%).

1H-NMR(CDCl3)δ(ppm): 7.48 (t, J=7.2Hz, 2H), 7.55 (t, J=7.6Hz, 4H), 7.60-7.68(m, 6H), 7.76(d, J=6.3Hz, 2H), 7.97(s,4H), 8.00(s, 2H), 8.14 (t, J=1.8Hz, 1H), 8.25(dd, J=8.5Hz, 1.4Hz, 4H), 8.80-8.84(m, 6H), 9.06 (t, J=1.8Hz, 1H), 9.14 (t, J=1.7Hz, 1H). 1 H-NMR (CDCl 3) δ (ppm): 7.48 (t, J = 7.2Hz, 2H), 7.55 (t, J = 7.6Hz, 4H), 7.60-7.68 (m, 6H), 7.76 (d, (D, J = 8.5 Hz, 1.4 Hz, 4H), 8.80 (s, 2H), 8.14 -8.84 (m, 6H), 9.06 (t, J = 1.8 Hz, 1H), 9.14 (t, J = 1.7 Hz, 1H).

얻어진 화합물 A-64의 Tg는 130℃였다.The obtained Compound A-64 had a Tg of 130 캜.

실시예-16Example-16

Figure pct00074
Figure pct00074

아르곤 기류 하, 합성예-15에서 얻어진 2-[5-클로로-4'-(2,6-다이페닐피리딘-4-일)바이페닐-3-일]-4,6-다이페닐-1,3,5-트라이아진(1.50g, 2.31m㏖), 탄산 칼륨(958㎎, 6.93m㏖) 및 6-페닐-3-(4,4,5,5-테트라메틸-1,3,2-다이옥사보로란-2-일)피리딘(780㎎, 2.77m㏖)을, 테트라하이드로퓨란(75㎖) 및 물(6㎖)의 혼합 용매에 현탁시켜서 70℃까지 승온시켰다. 다음에, 얻어진 혼합물에, 아세트산 팔라듐(10.4㎎, 0.046m㏖) 및 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(44.0㎎, 0.092m㏖)의 테트라하이드로퓨란(25㎖) 용액을 첨가하고, 70℃에서 21시간 교반하였다. 방랭 후, 물(100㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써, 목적물인 4,6-다이페닐-2-[4'-(2,6-다이페닐피리딘-4-일)-5-(2-페닐피리딘-5-일)-바이페닐-3-일]-1,3,5-트라이아진(A-225)의 회백색 고체(수득량 1.46g, 수율 82.3%)를 얻었다.4-yl) biphenyl-3-yl] -4,6-diphenyl-1, 2-dicarboxylic acid obtained in Synthesis Example- (1.50 g, 2.31 mmol), potassium carbonate (958 mg, 6.93 mmol) and 6-phenyl-3- (4,4,5,5-tetramethyl- 2-yl) pyridine (780 mg, 2.77 mmol) was suspended in a mixed solvent of tetrahydrofuran (75 ml) and water (6 ml) and the temperature was raised to 70 ° C. Next, to the resulting mixture was added a solution of tetra (2-pyridyl) -1,3-dioxolane in the presence of palladium acetate (10.4 mg, 0.046 mmol) and 2-dicyclohexylphosphino-2 ', 4' (25 ml) was added, and the mixture was stirred at 70 占 폚 for 21 hours. After cooling, water (100 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The resulting solid was recrystallized (toluene) to obtain the desired product, 4,6-diphenyl-2- [4 '- (2,6- diphenylpyridin- -Biphenyl-3-yl] -1,3,5-triazine (A-225) as an off-white solid (yield: 1.46 g, yield 82.3%).

1H-NMR(CDCl3)δ(ppm): 7.46-7.50(m, 3H), 7.52-7.57(m, 6H), 7.59-7.68(m, 6H), 7.94-8.00(m, 7H), 8.12(dd, J=8.4Hz, 1.4Hz, 2H), 8.15 (t, J=1.8Hz, 1H), 8.21(dd, J=8.5Hz, 2.5Hz, 1H), 8.25(dd, J=8.4Hz, 1.5Hz, 4H), 8.83(dd, J=8.1Hz, 1.5Hz, 4H), 9.10(dt, J=6.91Hz, 1.7Hz, 2H), 9.20(brd, J=2.2Hz, 1H). 1 H-NMR (CDCl 3 )? (Ppm): 7.46-7.50 (m, 3H), 7.52-7.57 (m, 6H), 7.59-7.68 (m, 6H), 7.94-8.00 (dd, J = 8.4 Hz, 1.4 Hz, 2H), 8.15 (t, J = 1.8 Hz, 1H), 8.21 (dd, J = 8.5 Hz, 2.5 Hz, 1H) (Dd, J = 8.1 Hz, 1.5 Hz, 4H), 9.10 (dt, J = 6.91 Hz, 1.7 Hz, 2H), 9.20 (brd, J = 2.2 Hz, 1H).

얻어진 화합물 A-225의 Tg는 135℃였다.The obtained Compound A-225 had a Tg of 135 占 폚.

실시예-17Example-17

Figure pct00075
Figure pct00075

아르곤 기류 하, 합성예-9에서 얻어진 2-[5-클로로-4'-(4,6-다이페닐피리딘-2-일)바이페닐-3-일]-4,6-다이페닐-1,3,5-트라이아진(1.50g, 2.31m㏖), 탄산 칼륨(958㎎, 6.93m㏖) 및 6-페닐-3-(4,4,5,5-테트라메틸-1,3,2-다이옥사보로란-2-일)피리딘(780㎎, 2.77m㏖)을, 테트라하이드로퓨란(36㎖) 및 물(6㎖)의 혼합 용매에 현탁시켜서 70℃까지 승온시켰다. 다음에, 얻어진 혼합물에, 아세트산 팔라듐(10.4㎎, 0.046m㏖) 및 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(44.0㎎, 0.092m㏖)의 테트라하이드로퓨란(15㎖) 용액을 첨가하고, 70℃에서 19시간 교반하였다. 방랭 후, 물(100㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써, 목적물인 4,6-다이페닐-2-[4'-(2,4-다이페닐피리딘-6-일)-5-(2-페닐피리딘-5-일)-바이페닐-3-일]-1,3,5-트라이아진(A-226)의 회백색 고체(수득량 1.60g, 수율 90.2%)를 얻었다.2- [5-chloro-4 '- (4,6-diphenylpyridin-2-yl) biphenyl-3-yl] -4,6-diphenyl- (1.50 g, 2.31 mmol), potassium carbonate (958 mg, 6.93 mmol) and 6-phenyl-3- (4,4,5,5-tetramethyl- Dioxaborolan-2-yl) pyridine (780 mg, 2.77 mmol) was suspended in a mixed solvent of tetrahydrofuran (36 mL) and water (6 mL) and the temperature was raised to 70 ° C. Next, to the resulting mixture was added a solution of tetra (2-pyridyl) -1,3-dioxolane in the presence of palladium acetate (10.4 mg, 0.046 mmol) and 2-dicyclohexylphosphino-2 ', 4' A solution of hydrofuran (15 ml) was added, and the mixture was stirred at 70 占 폚 for 19 hours. After cooling, water (100 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The resulting solid was recrystallized (toluene) to obtain the desired product, 4,6-diphenyl-2- [4 '- (2,4-diphenylpyridin-6-yl) -5- -Biphenyl-3-yl] -1,3,5-triazine (A-226) as an off-white solid (yield 1.60 g, yield 90.2%).

1H-NMR(CDCl3)δ(ppm): 7.45-7.67(m, 15H), 7.80(dd, J=8.3Hz, 1.4Hz, 2H), 7.95(brd, J=8.1Hz, 1H), 7.95(d, J=1.3Hz, 1H), 7.98(d, J=8.5Hz, 2H), 8.01(d, J=1.4Hz, 1H), 8.13(dd, J=8.7Hz, 1.6Hz, 2H), 8.14 (t, J=1.7Hz, 1H), 8.21(dd, J=8.5Hz, 2.5Hz, 1H), 8.26(dd, J=8.6Hz, 1.5Hz, 2H), 8.43(d, J=8.5Hz, 2H), 8.83(dd, J=8.0Hz, 1.8Hz, 4H), 9.08 (t, J=1.7Hz, 1H), 9.13 (t, J=1.7Hz, 1H), 9.21(brd, J=2.4Hz, 1H). 1 H-NMR (CDCl 3) δ (ppm): 7.45-7.67 (m, 15H), 7.80 (dd, J = 8.3Hz, 1.4Hz, 2H), 7.95 (brd, J = 8.1Hz, 1H), 7.95 (dd, J = 8.7 Hz, 1.6 Hz, 2H), 8.01 (d, J = 1.3 Hz, 1H) 8.24 (dd, J = 8.6 Hz, 1.5 Hz, 2H), 8.43 (d, J = 8.5 Hz, 1H) , 2H), 8.83 (dd, J = 8.0 Hz, 1.8 Hz, 4H), 9.08 (t, J = 1.7 Hz, 1H), 9.13 (t, J = 1.7 Hz, 1H), 9.21 Hz, 1H).

얻어진 화합물 A-226의 Tg는 133℃였다.The Tg of the obtained Compound A-226 was 133 占 폚.

합성예-16Synthesis Example-16

Figure pct00076
Figure pct00076

아르곤 기류 하, 합성예-9에서 얻어진 2-[5-클로로-4'-(4,6-다이페닐피리딘-2-일)바이페닐-3-일]-4,6-다이페닐-1,3,5-트라이아진(5.00g, 7.70m㏖), 비스피나콜라토 다이보론(2.35g, 9.24m㏖), 아세트산 팔라듐(34.6㎎, 0.15m㏖), 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(147㎎, 0.31m㏖), 아세트산 칼륨(2.27g, 23.1m㏖)을 1,4-다이옥산(200㎖)에 현탁시키고, 100℃에서 18시간 교반하였다. 방랭 후, 클로로폼(200㎖), 물(100㎖)을 첨가해서 교반한 후, 수층과 유기층을 분리하였다. 또한, 수층을 클로로폼(50㎖)으로 3회 추출하고, 상기 유기층과 합하였다. 유기층으로부터 저비점 성분을 감압증류 제거하고, 건조 고형물을 얻었다. 건조 고형물에 헥산을 첨가해서 교반한 후, 여과해서 고체를 얻었다. 얻어진 고체를 감압 건조시킴으로써, 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(4,4,5,5-테트라메틸-1,3,2-다이옥사보로란-2-일)바이페닐-3-일]-1,3,5-트라이아진의 유백색 분말(수득량 5.22g, 수율 91.5%)을 얻었다.2- [5-chloro-4 '- (4,6-diphenylpyridin-2-yl) biphenyl-3-yl] -4,6-diphenyl- (5.00 g, 7.70 mmol), bispinacolato diboron (2.35 g, 9.24 mmol), palladium acetate (34.6 mg, 0.15 mmol), 2-dicyclohexylphosphino- (147 mg, 0.31 mmol) and potassium acetate (2.27 g, 23.1 mmol) were suspended in 1,4-dioxane (200 ml) Lt; / RTI > After cooling, chloroform (200 ml) and water (100 ml) were added and stirred, and then the aqueous layer and the organic layer were separated. Further, the aqueous layer was extracted three times with chloroform (50 ml) and combined with the organic layer. The low boiling point component was distilled off under reduced pressure from the organic layer to obtain a dried solid. Hexane was added to the dried solid and stirred, followed by filtration to obtain a solid. The resulting solid was dried under reduced pressure to give 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridin-2-yl) -5- (4,4,5,5- Yl)] biphenyl-3-yl] -1,3,5-triazine (yield 5.22 g, yield 91.5%).

1H-NMR(CDCl3)δ(ppm): 1.45(s, 12H), 7.46-7.66(m, 12H), 7.80(dd, J=8.3Hz, 1.4Hz, 2H), 7.93-7.99(m, 4H), 8.25(dd, J=8.4Hz, 1.4Hz, 2H), 8.37-8.39(m, 3H), 8.84(dd, J=7.8Hz, 1.5Hz, 4H), 9.15(brs, 1H), 9.18(brt, J=1.9Hz, 1H). 1 H-NMR (CDCl 3) δ (ppm): 1.45 (s, 12H), 7.46-7.66 (m, 12H), 7.80 (dd, J = 8.3Hz, 1.4Hz, 2H), 7.93-7.99 (m, 4H), 8.25 (dd, J = 8.4 Hz, 1.4 Hz, 2H), 8.37-8.39 (m, 3H), 8.84 (dd, J = 7.8Hz, 1.5Hz, 4H), 9.15 (brt, J = 1.9 Hz, 1 H).

실시예-18Example -18

Figure pct00077
Figure pct00077

아르곤 기류 하, 합성예-16에서 얻어진 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(4,4,5,5-테트라메틸-1,3,2-다이옥사보로란-2-일)바이페닐-3-일]-1,3,5-트라이아진(2.00g, 2.70m㏖), 2-브로모피리미딘(0.52g, 3.24m㏖), 테트라키스트라이페닐포스핀팔라듐(93.6㎎, 0.081m㏖) 및 탄산 칼륨(1.12g, 8.10m㏖)을, 테트라하이드로퓨란(64㎖) 및 물(8㎖)의 혼합 용매에 현탁시켰다. 얻어진 혼합물을 70℃에서 20시간 교반하였다. 방랭 후, 물(50㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 실리카겔 칼럼 크로마토그래피(전개 용매:클로로폼) 및 재결정(톨루엔)에 의해 정제함으로써, 목적물인 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(2-피리미딜)-바이페닐-3-일]-1,3,5-트라이아진(A-73)의 백색 고체(수득량 0.54g, 수율 28.9%)를 얻었다.(4,4-diphenylpyridin-2-yl) -5- (4,4,5,5-tetramethyl- Yl] -1,3,5-triazine (2.00 g, 2.70 mmol), 2-bromopyrimidine (0.52 g, , Tetrakis triphenylphosphine palladium (93.6 mg, 0.081 mmol) and potassium carbonate (1.12 g, 8.10 mmol) were dissolved in a mixed solvent of tetrahydrofuran (64 ml) and water (8 ml) ≪ / RTI > The resulting mixture was stirred at 70 占 폚 for 20 hours. After cooling, water (50 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The obtained solid was purified by silica gel column chromatography (developing solvent: chloroform) and recrystallization (toluene) to obtain the desired product, 4,6-diphenyl-2- [4 '- (4,6- (Yield 0.54 g, yield 28.9%) of 5- (2-pyrimidyl) -biphenyl-3-yl] -1,3,5-triazine (A-73).

1H-NMR(CDCl3)δ(ppm): 7.32 (t, J=5.1Hz, 1H), 7.48-7.66(m, 13H), 7.81(brd, J=7.0Hz, 2H), 7.94(d, J=1.1Hz, 1H), 8.01(d, J=1.4Hz, 1H), 8.04(d, J=8.4Hz, 2H), 8.26(brd, J=7.3Hz, 2H), 8.41(d, J=8.5Hz, 2H), 8.85-8.88(m, 4H), 8.96(d, J=4.9Hz, 2H), 9.05 (t, J=1.8Hz, 1H), 9.23 (t, J=1.6Hz, 1H). 1 H-NMR (CDCl 3) δ (ppm): 7.32 (t, J = 5.1Hz, 1H), 7.48-7.66 (m, 13H), 7.81 (brd, J = 7.0Hz, 2H), 7.94 (d, J = 8.4 Hz, 2H), 8.26 (brd, J = 7.3 Hz, 2H), 8.41 (d, J = J = 1.8 Hz, 2H), 8.85-8.88 (m, 4H), 8.96 (d, J = 4.9 Hz, 2H), 9.05 .

얻어진 화합물 A-73의 Tg는 133℃였다.The obtained Compound A-73 had a Tg of 133 캜.

실시예-19Example-19

Figure pct00078
Figure pct00078

아르곤 기류 하, 합성예-16에서 얻어진 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(4,4,5,5-테트라메틸-1,3,2-다이옥사보로란-2-일)바이페닐-3-일]-1,3,5-트라이아진(2.00g, 2.70m㏖), 2-클로로피라진(0.29mL,3.24m㏖), 아세트산 팔라듐(12.1㎎, 0.054m㏖), 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(51.5㎎, 0.11m㏖) 및 탄산 칼륨(1.12g, 8.10m㏖)을, 테트라하이드로퓨란(64㎖) 및 물(8㎖)의 혼합 용매에 현탁시켰다. 얻어진 혼합물을 70℃에서 21시간 교반하였다. 방랭 후, 물(50㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 실리카겔 칼럼 크로마토그래피(전개 용매:클로로폼) 및 재결정(톨루엔)에 의해 정제함으로써, 목적물인 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(2-피라질)-바이페닐-3-일]-1,3,5-트라이아진(A-91)의 백색 고체(수득량 1.06g, 수율 56.9%)를 얻었다.(4,4-diphenylpyridin-2-yl) -5- (4,4,5,5-tetramethyl- Yl] -1,3,5-triazine (2.00 g, 2.70 mmol), 2-chloropyrazine (0.29 mL, 3.24 2, 4 ', 6'-triisopropylbiphenyl (51.5 mg, 0.11 mmol) and potassium carbonate (1.12 mg, g, 8.10 mmol) was suspended in a mixed solvent of tetrahydrofuran (64 ml) and water (8 ml). The resulting mixture was stirred at 70 占 폚 for 21 hours. After cooling, water (50 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The obtained solid was purified by silica gel column chromatography (developing solvent: chloroform) and recrystallization (toluene) to obtain the desired product, 4,6-diphenyl-2- [4 '- (4,6- Yl) -1,3,5-triazine (A-91) as a white solid (Yield 1.06 g, yield 56.9%).

1H-NMR(CDCl3)δ(ppm): 7.46-7.68(m, 12H), 7.80(dd, J=8.5Hz, 1.5Hz, 2H), 7.95(d, J=1.6Hz, 1H), 8.00-8.02(m, 3H), 8.26(dd, J=8.5Hz, 1.3Hz, 2H), 8.43(d, J=8.4Hz, 2H), 8.64-8.65(m, 2H), 8.78(dd, J=2.3Hz, 1.3Hz, 1H), 8.84(dd, J=8.0Hz, 2.0Hz, 4H), 9.20 (t, J=1.8Hz, 1H), 9.34(d, J=1.3Hz, 1H), 9.40 (t, J=1.7Hz, 1H). 1 H-NMR (CDCl 3) δ (ppm): 7.46-7.68 (m, 12H), 7.80 (dd, J = 8.5Hz, 1.5Hz, 2H), 7.95 (d, J = 1.6Hz, 1H), 8.00 J = 8.5 Hz, 1.3 Hz, 2H), 8.43 (d, J = 8.4 Hz, 2H), 8.64-8.65 (m, 2H), 8.78 (dd, J = (D, J = 8.0 Hz, 2.0 Hz, 4H), 9.20 (t, J = 1.8 Hz, 1H), 9.34 (d, J = 1.3 Hz, 1H), 9.40 t, J = 1.7 Hz, 1H).

얻어진 화합물 A-91의 Tg는 124℃였다.The obtained Compound A-91 had a Tg of 124 占 폚.

합성예-17Synthesis Example -17

Figure pct00079
Figure pct00079

질소 기류 하, 3'-브로모칼콘(10.0g, 34.8m㏖), 페나실피리디늄브로마이드(13.6g, 48.8m㏖) 및 아세트산 암모늄 (40.3g, 522m㏖)을, 아세트산(100㎖) 및 다이메틸폼아마이드(100㎖)의 혼합 용매에 용해시켜, 150℃에서 48시간 교반하였다. 실온까지 방랭 후, 반응 혼합물에 물(300㎖) 및 메탄올(200㎖)을 첨가하고, 석출물을 여과하여 취하였다. 여과하여 취한 석출물을 메탄올로 세정하여, 목적으로 하는 2-(3-브로모페닐)-4,6-다이페닐피리딘의 회백색 분말(수득량 11.1g, 수율 97.2%)을 얻었다.(10.0 g, 34.8 mmol), phenacylpyridinium bromide (13.6 g, 48.8 mmol) and ammonium acetate (40.3 g, 522 mmol) were dissolved in a mixture of acetic acid Was dissolved in a mixed solvent of dimethylformamide (100 ml), and the mixture was stirred at 150 占 폚 for 48 hours. After cooling to room temperature, water (300 ml) and methanol (200 ml) were added to the reaction mixture, and the precipitate was collected by filtration. The precipitate obtained by filtration was washed with methanol to obtain an objective off-white powder of the objective 2- (3-bromophenyl) -4,6-diphenylpyridine (yield 11.1 g, yield 97.2%).

1H-NMR(CDCl3)δ(ppm): 7.35(brt, J=8.0Hz, 1H), 7.43-7.57(m, 7H), 7.73(brd, J=8.3Hz, 2H), 7.84(brs, 1H), 7.90(brs, 1H), 8.11(brd, J=8.0Hz, 1H), 8.17(brd, J=8.1Hz, 2H), 8.35(brs, 1H). 1 H-NMR (CDCl 3) δ (ppm): 7.35 (brt, J = 8.0Hz, 1H), 7.43-7.57 (m, 7H), 7.73 (brd, J = 8.3Hz, 2H), 7.84 (brs, 1H), 7.90 (brs, 1H), 8.11 (brd, J = 8.0 Hz, 1H), 8.17 (brd, J = 8.1 Hz, 2H), 8.35 (brs, 1H).

합성예-18Synthesis Example-18

Figure pct00080
Figure pct00080

아르곤 기류 하, 합성예-17에서 얻어진 2-(3-브로모페닐)-4,6-다이페닐피리딘(5.0g, 15.3m㏖)을 테트라하이드로퓨란(20㎖)에 용해시켜, -78℃로 냉각시켰다. 얻어진 용액에, 1.55M의 n-뷰틸리튬/헥산 용액(10.9㎖, 16.9m㏖)을 천천히 적하한 후, 1시간 교반하였다. 얻어진 용액에, 붕산 트라이아이소프로필(4.60㎖, 19.9m㏖)을 천천히 적하하고, 1시간 교반하였다. 얻어진 용액을 실온까지 승온시키고, 6시간 교반하였다. 다음에, 얻어진 용액에, 1.5M의 수산화나트륨 수용액(26.6㎖, 39.9m㏖)을 첨가해서 교반한 후, 수층을 제거하였다. 추출에 의해 얻어진 유기층을 건조 고형화시킴으로써 목적 중간체인 3-(4,6-다이페닐피리딘-2-일)페닐보론산(3.38g, 수율 62.8%)을 얻었다.2- (3-bromophenyl) -4,6-diphenylpyridine (5.0 g, 15.3 mmol) obtained in Synthesis Example 17 was dissolved in tetrahydrofuran (20 ml) under an argon stream, Lt; / RTI > 1.55M n-butyllithium / hexane solution (10.9 ml, 16.9 mmol) was slowly added dropwise to the obtained solution, followed by stirring for 1 hour. To the obtained solution, triisopropyl borate (4.60 ml, 19.9 mmol) was slowly added dropwise and stirred for 1 hour. The resulting solution was warmed to room temperature and stirred for 6 hours. Next, 1.5M sodium hydroxide aqueous solution (26.6 mL, 39.9 mmol) was added to the obtained solution and stirred, and then the aqueous layer was removed. The organic layer obtained by the extraction was dried and solidified to obtain 3- (4,6-diphenylpyridin-2-yl) phenylboronic acid as a target intermediate (3.38 g, yield 62.8%).

실시예-20Example-20

Figure pct00081
Figure pct00081

아르곤 기류 하, 합성예-10에서 얻어진 2-(5-클로로바이페닐-3-일)-4,6-다이페닐-1,3,5-트라이아진(500㎎, 1.19m㏖), 합성예-18에서 얻어진 3-(4,6-다이페닐피리딘-2-일)페닐보론산(502㎎, 1.43m㏖), 아세트산 팔라듐(5.34㎎, 0.0238m㏖),및 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐(22.7㎎, 0.0476m㏖)을 테트라하이드로퓨란(20㎖)에 현탁한 후, 2M의 탄산 칼륨(1.79㎖,3.57m㏖)을 더하였다. 얻어진 혼합물을 70℃에서 24시간 교반하였다. 방랭 후, 농축 건조 고형화시켜, 얻어진 고체를 물, 메탄올, 헥산으로 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써, 목적물인 4,6-다이페닐-2-[3-(4,6-다이페닐피리딘-2-일)-1,1':3',1"-터페닐-5'-일]-1,3,5-트라이아진(A-241)의 회백색 고체(수득량 800㎎, 수율 97.0%)를 얻었다.2- (5-Chlorobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine (500 mg, 1.19 mmol) obtained in Synthesis Example-10, 3- (4,6-diphenylpyridin-2-yl) phenylboronic acid (502 mg, 1.43 mmol), palladium acetate (5.34 mg, 0.0238 mmol), and 2-dicyclohexylphosphino -2, 4 ', 6'-triisopropylbiphenyl (22.7 mg, 0.0476 mmol) was suspended in tetrahydrofuran (20 ml), and 2M potassium carbonate (1.79 ml, 3.57 mmol) Respectively. The resulting mixture was stirred at 70 占 폚 for 24 hours. After cooling, the mixture was concentrated to dryness, and the resulting solid was washed with water, methanol, and hexane. The resulting solid was recrystallized (toluene) to obtain the objective product, 4,6-diphenyl-2- [3- (4,6-diphenylpyridin-2-yl) -1,1 ': 3' Yl] -1,3,5-triazine (A-241) (yield 800 mg, yield 97.0%).

1H-NMR(CDCl3)δ(ppm): 7.41-7.61(m, 15H), 7.69 (t, J=7.6Hz, 1H), 7.77(brd, J=7.0Hz, 2H), 7.82(brd.J=7.2Hz, 2H), 7.87(brd, J=7.5Hz, 1H), 7.94(d, J=1.1Hz, 1H), 7.99(d, J=1.0Hz, 1H), 8.13 (t, J=1.8Hz, 1H), 8.23(brd, J=7.2Hz, 2H), 8.27(brd, J=7.9Hz, 1H), 8.55(brs, 1H), 8.80(dd, J=8.3Hz, 1.7Hz, 4H), 9.00 (t, J=1.7Hz, 1H), 9.06 (t, J=1.7Hz, 1H). 1 H-NMR (CDCl 3) δ (ppm): 7.41-7.61 (m, 15H), 7.69 (t, J = 7.6Hz, 1H), 7.77 (brd, J = 7.0Hz, 2H), 7.82 (brd. J = 7.2 Hz, 2H), 7.87 (brd, J = 7.5 Hz, 1H), 7.94 (d, J = 1.1 Hz, 1H) J = 7.9 Hz, 1H), 8.55 (brs, 1H), 8.80 (dd, J = 8.3 Hz, 1.7 Hz, 4H ), 9.00 (t, J = 1.7 Hz, 1H), 9.06 (t, J = 1.7 Hz, 1H).

참고예-1Reference Example 1

Figure pct00082
Figure pct00082

일본국 특허 공개 제2008-280330호에 기재되어 있는 화합물인 2,4-비스(1-나프틸)-6-[4,4"-비스(2-피리딜)-[1,1:3',1"]-터페닐-5'-일]-1,3,5-트라이아진의 열 분석을 한 결과, Tg는 104℃였다.(1-naphthyl) -6- [4,4 "-bis (2-pyridyl) - [1,1: 3 ' , 1 "] - terphenyl-5 ' -yl] -1,3,5-triazine as a result, the Tg was 104 deg.

참고예-2Reference Example-2

Figure pct00083
Figure pct00083

아르곤 기류 하, 2-(3-브로모페닐)-4,6-다이페닐-1,3,5-트라이아진(1.50g, 3.86m㏖), 4-(4,6-다이페닐피리딘-2-일)페닐보론산(1.63g, 4.64m㏖), 테트라키스트라이페닐포스핀팔라듐(134㎎, 1.16m㏖) 및 탄산 칼륨(1.60g, 11.6m㏖)을, 테트라하이드로퓨란(83㎖) 및 물(11㎖)의 혼합 용매에 현탁시켰다. 얻어진 혼합물을 70℃에서 25시간 교반하였다. 방랭 후, 물(100㎖)을 첨가하고, 석출된 고체를 여과 분별하고, 물, 메탄올, 헥산으로 고체를 세정하였다. 얻어진 고체를 재결정(톨루엔)시킴으로써 목적물인 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-바이페닐-3-일]-1,3,5-트라이아진(ETL-2)의 회백색 고체(수득량 1.79g, 수율 99.2%)를 얻었다.Diphenyl-1,3,5-triazine (1.50 g, 3.86 mmol), 4- (4,6-diphenylpyridin-2 (1.63 g, 4.64 mmol), tetrakis triphenylphosphine palladium (134 mg, 1.16 mmol) and potassium carbonate (1.60 g, 11.6 mmol) were dissolved in tetrahydrofuran (83 ml) And water (11 ml). The resulting mixture was stirred at 70 占 폚 for 25 hours. After cooling, water (100 ml) was added, the precipitated solid was filtered off, and the solid was washed with water, methanol and hexane. The resulting solid was recrystallized (toluene) to give the objective product, 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridin-2-yl) -Triazine (ETL-2) as an off-white solid (yield 1.79 g, yield 99.2%).

1H-NMR(CDCl3)δ(ppm): 7.43-7.64(m, 12H), 7.68 (t, J=8.1Hz, 1H), 7.78(dd, J=8.5Hz, 1.5Hz, 2H), 7.89-7.93(m, 4H), 7.98(d, J=1.4Hz, 1H), 8.23(dd, J=8.6Hz, 1.4Hz, 2H), 8.37(d, J=8.5Hz, 2H), 8.77-8.82(m, 5H), 9.08 (t, J=1.6Hz, 1H). 1 H-NMR (CDCl 3) δ (ppm): 7.43-7.64 (m, 12H), 7.68 (t, J = 8.1Hz, 1H), 7.78 (dd, J = 8.5Hz, 1.5Hz, 2H), 7.89 (D, J = 8.6 Hz, 1.4 Hz, 2H), 8.37 (d, J = 8.5 Hz, 2H), 8.77-8.82 (m, 5H), 9.08 (t, J = 1.6 Hz, 1H).

얻어진 화합물 ETL-2의 Tg는 102℃였다.The obtained compound ETL-2 had a Tg of 102 占 폚.

다음에 소자 평가에 대해서 기재한다.Next, device evaluation will be described.

소자 평가에 이용한 화합물의 구조식 및 그 약칭을 이하에 나타낸다.Structural formulas and abbreviations of the compounds used for device evaluation are shown below.

Figure pct00084
Figure pct00084

또, 전술한 화합물에 대해서는, 모두 승화 정제된 것을 소자 평가에 이용하였다.In addition, all of the above-mentioned compounds were subjected to sublimation purification and used for device evaluation.

소자 참고예 1-1Element Reference Example 1-1

기판에는, 2㎜ 폭의 산화인듐-주석(ITO)(막 두께 110㎚)이 스트라이프 형상으로 패턴화된 ITO 투명전극 부착 유리 기판을 사용하였다. 이 기판을 아이소프로필 알코올로 세정한 후, 오존 자외선 세정으로 표면처리를 행하였다. 세정 후의 기판에, 진공증착법으로 각 층의 진공증착을 행하고, 단면도를 도 1에 나타낸 바와 같은 발광 면적 4㎟인 유기 전계발광소자를 제작하였다. 또, 각 유기 재료는 저항 가열 방식에 의해 성막하였다.On the substrate, a glass substrate with an ITO transparent electrode, in which indium tin oxide (ITO) having a width of 2 mm (thickness: 110 nm) was patterned in a stripe shape was used. The substrate was washed with isopropyl alcohol, and then subjected to surface treatment by ozone ultraviolet cleaning. Vacuum deposition of each layer was carried out on the cleaned substrate by a vacuum vapor deposition method, and an organic electroluminescent device having a light emitting area of 4 mm 2 as shown in Fig. 1 was produced in a sectional view. Each of the organic materials was formed by a resistance heating method.

우선, 진공증착조 내에 전기 유리 기판을 도입하고, 1.0×100-4㎩까지 감압하였다.First, an electric glass substrate was introduced into a vacuum vapor deposition vessel, and the pressure was reduced to 1.0 x 100 <" 4 > Pa.

그 후, 도 1의 (1)로 나타낸 ITO 투명전극 부착 유리 기판 상에 유기 화합물층으로서, 정공주입층(2), 전하발생층(3), 정공수송층(4), 발광층(5), 전자수송층(6),및 음극층(7)을, 이 순서로 적층시키면서, 모두 진공증착으로 성막하였다.Thereafter, a hole injection layer 2, a charge generation layer 3, a hole transport layer 4, a light emitting layer 5, an electron transport layer 5, and an electron transport layer 6 are formed as an organic compound layer on the ITO transparent electrode- (6), and the cathode layer (7) were laminated in this order.

정공주입층(2)으로서는, 승화 정제된 HIL을 0.15㎚/초의 속도로 65㎚ 성막하였다.As the hole injecting layer 2, a sublimed and purified HIL was formed at 65 nm at a rate of 0.15 nm / sec.

전하발생층(3)으로서는, 승화 정제된 HAT를 0.05㎚/초의 속도로 5㎚ 성막하였다.As the charge generating layer 3, 5 nm of sublimed and purified HAT was deposited at a rate of 0.05 nm / sec.

정공수송층(4)로서는, HTL을 0.15㎚/초의 속도로 10㎚ 성막하였다.As the hole transport layer 4, 10 nm of HTL was formed at a rate of 0.15 nm / sec.

발광층(5)로서는, EML-1과 EML-2를 95:5의 비율로 25㎚ 성막하였다(성막속도 0.18㎚/초).As the light emitting layer 5, 25 nm of EML-1 and EML-2 were formed in a ratio of 95: 5 (film formation rate: 0.18 nm / second).

전자수송층(6)으로서는, 일본국 공개 특허 제2011-063584에 기재되어 있는 2-[5-(9-페난트릴)-4'-(2-피리미딜)바이페닐-3-일]-4,6-다이페닐-1,3,5-트라이아진(ETL-1) 및 Liq를 50:50(중량비)의 비율로 30㎚ 성막하였다(성막속도 0.15㎚/초).As the electron transport layer 6, 2- [5- (9-phenanthryl) -4 '- (2-pyrimidyl) biphenyl- 6-diphenyl-1,3,5-triazine (ETL-1) and Liq in a ratio of 50: 50 (weight ratio) were formed at a film thickness of 30 nm (film formation rate: 0.15 nm / sec).

최후에, ITO 스트라이프와 직행하도록 메탈 마스크를 배치하고, 음극층(7)을 성막하였다. 음극층(7)은, 은/마그네슘(중량비1/10)과 은을, 이 순서로, 각각 80㎚(성막속도 0.5㎚/초)와 20㎚(성막속도 0.2㎚/초)로 제막하여, 2층 구조로 하였다.Finally, a metal mask was disposed so as to be in direct contact with the ITO stripe, and the cathode layer 7 was formed. The cathode layer 7 was formed into a film of 80 nm (film formation rate 0.5 nm / sec) and 20 nm (film formation rate 0.2 nm / sec) respectively in this order of silver / magnesium Layer structure.

각각의 막 두께는, 촉침식 막 두께 측정계(DEKTAK)로 측정하였다.Each film thickness was measured with a stylus type film thickness meter (DEKTAK).

또한, 이 소자를 산소 및 수분농도 1ppm 이하의 질소분위기 글러브박스(glove box) 내에서 밀봉하였다. 밀봉은, 유리제의 밀봉캡과 상기 성막 기판 에폭시형 자외선 경화 수지(나가세켐텍스사 제품)를 이용하였다.The device was also sealed in a nitrogen atmosphere glove box with oxygen and moisture concentration of 1 ppm or less. As the sealing, a sealing cap made of glass and an epoxy type ultraviolet curing resin (manufactured by Nagase Chemtech Co., Ltd.) were used.

상기한 바와 같이 해서 제작한 유기 전계발광소자에 직류 전류를 인가하고, 탑콘사(TOPCON Corporation) 제품인 LUMINANCE METER(BM-9)의 휘도계를 이용해서 발광 특성을 평가하였다. 발광 특성으로서, 전류밀도 10 mA/㎠를 흘린 때의 전압(V), 전류효율(cd/A)을 측정하고, 연속 점등 시의 소자 수명(h)을 측정하였다. 또, 표 1의 소자 수명(h)은, 제작한 소자를 초기 휘도 800 cd/㎡로 구동했을 때의 연속 점등 시의 휘도 감쇠 시간을 측정하고, 휘도(cd/㎡)가 20% 감소될 때까지 소요된 시간을 측정하였다. 소자 수명은, 본 소자 참고예 1-1에 있어서의 소자 수명(h)을 기준값(100)으로 하였다. 결과를 표 1에 나타낸다.A direct current was applied to the thus fabricated organic electroluminescent device and the luminescent characteristics were evaluated using a luminance meter of LUMINANCE METER (BM-9) manufactured by TOPCON Corporation. The voltage (V) and the current efficiency (cd / A) at the time when the current density was 10 mA / cm 2 were measured as the light emitting characteristics and the device lifetime (h) at the time of continuous lighting was measured. The device lifetime h in Table 1 was obtained by measuring the luminance decay time during continuous lighting when the manufactured device was driven at an initial luminance of 800 cd / m 2 and when the luminance (cd / m 2) was reduced by 20% And the time required for the measurement was measured. The device lifetime was defined as a reference value (100) for the lifetime (h) of the device in Reference Example 1-1 of this device. The results are shown in Table 1.

소자 참고예 1-2Element Reference Example 1-2

소자 참고예 1-1에 있어서, ETL-1 대신에 참고예-2에서 합성한 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-바이페닐-3-일]-1,3,5-트라이아진(ETL-2)을 이용한 이외에는, 소자 참고예-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 1에 나타낸다. 또, 소자 수명에 대해서는, 소자 수명(h)을 측정한 뒤에, 소자 참고예 1-1의 소자 수명을 100으로 한 상대값으로 나타내었다.In the same manner as in Reference Example 1-1 except that 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridin-2-yl) -biphenyl -3-yl] -1,3,5-triazine (ETL-2) was used as the organic EL device, and an organic EL device was prepared and evaluated. The results are shown in Table 1. The device lifetime is represented by a relative value obtained by measuring the lifetime (h) of the device and the lifetime of the device in Reference Example 1-1 from 100.

소자 실시예 1-1Device Example 1-1

소자 참고예 1-1에 있어서, ETL-1 대신에 실시예-1에서 합성한 4,6-다이페닐-2-[4-(4,6-다이페닐피리딘-2-일)-4"-(2-피리딜)-1,1':3',1"-터페닐-5'-일]-1,3,5-트라이아진(화합물 A-127)을 이용한 이외에는, 소자 참고예 1-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 1에 나타내었다. 또, 소자 수명에 대해서는, 소자 수명(h)을 측정한 뒤에, 소자 참고예 1-1의 소자 수명을 100으로 한 상대값으로 나타내었다.In the same manner as in Example 1-1 except that 4,6-diphenyl-2- [4- (4,6-diphenylpyridin-2-yl) -4 " (Compound A-127) was used in place of (2-pyridyl) -1,1 ': 3', 1 '' - terphenyl-5'- 1, an organic electroluminescent device was fabricated and evaluated. The results are shown in Table 1. The device lifetime is represented by a relative value obtained by measuring the lifetime (h) of the device and the lifetime of the device in Reference Example 1-1 from 100.

소자 실시예 1-2Device Example 1-2

소자 참고예 1-1에 있어서, ETL-1 대신에 실시예-2에서 합성한 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(3-피리딜)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-37)을 이용한 이외에는, 소자 참고예 1-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 1에 나타내었다. 또, 소자 수명에 대해서는, 소자 수명(h)을 측정한 뒤에, 소자 참고예 1-1의 소자 수명을 100으로 한 상대값으로 나타내었다.In the same manner as in Example 1-1 except that 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridin-2-yl) An organic electroluminescent device was prepared in the same manner as in Reference Example 1-1 except that (3-pyridyl) -biphenyl-3-yl] -1,3,5-triazine (Compound A-37) , Respectively. The results are shown in Table 1. The device lifetime is represented by a relative value obtained by measuring the lifetime (h) of the device and the lifetime of the device in Reference Example 1-1 from 100.

소자 실시예 1-3Device Embodiment 1-3

소자 참고예 1-1에 있어서, ETL-1 대신에 실시예-3에서 합성한 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(9-페난트릴)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-165)을 이용한 이외에는, 소자 참고예 1-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 1에 나타내었다. 또, 소자 수명에 대해서는, 소자 수명(h)을 측정한 뒤에, 소자 참고예 1-1의 소자 수명을 100으로 한 상대값으로 나타내었다.In the element reference example 1-1, 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridin-2-yl) -5- An organic electroluminescent device was fabricated in the same manner as in Reference Example 1-1 except for using (9-phenanthryl) -biphenyl-3-yl] -1,3,5-triazine (Compound A-165) , Respectively. The results are shown in Table 1. The device lifetime is represented by a relative value obtained by measuring the lifetime (h) of the device and the lifetime of the device in Reference Example 1-1 from 100.

소자 실시예 1-4Device Embodiments 1-4

소자 참고예 1-1에 있어서, ETL-1 대신에 실시예-4에서 합성한 4,6-다이페닐-2-[4-(4,6-다이페닐피리딘-2-일)-1,1':3',1"-터페닐-5'-일]-1,3,5-트라이아진(화합물 A-1)을 이용한 이외에는, 소자 참고예 1-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 1에 나타내었다. 또, 소자 수명에 대해서는, 소자 수명(h)을 측정한 뒤에, 소자 참고예 1-1의 소자 수명을 100으로 한 상대값으로 나타내었다.In the device Reference Example 1-1, the same procedure as in Example 1 was repeated except that 4,6-diphenyl-2- [4- (4,6-diphenylpyridin-2-yl) -1,1 Except that an organic electroluminescent device was used in the same manner as in Reference Example 1-1 except that the organic electroluminescent device was used, except that the organic electroluminescent device was used in place of the organic electroluminescent device ': 3', 1 "-terphenyl-5'-yl] -1,3,5-triazine (Compound A- The results are shown in Table 1. The lifetime of the device is represented by a relative value obtained by measuring the lifetime (h) of the device and the lifetime of the device in Reference Example 1-1.

소자 실시예 1-5Device Embodiments 1-5

소자 참고예 1-1에 있어서, ETL-1 대신에 실시예-5에서 합성한 4,6-다이페닐-2-[4-(4,6-다이페닐피리딘-2-일)-1,1':3',1":4",1"'-쿼터페닐-5'-일]-1,3,5-트라이아진(화합물 A-109)을 이용한 이외에는, 소자 참고예 1-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 1에 나타내었다. 또, 소자 수명에 대해서는, 소자 수명(h)을 측정한 뒤에, 소자 참고예 1-1의 소자 수명을 100으로 한 상대값으로 나타내었다.In the same manner as in Example 1-1 except that 4,6-diphenyl-2- [4- (4,6-diphenylpyridin-2-yl) -1,1 (Compound A-109) were used in the same manner as in Reference Example 1-1 except that 1 ': 3', 1 ": 4", 1 "'-tetraphenyl-5'-yl] -1,3,5- The results are shown in Table 1. The device lifetime was measured by measuring the lifetime (h) of the device and setting the lifetime of the device in Reference Example 1-1 to 100 As a relative value.

소자 실시예 1-6Device Example 1-6

소자 참고예 1-1에 있어서, ETL-1 대신에 실시예-6에서 합성한 4,6-다이페닐-2-[4-(2,6-다이페닐피리딘-4-일)-4"-(2-피리딜)-1,1':3',1"-터페닐-5'-일]-1,3,5-트라이아진(화합물 A-136)을 이용한 이외에는, 소자 참고예 1-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 1에 나타내었다. 또, 소자 수명에 대해서는, 소자 수명(h)을 측정한 뒤에, 소자 참고예 1-1의 소자 수명을 100으로 한 상대값으로 나타내었다.In the same manner as in Example 1-1 except that 4,6-diphenyl-2- [4- (2,6-diphenylpyridin-4-yl) -4 " (Compound A-136) was used in place of (2-pyridyl) -1,1 ': 3', 1 '' - terphenyl-5'- 1, an organic electroluminescent device was fabricated and evaluated. The results are shown in Table 1. The device lifetime is represented by a relative value obtained by measuring the lifetime (h) of the device and the lifetime of the device in Reference Example 1-1 from 100.

소자 실시예 1-7Device Example 1-7

소자 참고예 1-1에 있어서, ETL-1 대신에 실시예-9에서 합성한 4,6-다이페닐-2-[4-(4,6-다이페닐피리딘-2-일)-4"-(3-피리딜)-1,1':3',1"-터페닐-5'-일]-1,3,5-트라이아진(화합물 A-145)을 이용한 이외에는, 소자 참고예 1-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 1에 나타내었다. 또, 소자 수명에 대해서는, 소자 수명(h)을 측정한 뒤에, 소자 참고예 1-1의 소자 수명을 100으로 한 상대값으로 나타내었다.In the same manner as in Example 1-1 except that 4,6-diphenyl-2- [4- (4,6-diphenylpyridin-2-yl) -4 " (Compound A-145) was used in place of 1- (3-pyridyl) -1,1 ': 3', 1 '' - terphenyl-5'- 1, an organic electroluminescent device was fabricated and evaluated. The results are shown in Table 1. The device lifetime is represented by a relative value obtained by measuring the lifetime (h) of the device and the lifetime of the device in Reference Example 1-1 from 100.

소자 실시예 1-8Device Examples 1-8

소자 참고예 1-1에 있어서, ETL-1 대신에 실시예-10에서 합성한 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(2-나프틸)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-164)을 이용한 이외에는, 소자 참고예 1-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 1에 나타내었다. 또, 소자 수명에 대해서는, 소자 수명(h)을 측정한 뒤에, 소자 참고예 1-1의 소자 수명을 100으로 한 상대값으로 나타내었다.In the same manner as in Example 1-1, except that 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridin-2-yl) (Compound A-164) was used in place of the compound (A-164) used in Reference Example 1-1, an organic electroluminescent device was prepared , Respectively. The results are shown in Table 1. The device lifetime is represented by a relative value obtained by measuring the lifetime (h) of the device and the lifetime of the device in Reference Example 1-1 from 100.

소자 실시예 1-9Device Example 1-9

소자 참고예 1-1에 있어서, ETL-1 대신에 실시예-11에서 합성한 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(1-나프틸)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-163)을 이용한 이외에는, 소자 참고예 1-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 1에 나타내었다. 또, 소자 수명에 대해서는, 소자 수명(h)을 측정한 뒤에, 소자 참고예 1-1의 소자 수명을 100으로 한 상대값으로 나타내었다.In the same manner as in Example 1-1 except that 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridin-2-yl) -5- (Compound A-163) was used in place of the compound (A-163) used in Reference Example 1-1, an organic electroluminescent device was prepared , Respectively. The results are shown in Table 1. The device lifetime is represented by a relative value obtained by measuring the lifetime (h) of the device and the lifetime of the device in Reference Example 1-1 from 100.

소자 실시예 1-10Device Embodiment 1-10

소자 참고예 1-1에 있어서, ETL-1 대신에 실시예-14에서 합성한 4,6-다이페닐-2-[4-(2,6-다이페닐피리딘-4-일)-1,1':3',1":4",1"'-쿼터페닐-5'-일]-1,3,5-트라이아진(화합물 A-118)을 이용한 이외에는, 소자 참고예 1-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 1에 나타내었다. 또, 소자 수명에 대해서는, 소자 수명(h)을 측정한 뒤에, 소자 참고예 1-1의 소자 수명을 100으로 한 상대값으로 나타내었다.In the device Reference Example 1-1, the same procedure as in Example 1-1 was repeated except that 4,6-diphenyl-2- [4- (2,6-diphenylpyridin-4-yl) (Compound A-118) was obtained in the same manner as in Reference Example 1-1, except that 1 ': 3', 1 ": 4" The results are shown in Table 1. The device lifetime was measured by measuring the lifetime (h) of the device and setting the lifetime of the device in Reference Example 1-1 to 100 As a relative value.

소자 실시예 1-11Device Example 1-11

소자 참고예 1-1에 있어서, ETL-1 대신에 실시예-16에서 합성한 4,6-다이페닐-2-[4'-(2,6-다이페닐피리딘-4-일)-5-(2-페닐피리딘-5-일)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-225)을 이용한 이외에는, 소자 참고예 1-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 1에 나타내었다. 또, 소자 수명에 대해서는, 소자 수명(h)을 측정한 뒤에, 소자 참고예 1-1의 소자 수명을 100으로 한 상대값으로 나타내었다.In the same manner as in Example 1-1, except that 4,6-diphenyl-2- [4 '- (2,6-diphenylpyridin-4-yl) (Compound A-225) was used in place of the compound (A-225) used in Reference Example 1-1 except for using 2-phenyl-2- The device was fabricated and evaluated. The results are shown in Table 1. The device lifetime is represented by a relative value obtained by measuring the lifetime (h) of the device and the lifetime of the device in Reference Example 1-1 from 100.

소자 실시예 1-12Device Example 1-12

소자 참고예 1-1에 있어서, ETL-1 대신에 실시예-17에서 합성한 4,6-다이페닐-2-[4'-(2,4-다이페닐피리딘-6-일)-5-(2-페닐피리딘-5-일)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-226)을 이용한 이외에는, 소자 참고예 1-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 1에 나타내었다. 또, 소자 수명에 대해서는, 소자 수명(h)을 측정한 뒤에, 소자 참고예 1-1의 소자 수명을 100으로 한 상대값으로 나타내었다.In the same manner as in Reference Example 1-1 except that ETL-1 was used instead of 4,6-diphenyl-2- [4 '- (2,4-diphenylpyridin-6-yl) (Compound A-226) was used in place of the compound (A-226) used in Reference Example 1-1, the organic electroluminescence The device was fabricated and evaluated. The results are shown in Table 1. The device lifetime is represented by a relative value obtained by measuring the lifetime (h) of the device and the lifetime of the device in Reference Example 1-1 from 100.

소자 실시예 1-13Device Example 1-13

소자 참고예 1-1에 있어서, ETL-1 대신에 실시예-18에서 합성한 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(2-피리미딜)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-73)을 이용한 이외에는, 소자 참고예 1-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 1에 나타내었다. 또, 소자 수명에 대해서는, 소자 수명(h)을 측정한 뒤에, 소자 참고예 1-1의 소자 수명을 100으로 한 상대값으로 나타내었다.In the same manner as in Example 1-1 except that 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridin-2-yl) (Compound A-73) was used in place of the compound (A-73) used in Reference Example 1-1, an organic electroluminescent device was prepared , Respectively. The results are shown in Table 1. The device lifetime is represented by a relative value obtained by measuring the lifetime (h) of the device and the lifetime of the device in Reference Example 1-1 from 100.

소자 실시예 1-14Device Example 1-14

소자 참고예 1-1에 있어서, ETL-1 대신에 실시예-19에서 합성한 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(2-피라질)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-91)을 이용한 이외에는, 소자 참고예 1-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 1에 나타내었다. 또, 소자 수명에 대해서는, 소자 수명(h)을 측정한 뒤에, 소자 참고예 1-1의 소자 수명을 100으로 한 상대값으로 나타내었다.In the same manner as in Reference Example 1-1 except that ETL-1 was replaced with 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridin-2- (Compound A-91) was used in place of the compound (A-91) used in Reference Example 1-1, an organic electroluminescent device was prepared , Respectively. The results are shown in Table 1. The device lifetime is represented by a relative value obtained by measuring the lifetime (h) of the device and the lifetime of the device in Reference Example 1-1 from 100.

Figure pct00085
Figure pct00085

소자 참고예 2-1Element Reference Example 2-1

소자 참고예 1-1에 있어서, 전자수송층(6)에 대해서, ETL-1만을 이용한 30㎚으로 층으로 한 이외에는, 소자 참고예 1-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 2에 나타내었다.An organic electroluminescent device was fabricated and evaluated in the same manner as in Reference Example 1-1 except that the electron transport layer 6 was made to have a thickness of 30 nm using only ETL-1 in Reference Example 1-1 . The results are shown in Table 2.

또, 표 2의 소자 수명(h)은, 제작한 소자를 초기 휘도 800cd/㎡로 구동했을 때의 연속 점등 시의 휘도 감쇠 시간을 측정하고, 휘도(cd/㎡)가 20% 감소될 때까지 소요된 시간을 측정하였다. 소자 수명은, 본 소자 참고예 2-1에 있어서의 소자 수명(h)을 기준값(100)으로 하였다.The device lifetime h in Table 2 was obtained by measuring the luminance decay time at the time of continuous lighting when the manufactured device was driven at an initial luminance of 800 cd / m 2, and until the luminance (cd / m 2) The time spent was measured. The device life span was the reference value (100) as the device lifetime (h) in Reference Example 2-1 of this device.

소자 실시예 2-1Device Embodiment 2-1

소자 참고예 2-1에 있어서, 전자수송층(6)에서 이용한 ETL-1 대신에, 실시예-1에서 합성한 4,6-다이페닐-2-[4-(4,6-다이페닐피리딘-2-일)-4"-(2-피리딜)-1,1':3',1"-터페닐-5'-일]-1,3,5-트라이아진(화합물 A-127)을 이용한 이외에는, 소자 참고예 2-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 2에 나타내었다.In the same manner as in Reference Reference Example 2-1, except that ETL-1 used in the electron transport layer 6 was replaced with 4,6-diphenyl-2- [4- (4,6-diphenylpyridine- Yl) -1,3,5-triazine (Compound A-127) was reacted with (2-pyridyl) An organic electroluminescent device was fabricated and evaluated in the same manner as in Reference Example 2-1. The results are shown in Table 2.

소자 실시예 2-2Device Example 2-2

소자 참고예 2-1에 있어서, 전자수송층(6)에서 이용한 ETL-1 대신에, 실시예-2에서 합성한 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(3-피리딜)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-37)을 이용한 이외에는, 소자 참고예 2-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 2에 나타내었다.In the same manner as in Reference Reference Example 2-1, except that ETL-1 used in the electron transport layer 6 was replaced with 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridine 2-yl) -5- (3-pyridyl) -biphenyl-3-yl] -1,3,5-triazine (Compound A-37) , An organic electroluminescent device was fabricated and evaluated. The results are shown in Table 2.

소자 실시예 2-3Device Embodiment 2-3

소자 참고예 2-1에 있어서, 전자수송층(6)에서 이용한 ETL-1 대신에, 실시예-4에서 합성한 4,6-다이페닐-2-[4-(4,6-다이페닐피리딘-2-일)-1,1':3',1"-터페닐-5'-일]-1,3,5-트라이아진(화합물 A-1)을 이용한 이외에는, 소자 참고예 2-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 2에 나타내었다.In the same manner as in Reference Reference Example 2-1, except that ETL-1 used in the electron transport layer 6 was replaced with 4,6-diphenyl-2- [4- (4,6-diphenylpyridine- 2-yl) -1,1 ': 3', 1 "-terphenyl-5'-yl] -1,3,5-triazine (Compound A- An organic electroluminescent device was fabricated and evaluated in the same manner. The results are shown in Table 2.

소자 실시예 2-4Device Example 2-4

소자 참고예 2-1에 있어서, 전자수송층(6)에서 이용한 ETL-1 대신에, 실시예-5에서 합성한 4,6-다이페닐-2-[4-(4,6-다이페닐피리딘-2-일)-1,1':3',1":4",1"'-쿼터페닐-5'-일]-1,3,5-트라이아진(화합물 A-109)을 이용한 이외에는, 소자 참고예 2-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 2에 나타내었다.In the same manner as in Reference Example 2-1, except that ETL-1 used in the electron transport layer 6 was replaced with 4,6-diphenyl-2- [4- (4,6-diphenylpyridine- (Compound A-109) was used instead of 2-amino-2-thiophene-2-yl) -1,1 ': 3', 1 " An organic electroluminescent device was fabricated and evaluated in the same manner as in Reference Example 2-1. The results are shown in Table 2.

소자 실시예 2-5Device Example 2-5

소자 참고예 2-1에 있어서, 전자수송층(6)에서 이용한 ETL-1 대신에, 실시예-6에서 합성한 4,6-다이페닐-2-[4-(2,6-다이페닐피리딘-4-일)-4"-(2-피리딜)-1,1':3',1"-터페닐-5'-일]-1,3,5-트라이아진(화합물 A-136)을 이용한 이외에는, 소자 참고예 2-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 2에 나타내었다.In the same manner as in Reference Reference Example 2-1, except that ETL-1 used in the electron transport layer 6 was replaced with 4,6-diphenyl-2- [4- (2,6-diphenylpyridine- Yl) -1,3,5-triazine (Compound A-136) was reacted with 4-chloro- An organic electroluminescent device was fabricated and evaluated in the same manner as in Reference Example 2-1. The results are shown in Table 2.

소자 실시예 2-6Device Example 2-6

소자 참고예 2-1에 있어서, 전자수송층(6)에서 이용한 ETL-1 대신에, 실시예-9에서 합성한 4,6-다이페닐-2-[4-(4,6-다이페닐피리딘-2-일)-4"-(3-피리딜)-1,1':3',1"-터페닐-5'-일]-1,3,5-트라이아진(화합물 A-145)을 이용한 이외에는, 소자 참고예 2-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 2에 나타내었다.In the same manner as in Reference Reference Example 2-1, except that ETL-1 used in the electron transport layer 6 was replaced with 4,6-diphenyl-2- [4- (4,6-diphenylpyridine- Yl) -1,3,5-triazine (Compound A-145) was reacted with 4-chloro- An organic electroluminescent device was fabricated and evaluated in the same manner as in Reference Example 2-1. The results are shown in Table 2.

소자 실시예 2-7Device Example 2-7

소자 참고예 2-1에 있어서, 전자수송층(6)에서 이용한 ETL-1 대신에, 실시예-10에서 합성한 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(2-나프틸)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-164)을 이용한 이외에는, 소자 참고예 2-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 2에 나타내었다.In the same manner as in Reference Reference Example 2-1, except that ETL-1 used in the electron transport layer 6 was replaced with 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridine 2-yl) -5- (2-naphthyl) -biphenyl-3-yl] -1,3,5-triazine (Compound A-164) , An organic electroluminescent device was fabricated and evaluated. The results are shown in Table 2.

소자 실시예 2-8Device Example 2-8

소자 참고예 2-1에 있어서, 전자수송층(6)에서 이용한 ETL-1 대신에, 실시예-11에서 합성한 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(1-나프틸)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-163)을 이용한 이외에는, 소자 참고예 2-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 2에 나타내었다.In the same manner as in Reference Reference Example 2-1, except that ETL-1 used in the electron transport layer 6 was replaced with 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridine 2-yl) -5- (1-naphthyl) -biphenyl-3-yl] -1,3,5-triazine (Compound A-163) , An organic electroluminescent device was fabricated and evaluated. The results are shown in Table 2.

소자 실시예 2-9Device Example 2-9

소자 참고예 2-1에 있어서, 전자수송층(6)에서 이용한 ETL-1 대신에, 실시예-14에서 합성한 4,6-다이페닐-2-[4-(2,6-다이페닐피리딘-4-일)-1,1':3',1":4",1"'-쿼터페닐-5'-일]-1,3,5-트라이아진(화합물 A-118)을 이용한 이외에는, 소자 참고예 2-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 2에 나타내었다.In the same manner as in Reference Reference Example 2-1, except that ETL-1 used in the electron transport layer 6 was replaced with 4,6-diphenyl-2- [4- (2,6-diphenylpyridine- 4-yl) -1,1 ': 3', 1 ": 4", 1 "'-tetraphenyl-5'- yl] -1,3,5- triazine (Compound A- An organic electroluminescent device was fabricated and evaluated in the same manner as in Reference Example 2-1. The results are shown in Table 2.

소자 실시예 2-10Device Example 2-10

소자 참고예 2-1에 있어서, 전자수송층(6)에서 이용한 ETL-1 대신에, 실시예-16에서 합성한 4,6-다이페닐-2-[4'-(2,6-다이페닐피리딘-4-일)-5-(2-페닐피리딘-5-일)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-225)을 이용한 이외에는, 소자 참고예 2-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 2에 나타내었다.In the same manner as in Reference Reference Example 2-1, except that ETL-1 used in the electron transport layer 6 was replaced with 4,6-diphenyl-2- [4 '- (2,6-diphenylpyridine (Compound A-225) was used in place of 2- (4-fluorophenyl) -5- 1, an organic electroluminescent device was fabricated and evaluated. The results are shown in Table 2.

소자 실시예 2-11Element Embodiments 2-11

소자 참고예 2-1에 있어서, 전자수송층(6)에서 이용한 ETL-1 대신에, 실시예-17에서 합성한 4,6-다이페닐-2-[4'-(2,4-다이페닐피리딘-6-일)-5-(2-페닐피리딘-5-일)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-226)을 이용한 이외에는, 소자 참고예 2-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 2에 나타내었다.In the same manner as in Reference Reference Example 2-1, except that ETL-1 used in the electron transport layer 6 was replaced with 4,6-diphenyl-2- [4 '- (2,4-diphenylpyridine (Compound A-226) was used in place of 2- (2-phenylpyridin-5-yl) 1, an organic electroluminescent device was fabricated and evaluated. The results are shown in Table 2.

소자 실시예 2-12Device Examples 2-12

소자 참고예 2-1에 있어서, 전자수송층(6)에서 이용한 ETL-1 대신에, 실시예-18에서 합성한 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(2-피리미딜)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-73)을 이용한 이외에는, 소자 참고예 2-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 2에 나타내었다.In the same manner as in Reference Reference Example 2-1 except that ETL-1 used in the electron transport layer 6 was replaced with 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridine 2-yl) -5- (2-pyrimidyl) -biphenyl-3-yl] -1,3,5-triazine (Compound A-73) , An organic electroluminescent device was fabricated and evaluated. The results are shown in Table 2.

소자 실시예 2-13Device Example 2-13

소자 참고예 2-1에 있어서, 전자수송층(6)에서 이용한 ETL-1 대신에, 실시예-19에서 합성한 4,6-다이페닐-2-[4'-(4,6-다이페닐피리딘-2-일)-5-(2-피라질)-바이페닐-3-일]-1,3,5-트라이아진(화합물 A-91)을 이용한 이외에는, 소자 참고예 2-1과 같은 방법으로 유기 전계발광소자를 제작하고, 평가하였다. 결과를 표 2에 나타내었다.In the same manner as in Reference Reference Example 2-1 except that ETL-1 used in the electron transport layer 6 was replaced with 4,6-diphenyl-2- [4 '- (4,6-diphenylpyridine Yl] -1,3,5-triazine (Compound A-91) was used in place of 2- , An organic electroluminescent device was fabricated and evaluated. The results are shown in Table 2.

Figure pct00086
Figure pct00086

본 발명을 상세히, 또한 특정 실시형태를 참조해서 설명했지만, 본 발명의 본질과 범위를 일탈하는 일 없이 각종 변경이나 수정을 가할 수 있는 것은 당업자에 있어서 명확하다.While the invention has been described in detail and with reference to specific embodiments thereof, it will be apparent to those skilled in the art that various changes and modifications can be made without departing from the spirit and scope of the invention.

또, 2014년 2월 21일자로 출원된 일본 특허출원 2014-32254호 및 2014년 12월 26일자로 출원된 일본 특허출원 2014-264073호의 명세서, 특허청구의 범위, 도면 및 요약서의 전체 내용을 여기에 인용하고, 본 발명의 명세서의 개시로서 받아들이는 것이다.The contents of the specification, claims, drawings and summary of Japanese Patent Application No. 2014-32254 filed on February 21, 2014 and Japanese Patent Application No. 2014-264073 filed on December 26, 2014 are hereby incorporated by reference herein. Quot ;, which is incorporated herein by reference in its entirety.

본 발명의 트라이아진 화합물(1)은 내열성이 우수하고, 해당 화합물을 이용함으로써 장수명성 및 발광 효율이 우수한 유기 전계발광소자를 제공할 수 있다.The triazine compound (1) of the present invention is excellent in heat resistance and can provide an organic electroluminescent device excellent in longevity and luminescence efficiency by using the compound.

또, 본 발명의 트라이아진 화합물(1)은, 저구동 전압이 우수한 유기 전계발광소자용 전자수송 재료로서 이용된다. 또한, 본 발명에 따르면, 소비 전력이 우수한 유기 전계발광소자를 제공할 수 있다.In addition, the triazine compound (1) of the present invention is used as an electron transporting material for an organic electroluminescence device having a low driving voltage. Further, according to the present invention, an organic electroluminescent device having excellent power consumption can be provided.

또, 본 발명의 트라이아진 화합물은, 승화 정제 시의 열안정성이 양호하므로 승화 정제의 조작성이 우수하고, 유기 전계발광소자의 소자 열화의 원인이 되는 불순물이 적은 재료를 제공할 수 있다. 또한, 본 발명의 트라이아진 화합물은 증착 막의 안정성이 우수하므로 장수명의 유기 전계발광소자를 제공할 수 있다.In addition, the triazine compound of the present invention has a good thermal stability at the time of sublimation purification, so that it is possible to provide a material which is excellent in operability of a sublimation purification and has few impurities that cause element deterioration of the organic electroluminescence device. In addition, the triazine compound of the present invention is excellent in stability of a vapor deposition film, and thus can provide an organic electroluminescent device with a long life.

또한, 본 발명의 트라이아진 화합물(1)로 이루어진 박막은, 전자 수송 능력, 정공 블록 능력, 산화환원 내성, 내수성, 내산소성, 전자 주입 특성 등이 우수하므로, 유기 전계발광소자의 재료로서 유용하고, 특히 전자수송 재료, 정공 블록 재료, 발광 호스트 재료 등으로서 유용하다. 또 본 발명의 트라이아진 화합물(1)은 와이드밴드 갭 화합물이므로, 종래의 형광소자용도뿐만 아니라, 인광소자에 적합하게 이용할 수 있다.Further, the thin film made of the triazine compound (1) of the present invention is excellent as an electron transporting ability, a hole blocking ability, an oxidation-reduction resistance, a water resistance, an acid firing and an electron injection property, , Particularly, an electron transporting material, a hole blocking material, a light emitting host material, and the like. Further, since the triazine compound (1) of the present invention is a wide band gap compound, it can be suitably used for a conventional phosphorescent device as well as a conventional phosphorescent device.

또, 일반식 (5) 또는 (9)로 표시되는 화합물, 및 그것을 이용한 일반식 (1)로 표시되는 트라이아진 화합물의 제조 방법은, 해당 일반식 (1)로 표시되는 트라이아진 화합물을 공업적으로 효율적으로 제공하기 위해서 산업상 매우 중요하다.The compound represented by the general formula (5) or (9) and the method for producing the triazine compound represented by the general formula (1) using the triazine compound represented by the general formula (1) In order to efficiently provide the information to the user.

1: ITO투명전극 부착 유리 기판
2: 정공주입층
3: 전하발생층
4: 정공수송층
5: 발광층
6: 전자수송층
7: 음극층
1: Glass substrate with ITO transparent electrode
2: Hole injection layer
3: charge generation layer
4: hole transport layer
5: light emitting layer
6: electron transport layer
7: cathode layer

Claims (21)

하기 일반식 (1)로 표시되는 트라이아진 화합물:
Figure pct00087

일반식 (1) 중,
2개의 Ar4는, 동일하며, 수소 원자, 불소 원자, 메틸기, 메톡시기 또는 페닐기를 나타내고;
Ar1 및 Ar2는, 각각 독립적으로, 탄소수 6 내지 18의 단환, 연결 혹은 축환방향족 탄화수소기 또는 6원환만으로 구성되는 탄소수 3 내지 13의 단환 혹은 축환 질소 함유 방향족 탄화수소기(이들 기는, 각각 독립적으로, 불소 원자, 탄소수 1 내지 4의 알킬기, 탄소수 1 내지 4의 알콕시기, 페닐기 또는 피리딜기로 치환되어 있어도 됨)를 나타내며;
Ar3은, 탄소수 6 내지 18의 단환, 연결 혹은 축환방향족 탄화수소기(해당 기는, 불소 원자, 탄소수 1 내지 4의 알킬기, 탄소수 1 내지 4의 알콕시기, 페닐기 또는 피리딜기로 치환되어 있어도 됨) 또는 6원환만으로 구성되는 탄소수 3 내지 13의 단환 혹은 축환 질소 함유 방향족 탄화수소기(해당 기는, 불소 원자, 탄소수 1 내지 4의 알킬기, 탄소수 1 내지 4의 알콕시기, 피리딜기, 페닐기, 나프틸기 또는 바이페닐기로 치환되어 있어도 됨)를 나타내고;
Z1 및 Z2 중 어느 한쪽이 질소 원자를 나타내고, 또 한쪽은 C-H를 나타낸다.
A triazine compound represented by the following general formula (1):
Figure pct00087

In the general formula (1)
Two Ar 4 s are the same and represent a hydrogen atom, a fluorine atom, a methyl group, a methoxy group or a phenyl group;
Ar 1 and Ar 2 each independently represent a monocyclic or a cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms which is composed of a monocyclic, a linking or a cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms or a 6-membered ring, , A fluorine atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a phenyl group, or a pyridyl group;
Ar 3 represents a monocyclic, fused or cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms (the group may be substituted by a fluorine atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a phenyl group, or a pyridyl group) A monocyclic or a cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms (the group is selected from the group consisting of a fluorine atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a pyridyl group, a phenyl group, a naphthyl group, Which may be optionally substituted;
Provided that either one of Z 1 and Z 2 represents a nitrogen atom and the other represents CH.
제1항에 있어서, 일반식 (1)' 또는 (1)"로 표시되는, 트라이아진 화합물:
Figure pct00088

일반식 (1)' 및 (1)" 중,
2개의 Ar4는, 동일하며, 제1항과 같은 의미이고;
Ar1, Ar2, Ar3, Z1 및 Z2는, 제1항과 같은 의미이다.
The triazine compound according to claim 1, which is represented by the general formula (1) 'or (1) ":
Figure pct00088

Among the general formulas (1) 'and (1)',
Two Ar 4 are identical, and means the same as Claim 1 and;
Ar 1 , Ar 2 , Ar 3 , Z 1 and Z 2 have the same meanings as in claim 1.
제1항 또는 제2항에 있어서, Ar4가 페닐기, 메틸기 또는 수소 원자인, 트라이아진 화합물.3. The triazine compound according to claim 1 or 2, wherein Ar < 4 > is a phenyl group, a methyl group or a hydrogen atom. 제1항 또는 제2항에 있어서, Ar4가, 수소 원자인, 트라이아진 화합물.3. The triazine compound according to claim 1 or 2, wherein Ar < 4 > is a hydrogen atom. 제1항 또는 제2항에 있어서, Ar1 및 Ar2가, 각각 독립적으로, 탄소수 6 내지 18의 단환, 연결 또는 축환방향족 탄화수소기(해당 기는, 불소 원자, 탄소수 1 내지 4의 알킬기, 탄소수 1 내지 4의 알콕시기, 페닐기 또는 피리딜기로 치환되어 있어도 됨)인, 트라이아진 화합물.The compound according to Claim 1 or 2, wherein Ar 1 and Ar 2 each independently represent a monocyclic, a linking or a cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms (the group includes a fluorine atom, an alkyl group having 1 to 4 carbon atoms, Or an alkoxy group of 1 to 4 carbon atoms, a phenyl group, or a pyridyl group). 제1항 또는 제2항에 있어서, Ar1 및 Ar2가, 각각 독립적으로, 페닐기, 나프틸기 또는 페난트릴기(이들 기는, 불소 원자, 메틸기, 페닐기 또는 피리딜기로 치환되어 있어도 됨)인, 트라이아진 화합물.3. The compound according to claim 1 or 2, wherein Ar 1 and Ar 2 each independently represent a phenyl group, a naphthyl group or a phenanthryl group (these groups may be substituted with a fluorine atom, a methyl group, a phenyl group or a pyridyl group) Triazine compound. 제1항 또는 제2항에 있어서, Ar1 및 Ar2가, 각각 독립적으로, 페닐기, 바이페닐기, 나프틸기 또는 페난트릴기인, 트라이아진 화합물.3. The triazine compound according to claim 1 or 2, wherein Ar 1 and Ar 2 are each independently a phenyl group, a biphenyl group, a naphthyl group or a phenanthryl group. 제1항 또는 제2항에 있어서, Ar1 및 Ar2가 페닐기인, 트라이아진 화합물.3. The triazine compound according to claim 1 or 2, wherein Ar < 1 > and Ar < 2 > 제1항 또는 제2항에 있어서, Ar3이, 탄소수 6 내지 18의 단환, 연결 혹은 축환방향족 탄화수소기(해당 기는, 페닐기 또는 피리딜기로 치환되어 있어도 됨) 또는 6원환만으로 구성되는 탄소수 3 내지 13의 단환 혹은 축환 질소 함유 방향족 탄화수소기(해당 기는, 페닐기, 바이페닐기 또는 나프틸기로 치환되어 있어도 됨)인, 트라이아진 화합물. 3. The compound according to claim 1 or 2, wherein Ar 3 is a C3-C18 monocyclic, bicyclic or tricyclic aromatic hydrocarbon group (said group may be substituted with a phenyl group or a pyridyl group) Triazine ring or thiazole ring-containing nitrogen-containing aromatic hydrocarbon group (said group may be substituted with a phenyl group, a biphenyl group or a naphthyl group). 제1항 또는 제2항에 있어서, Ar3이, 페닐기, 나프틸기 또는 바이페닐기(이들 기는, 페닐기 또는 피리딜기로 치환되어 있어도 됨) 또는 탄소수 3 내지 9의 단환 또는 축환 질소 함유 방향족 탄화수소기(해당 기는, 페닐기, 바이페닐기 또는 나프틸기로 치환되어 있어도 됨)인, 트라이아진 화합물. 3. The compound according to claim 1 or 2, wherein Ar 3 is a phenyl group, a naphthyl group or a biphenyl group (these groups may be substituted with a phenyl group or a pyridyl group), a monocyclic or a condensed ring nitrogenous aromatic hydrocarbon group having 3 to 9 carbon atoms And the corresponding group may be substituted with a phenyl group, a biphenyl group or a naphthyl group). 제1항 또는 제2항에 있어서, Ar3이, 페닐기, 바이페닐기, 터페닐기, 나프틸기, 피리딜페닐기, 피리딜기, 피라질기, 피리미딜기, 퀴놀릴기, 아이소퀴놀릴기, 페닐피리딜기, 바이페닐피리딜기, 페닐피라질기, 바이페닐피라질기, 페닐피리미딜기, 바이페닐피리미딜기, 페닐퀴놀릴기, 바이페닐퀴놀릴기 또는 페닐이소퀴놀릴기인, 트라이아진 화합물.The compound according to Claim 1 or 2, wherein Ar 3 is a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a pyridylphenyl group, a pyridyl group, a pyrazyl group, a pyrimidyl group, a quinolyl group, an isoquinolyl group, Wherein the triazine compound is a thiazine compound, wherein the triazine compound is a thiazine compound, a thiadiazole compound, a thiadiazole compound, a thiophene compound, a thiadiazole compound, 제1항 또는 제2항에 있어서, Ar3이, 페닐기, 바이페닐기, 나프틸기, 피리딜기, 페닐피리딜기, 피라질기, 피리미딜기, 퀴놀릴기 또는 아이소퀴놀릴기인, 트라이아진 화합물. 3. The triazine compound according to claim 1 or 2, wherein Ar 3 is phenyl, biphenyl, naphthyl, pyridyl, phenylpyridyl, pyrazyl, pyrimidyl, quinolyl or isoquinolyl. 제1항에 기재된 트라이아진 화합물의 제조 방법으로서,
하기 일반식 (2)로 표시되는 화합물과, 하기 일반식 (3) 및 하기 일반식 (4)로 표시되는 화합물을, 염기의 존재 하 또는 염기의 비존재 하에, 팔라듐 촉매의 존재 하에서, 순차 또는 동시에 커플링 반응시키는 것을 특징으로 하는, 트라이아진 화합물의 제조 방법:
Figure pct00089

일반식 (1), (2), (3) 및 (4) 중,
2개의 Ar4는, 동일하며, 제1항과 같은 의미이고;
Ar1, Ar2, Ar3, Z1 및 Z2는, 제1항과 같은 의미이며;
Y1 및 Y2는, 각각 독립적으로, 이탈기를 나타내고;
M1 및 M2는, 각각 독립적으로, ZnR1, MgR2, Sn(R3)3 또는 B(OR4)2를 나타내며;
단, R1 및 R2는, 각각 독립적으로, 염소 원자, 브로민 원자 또는 요오드 원자를 나타내고, R3은 탄소수 1로부터 4의 알킬기 또는 페닐기를 나타내며, R4는 수소 원자, 탄소수 1로부터 4의 알킬기 또는 페닐기를 나타내고, B(OR4)2의 2개의 R4는, 동일 또는 상이해도 되며, 또한, 2개의 R4는 일체로 되어서 산소 원자 및 붕소 원자를 포함해서 환을 형성할 수도 있다.
A process for producing a triazine compound according to claim 1,
A process for the preparation of a compound represented by the general formula (2) below, a compound represented by the following general formula (3) and a general formula (4) in the presence of a base or in the absence of a base in the presence of a palladium catalyst, And at the same time a coupling reaction is carried out.
Figure pct00089

Of the general formulas (1), (2), (3) and (4)
Two Ar 4 are identical, and means the same as Claim 1 and;
Ar 1 , Ar 2 , Ar 3 , Z 1 and Z 2 have the same meanings as in claim 1;
Y 1 and Y 2 each independently represent a leaving group;
M 1 and M 2 each independently represent ZnR 1 , MgR 2 , Sn (R 3 ) 3 or B (OR 4 ) 2 ;
However, R 1 and R 2 are, each independently, a chlorine atom, a bromine atom or an iodine atom, R 3 represents an alkyl group or a phenyl group of 4 from having 1, R 4 is a 4-from a hydrogen atom, a C 1 An alkyl group or a phenyl group, two R 4 s of B (OR 4 ) 2 may be the same or different and two R 4 s may be integral to form a ring including an oxygen atom and a boron atom.
제1항에 기재된 트라이아진 화합물의 제조 방법으로서,
하기 일반식 (5)로 표시되는 화합물과, 하기 일반식 (6)로 표시되는 화합물을, 염기의 존재 하 또는 염기의 비존재 하에, 팔라듐 촉매의 존재 하에서, 커플링 반응시키는 것을 특징으로 하는, 트라이아진 화합물의 제조 방법:
Figure pct00090

일반식 (1), (5) 및 (6) 중,
2개의 Ar4는, 동일하며, 제1항과 같은 의미이고;
Ar1, Ar2, Ar3, Z1 및 Z2는, 제1항과 같은 의미이며;
Y3은 이탈기를 나타내고;
M3은 ZnR1, MgR2, Sn(R3)3 또는 B(OR4)2를 나타내며;
단, R1 및 R2는, 각각 독립적으로, 염소 원자, 브로민 원자 또는 요오드 원자를 나타내고, R3은, 탄소수 1로부터 4의 알킬기 또는 페닐기를 나타내고, R4는 수소 원자, 탄소수 1로부터 4의 알킬기 또는 페닐기를 나타내고, B(OR4)2의 2개의 R4는, 동일 또는 상이해도 되며, 또한, 2개의 R4는 일체로 되어서 산소 원자 및 붕소 원자를 포함해서 환을 형성할 수도 있다.
A process for producing a triazine compound according to claim 1,
Characterized in that the compound represented by the following general formula (5) and the compound represented by the following general formula (6) are subjected to a coupling reaction in the presence of a base or in the absence of a base in the presence of a palladium catalyst. Method of preparing triazine compound:
Figure pct00090

Of the general formulas (1), (5) and (6)
Two Ar 4 are identical, and means the same as Claim 1 and;
Ar 1 , Ar 2 , Ar 3 , Z 1 and Z 2 have the same meanings as in claim 1;
Y 3 represents a leaving group;
M 3 represents ZnR 1 , MgR 2 , Sn (R 3 ) 3 or B (OR 4 ) 2 ;
R 1 and R 2 each independently represent a chlorine atom, a bromine atom or an iodine atom, R 3 represents an alkyl group having 1 to 4 carbon atoms or a phenyl group, R 4 represents a hydrogen atom, , Two R 4 groups of B (OR 4 ) 2 may be the same or different and two R 4 groups may be combined to form a ring including an oxygen atom and a boron atom .
제1항에 기재된 트라이아진 화합물의 제조 방법으로서,
하기 일반식 (7)로 표시되는 화합물과, 하기 일반식 (8)로 표시되는 화합물을, 염기의 존재 하 또는 염기의 비존재 하에, 팔라듐 촉매의 존재 하에서, 커플링 반응시키는 것을 특징으로 하는, 트라이아진 화합물의 제조 방법:
Figure pct00091

일반식 (1), (7),및 (8) 중,
2개의 Ar4는, 동일하며, 제1항과 같은 의미이고;
Ar1, Ar2, Ar3, Z1 및 Z2는, 제1항과 같은 의미이며;
M4는 ZnR1, MgR2, Sn(R3)3 또는 B(OR4)2를 나타내고;
단, R1 및 R2는, 각각 독립적으로, 염소 원자, 브로민 원자 또는 요오드 원자를 나타내고, R3은, 탄소수 1로부터 4의 알킬기 또는 페닐기를 나타내며, R4는 수소 원자, 탄소수 1로부터 4의 알킬기 또는 페닐기를 나타내고, B(OR4)2의 2개의 R4는, 동일 또는 상이해도 되며, 또한, 2개의 R4는 일체로 되어서 산소 원자 및 붕소 원자를 포함해서 환을 형성할 수도 있고;
Y4는 이탈기를 나타낸다.
A process for producing a triazine compound according to claim 1,
A process for producing a compound represented by the following general formula (7) and a compound represented by the following general formula (8) in the presence of a base or in the absence of a base in the presence of a palladium catalyst, Method of preparing triazine compound:
Figure pct00091

Among the general formulas (1), (7) and (8)
Two Ar 4 are identical, and means the same as Claim 1 and;
Ar 1 , Ar 2 , Ar 3 , Z 1 and Z 2 have the same meanings as in claim 1;
M 4 represents ZnR 1 , MgR 2 , Sn (R 3 ) 3 or B (OR 4 ) 2 ;
However, R 1 and R 2 are, each independently, a chlorine atom, a bromine atom or an iodine atom, R 3 is, shows a 4 alkyl group or a phenyl group from C 1, R 4 is 4 from a hydrogen atom, a C 1 , Two R 4 groups of B (OR 4 ) 2 may be the same or different and two R 4 groups may be combined to form a ring including an oxygen atom and a boron atom ;
Y 4 represents a leaving group.
제13항 내지 제15항 중 어느 한 항에 있어서, 팔라듐 촉매가 제3급 포스핀을 배위자로서 지니는 팔라듐 촉매인, 트라이아진 화합물의 제조 방법.16. The process for producing a triazine compound according to any one of claims 13 to 15, wherein the palladium catalyst is a palladium catalyst having a tertiary phosphine as a ligand. 제13항 내지 제15항 중 어느 한 항에 있어서, 팔라듐 촉매가, 트라이페닐포스핀 또는 2-다이사이클로헥실포스피노-2',4',6'-트라이아이소프로필바이페닐을 배위자로서 지니는 팔라듐 촉매인, 트라이아진 화합물의 제조 방법.16. The process according to any one of claims 13 to 15, wherein the palladium catalyst is selected from the group consisting of palladium (II) palladium (II) having triphenylphosphine or 2-dicyclohexylphosphino-2 ', 4', 6'- triisopropylbiphenyl as ligands Wherein the catalyst is a triazine compound. 하기 일반식 (9)로 표시되는 화합물:
Figure pct00092

일반식 (9) 중,
2개의 Ar4는, 동일하고, 수소 원자, 불소 원자, 메틸기, 메톡시기 또는 페닐기를 나타내고;
Ar1 및 Ar2는, 각각 독립적으로, 탄소수 6 내지 18의 단환, 연결 혹은 축환방향족 탄화수소기 또는 6원환만으로 구성되는 탄소수 3 내지 13의 단환 혹은 축환 질소 함유 방향족 탄화수소기(이들 기는, 각각 독립적으로, 불소 원자, 탄소수 1 내지 4의 알킬기, 탄소수 1 내지 4의 알콕시기, 페닐기 또는 피리딜기로 치환되어 있어도 됨)를 나타내며;
Z1 및 Z2 중 어느 한쪽이 질소 원자를 나타내고, 또 한쪽은 C-H를 나타내며;
Y2는 이탈기를 나타낸다.
A compound represented by the following general formula (9):
Figure pct00092

In the general formula (9)
Two Ar 4 are the same and represent a hydrogen atom, a fluorine atom, a methyl group, a methoxy group or a phenyl group;
Ar 1 and Ar 2 each independently represent a monocyclic or a cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms which is composed of a monocyclic, a linking or a cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms or a 6-membered ring, , A fluorine atom, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a phenyl group, or a pyridyl group;
Provided that either one of Z 1 and Z 2 represents a nitrogen atom and the other represents CH;
Y 2 represents a leaving group.
하기 일반식 (5)로 표시되는, 제14항에 기재된 화합물:
Figure pct00093

일반식 (5) 중,
2개의 Ar4는, 동일하고, 수소 원자, 불소 원자, 메틸기, 메톡시기 또는 페닐기를 나타내고;
Ar1 및 Ar2는, 각각 독립적으로, 탄소수 6 내지 18의 단환, 연결 혹은 축환방향족 탄화수소기 또는 6원환만으로 구성되는 탄소수 3 내지 13의 단환 혹은 축환 질소 함유 방향족 탄화수소기(이들 기는, 불소 원자, 탄소수 1 내지 4의 알킬기, 탄소수 1 내지 4의 알콕시기, 페닐기 또는 피리딜기로 치환되어 있어도 됨)를 나타내며;
Z1 및 Z2 중 어느 한쪽이 질소 원자를 나타내고, 또 한쪽은 C-H를 나타내고;
M3은 ZnR1, MgR2, Sn(R3)3 또는 B(OR4)2를 나타내며;
단, R1 및 R2는, 각각 독립적으로, 염소 원자, 브로민 원자 또는 요오드 원자를 나타내고, R3은, 탄소수 1로부터 4의 알킬기 또는 페닐기를 나타내고, R4는 수소 원자, 탄소수 1로부터 4의 알킬기 또는 페닐기를 나타내고, B(OR4)2의 2개의 R4는, 동일 또는 상이해도 된다. 또한, 2개의 R4는 일체로 되어서 산소 원자 및 붕소 원자를 포함해서 환을 형성할 수도 있다.
The compound according to claim 14 represented by the following formula (5):
Figure pct00093

In the general formula (5)
Two Ar 4 are the same and represent a hydrogen atom, a fluorine atom, a methyl group, a methoxy group or a phenyl group;
Ar 1 and Ar 2 each independently represent a monocyclic or a cyclic nitrogen-containing aromatic hydrocarbon group having 3 to 13 carbon atoms which is composed of a monocyclic, a linking or a cyclic aromatic hydrocarbon group having 6 to 18 carbon atoms or a 6-membered ring (these groups are fluorine, An alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 4 carbon atoms, a phenyl group, or a pyridyl group);
Provided that either one of Z 1 and Z 2 represents a nitrogen atom and the other represents CH;
M 3 represents ZnR 1 , MgR 2 , Sn (R 3 ) 3 or B (OR 4 ) 2 ;
R 1 and R 2 each independently represent a chlorine atom, a bromine atom or an iodine atom, R 3 represents an alkyl group having 1 to 4 carbon atoms or a phenyl group, R 4 represents a hydrogen atom, , And two R 4 groups of B (OR 4 ) 2 may be the same or different. The two R 4 may be monosubstituted to form a ring including an oxygen atom and a boron atom.
제1항에 기재된 트라이아진 화합물을 함유하는 것을 특징으로 하는, 유기 전계발광소자.An organic electroluminescent device comprising the triazine compound according to claim 1. 제20항에 있어서, 트라이아진 화합물을 전자수송층에 함유하는 것을 특징으로 하는, 유기 전계발광소자.21. The organic electroluminescent device according to claim 20, wherein the electron transport layer contains a triazine compound.
KR1020167022802A 2014-02-21 2015-02-18 Triazine compound and method for producing same KR102365498B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2014032254 2014-02-21
JPJP-P-2014-032254 2014-02-21
JP2014264073 2014-12-26
JPJP-P-2014-264073 2014-12-26
PCT/JP2015/054405 WO2015125814A1 (en) 2014-02-21 2015-02-18 Triazine compound and method for producing same

Publications (2)

Publication Number Publication Date
KR20160117492A true KR20160117492A (en) 2016-10-10
KR102365498B1 KR102365498B1 (en) 2022-02-21

Family

ID=53878314

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167022802A KR102365498B1 (en) 2014-02-21 2015-02-18 Triazine compound and method for producing same

Country Status (5)

Country Link
JP (1) JP6443107B2 (en)
KR (1) KR102365498B1 (en)
CN (1) CN106232592B (en)
TW (1) TW201540708A (en)
WO (1) WO2015125814A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160149041A (en) * 2015-06-17 2016-12-27 삼성에스디아이 주식회사 Organic compound for optoelectric device and organic optoelectric device and display device

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017043645A1 (en) * 2015-09-10 2017-03-16 東ソー株式会社 Cyclic azine compound, and production method, production intermediate, and use thereof
JP6638428B2 (en) * 2016-01-29 2020-01-29 東ソー株式会社 Triazine compound having phenanthridinyl group and use thereof
JP6977325B2 (en) * 2016-06-24 2021-12-08 東ソー株式会社 Triazine compounds, their manufacturing methods, and organic electroluminescent devices containing them as constituents.
JP6902859B2 (en) * 2016-12-08 2021-07-14 東ソー株式会社 Soluble azine compound and its manufacturing method, and organic electroluminescent device using it
KR101847347B1 (en) * 2017-06-30 2018-04-09 주식회사 두산 Organic compound and organic electroluminescent device using the same
KR102101473B1 (en) 2017-07-10 2020-04-16 주식회사 엘지화학 Hetero-cyclic compound and organic light emitting device comprising the same
JP7206816B2 (en) * 2018-11-01 2023-01-18 東ソー株式会社 Cyclic azine compound, material for organic electroluminescence device, electron transport material for organic electroluminescence device, and organic electroluminescence device
JP7450432B2 (en) 2020-03-30 2024-03-15 東ソー株式会社 triazine compounds
CN115703759A (en) * 2021-08-10 2023-02-17 江苏三月科技股份有限公司 Compound containing triazine and pyrimidine groups and organic electroluminescent device containing compound
CN114437032B (en) * 2021-12-31 2023-11-21 上海传勤新材料有限公司 Compound containing tetrabiphenyl and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008280330A (en) 2007-04-12 2008-11-20 Tosoh Corp Phenyl-substituted 1,3,5-triazine compound, method for producing the same, and organic electroluminescent device containing the same as component
JP2010100552A (en) * 2008-10-22 2010-05-06 Tosoh Corp Method for producing 1,3,5-triazine compound
JP2011063584A (en) 2009-08-21 2011-03-31 Tosoh Corp Triazine derivative, method for producing the same and organic electroluminescent element comprising the same as constituent component

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010103264A (en) * 2008-10-22 2010-05-06 Tosoh Corp Organic electroluminescent material and organic electroluminescent element containing the same as constituent
TWI475011B (en) * 2008-12-01 2015-03-01 Tosoh Corp 1,3,5-triazine derivatives and method for producing thereof, and organic electroluminescent elements using them as components
KR101761431B1 (en) * 2009-08-21 2017-07-25 토소가부시키가이샤 Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component
JP6034146B2 (en) * 2011-11-11 2016-11-30 東ソー株式会社 Cyclic azine compound having nitrogen-containing fused aromatic group, method for producing the same, and organic electroluminescent device comprising them as constituent components
JP6421474B2 (en) * 2013-06-28 2018-11-14 東ソー株式会社 Cyclic azine compound, method for producing the same, and organic electroluminescent device using the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008280330A (en) 2007-04-12 2008-11-20 Tosoh Corp Phenyl-substituted 1,3,5-triazine compound, method for producing the same, and organic electroluminescent device containing the same as component
JP2010100552A (en) * 2008-10-22 2010-05-06 Tosoh Corp Method for producing 1,3,5-triazine compound
JP2011063584A (en) 2009-08-21 2011-03-31 Tosoh Corp Triazine derivative, method for producing the same and organic electroluminescent element comprising the same as constituent component

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160149041A (en) * 2015-06-17 2016-12-27 삼성에스디아이 주식회사 Organic compound for optoelectric device and organic optoelectric device and display device
US10312454B2 (en) 2015-06-17 2019-06-04 Samsung Sdi Co., Ltd. Compound for organic optoelectric device, organic optoelectric device and display device

Also Published As

Publication number Publication date
CN106232592A (en) 2016-12-14
JP2016121120A (en) 2016-07-07
KR102365498B1 (en) 2022-02-21
WO2015125814A1 (en) 2015-08-27
CN106232592B (en) 2018-12-21
TW201540708A (en) 2015-11-01
JP6443107B2 (en) 2018-12-26

Similar Documents

Publication Publication Date Title
KR102365498B1 (en) Triazine compound and method for producing same
JP6822508B2 (en) A benzothienopyrimidine compound, a method for producing the same, and an organic electroluminescent device containing the same.
KR102149568B1 (en) Heterocyclic compound for organic electroluminescence element and application therefor
EP2468731B1 (en) Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component
KR101838694B1 (en) Hetero-cyclic compound and organic light emitting device using the same
CN107266481B (en) Material for organic electroluminescent element, display device, and lighting device
KR102225715B1 (en) Cyclic azine compound having adamantyl group, production method, and organic electroluminescent element containing said compound as constituent
JP5898950B2 (en) 1,3,5-triazine compound, method for producing the same, and organic electroluminescent device comprising them as constituent components
WO2014208755A1 (en) Cyclic azine compound, method for producing same, and organic electroluminescent element using same
EP2778160A1 (en) Cyclic azine compound having nitrogen-containing fused aromatic group, method for producing same, and organic electroluminescent element using same as constituent component
KR20160082067A (en) Compound and organic light emitting device using the same
KR20150018776A (en) Cyclic azine compound, method for producing same, and organic electroluminescent element containing same
CN112534593A (en) Organic light emitting diode
KR20110002155A (en) New compounds and organic electronic device using the same
JP6264877B2 (en) 1,2,4-Tris-substituted benzene compound, method for producing the same, and organic electroluminescent device
KR20170023025A (en) Triazine compound, method for producing same, and application for same
WO2018101691A1 (en) Organic light-emitting element
KR20140023283A (en) Compound containing substituted o-terphenyl structure, and organic electroluminescent element
KR20210069866A (en) Organic compound and organic electroluminescent device using the same
TW201410691A (en) Compound having triphenylsilyl pyridyl group and carbazole ring structure and organic electroluminescence device
KR20160001537A (en) Pyrazole-based compound and organic light emitting device using the same
JP2016020333A (en) Benzoquinazoline compounds, production method thereof and use thereof

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant